registry_id,year,age,age_group,sex,cancer_type,morphology,grade,basis_of_diagnosis,behavior,residence,treatment_status,vital_status,survival_months,scenario
KE-NRB-2017-00001,2017,65,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,31.2,low_burden
KE-NRB-2017-00002,2017,41,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,11.8,low_burden
KE-NRB-2011-00003,2011,30,25-34,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.5,low_burden
KE-NRB-2012-00004,2012,46,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,3.0,low_burden
KE-NRB-2011-00005,2011,72,65-74,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00006,2017,61,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.4,low_burden
KE-NRB-2012-00007,2012,56,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.1,low_burden
KE-NRB-2011-00008,2011,40,35-44,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00009,2018,42,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,14.9,low_burden
KE-NRB-2015-00010,2015,74,65-74,Male,Multiple myeloma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.4,low_burden
KE-NRB-2014-00011,2014,41,35-44,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,32.3,low_burden
KE-NRB-2017-00012,2017,46,45-54,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.4,low_burden
KE-NRB-2017-00013,2017,28,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,17.7,low_burden
KE-NRB-2009-00014,2009,50,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,5.4,low_burden
KE-NRB-2009-00015,2009,78,75+,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,4.4,low_burden
KE-NRB-2017-00016,2017,93,75+,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.4,low_burden
KE-NRB-2017-00017,2017,49,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.2,low_burden
KE-NRB-2017-00018,2017,56,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,50.2,low_burden
KE-NRB-2018-00019,2018,56,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-00020,2009,71,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.1,low_burden
KE-NRB-2014-00021,2014,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,22.6,low_burden
KE-NRB-2013-00022,2013,84,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00023,2016,44,35-44,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.0,low_burden
KE-NRB-2013-00024,2013,30,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,24.9,low_burden
KE-NRB-2016-00025,2016,33,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.3,low_burden
KE-NRB-2012-00026,2012,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,30.7,low_burden
KE-NRB-2015-00027,2015,57,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,53.4,low_burden
KE-NRB-2010-00028,2010,33,25-34,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,13.3,low_burden
KE-NRB-2015-00029,2015,56,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.1,low_burden
KE-NRB-2010-00030,2010,26,25-34,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,23.6,low_burden
KE-NRB-2013-00031,2013,35,35-44,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,31.8,low_burden
KE-NRB-2018-00032,2018,94,75+,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00033,2012,45,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Other,In situ,Urban,N/A,Dead,0.3,low_burden
KE-NRB-2018-00034,2018,58,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,39.2,low_burden
KE-NRB-2009-00035,2009,33,25-34,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,29.6,low_burden
KE-NRB-2009-00036,2009,31,25-34,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,9.3,low_burden
KE-NRB-2018-00037,2018,25,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,42.2,low_burden
KE-NRB-2016-00038,2016,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,21.5,low_burden
KE-NRB-2014-00039,2014,44,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.4,low_burden
KE-NRB-2009-00040,2009,47,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,5.6,low_burden
KE-NRB-2014-00041,2014,54,45-54,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.5,low_burden
KE-NRB-2010-00042,2010,70,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2013-00043,2013,61,55-64,Male,Non-Hodgkin lymphoma,Other specified,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-00044,2009,56,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Peri-urban,No treatment,Alive,26.9,low_burden
KE-NRB-2013-00045,2013,65,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-00046,2014,39,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,28.2,low_burden
KE-NRB-2017-00047,2017,71,65-74,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,40.4,low_burden
KE-NRB-2018-00048,2018,43,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,38.6,low_burden
KE-NRB-2016-00049,2016,91,75+,Female,Cervix uteri,Sarcoma,Unknown,Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,2.0,low_burden
KE-NRB-2016-00050,2016,61,55-64,Female,Corpus uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.2,low_burden
KE-NRB-2017-00051,2017,93,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,0.7,low_burden
KE-NRB-2013-00052,2013,29,25-34,Male,Bladder,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,11.1,low_burden
KE-NRB-2017-00053,2017,57,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,12.0,low_burden
KE-NRB-2015-00054,2015,41,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,44.8,low_burden
KE-NRB-2011-00055,2011,92,75+,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.9,low_burden
KE-NRB-2014-00056,2014,52,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-00057,2015,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.9,low_burden
KE-NRB-2017-00058,2017,51,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-00059,2018,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.2,low_burden
KE-NRB-2010-00060,2010,25,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.0,low_burden
KE-NRB-2014-00061,2014,49,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-00062,2018,49,45-54,Male,Kidney,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.4,low_burden
KE-NRB-2010-00063,2010,35,35-44,Female,Ovary,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,12.3,low_burden
KE-NRB-2018-00064,2018,60,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.4,low_burden
KE-NRB-2010-00065,2010,48,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,12.6,low_burden
KE-NRB-2016-00066,2016,55,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Palliative care only,Dead,20.7,low_burden
KE-NRB-2016-00067,2016,29,25-34,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-00068,2015,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,17.6,low_burden
KE-NRB-2014-00069,2014,71,65-74,Male,Bladder,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2016-00070,2016,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,12.9,low_burden
KE-NRB-2010-00071,2010,69,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,12.0,low_burden
KE-NRB-2015-00072,2015,45,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,26.0,low_burden
KE-NRB-2010-00073,2010,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2014-00074,2014,37,35-44,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Rural,N/A,Lost to follow-up,5.3,low_burden
KE-NRB-2011-00075,2011,59,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,51.3,low_burden
KE-NRB-2012-00076,2012,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-00077,2011,46,45-54,Female,Thyroid,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00078,2018,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2011-00079,2011,36,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.9,low_burden
KE-NRB-2018-00080,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,low_burden
KE-NRB-2017-00081,2017,86,75+,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.2,low_burden
KE-NRB-2013-00082,2013,39,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,14.0,low_burden
KE-NRB-2017-00083,2017,47,45-54,Male,Skin (melanoma),Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,15.4,low_burden
KE-NRB-2015-00084,2015,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.3,low_burden
KE-NRB-2016-00085,2016,23,15-24,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.6,low_burden
KE-NRB-2016-00086,2016,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,54.2,low_burden
KE-NRB-2016-00087,2016,52,45-54,Male,Lung,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,23.9,low_burden
KE-NRB-2012-00088,2012,73,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2012-00089,2012,58,55-64,Male,Oesophagus,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.2,low_burden
KE-NRB-2017-00090,2017,49,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,28.7,low_burden
KE-NRB-2017-00091,2017,67,65-74,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,33.9,low_burden
KE-NRB-2010-00092,2010,88,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,21.3,low_burden
KE-NRB-2014-00093,2014,72,65-74,Male,Liver,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,0.6,low_burden
KE-NRB-2009-00094,2009,73,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-00095,2010,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,low_burden
KE-NRB-2010-00096,2010,37,35-44,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,56.6,low_burden
KE-NRB-2018-00097,2018,39,35-44,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.5,low_burden
KE-NRB-2014-00098,2014,51,45-54,Male,Multiple myeloma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2010-00099,2010,40,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,35.8,low_burden
KE-NRB-2011-00100,2011,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.3,low_burden
KE-NRB-2013-00101,2013,59,55-64,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.3,low_burden
KE-NRB-2017-00102,2017,79,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Lost to follow-up,16.7,low_burden
KE-NRB-2014-00103,2014,53,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,16.7,low_burden
KE-NRB-2014-00104,2014,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.9,low_burden
KE-NRB-2013-00105,2013,28,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.8,low_burden
KE-NRB-2016-00106,2016,78,75+,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-00107,2017,49,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.3,low_burden
KE-NRB-2015-00108,2015,75,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,57.6,low_burden
KE-NRB-2018-00109,2018,54,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,13.4,low_burden
KE-NRB-2014-00110,2014,38,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.4,low_burden
KE-NRB-2013-00111,2013,79,75+,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.8,low_burden
KE-NRB-2009-00112,2009,83,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,60.0,low_burden
KE-NRB-2010-00113,2010,74,65-74,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,5.7,low_burden
KE-NRB-2012-00114,2012,26,25-34,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Rural,Surgery only,Dead,30.0,low_burden
KE-NRB-2015-00115,2015,84,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.6,low_burden
KE-NRB-2018-00116,2018,22,15-24,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,1.5,low_burden
KE-NRB-2011-00117,2011,36,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.0,low_burden
KE-NRB-2010-00118,2010,50,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.0,low_burden
KE-NRB-2012-00119,2012,42,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,41.9,low_burden
KE-NRB-2014-00120,2014,64,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Radiotherapy only,Alive,6.5,low_burden
KE-NRB-2016-00121,2016,49,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,46.7,low_burden
KE-NRB-2014-00122,2014,51,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.8,low_burden
KE-NRB-2018-00123,2018,38,35-44,Male,Liver,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,2.5,low_burden
KE-NRB-2013-00124,2013,57,55-64,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,9.3,low_burden
KE-NRB-2013-00125,2013,48,45-54,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.5,low_burden
KE-NRB-2017-00126,2017,48,45-54,Female,Corpus uteri,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,9.3,low_burden
KE-NRB-2010-00127,2010,49,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,25.6,low_burden
KE-NRB-2013-00128,2013,39,35-44,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00129,2014,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,12.5,low_burden
KE-NRB-2018-00130,2018,46,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,53.1,low_burden
KE-NRB-2018-00131,2018,43,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,34.5,low_burden
KE-NRB-2017-00132,2017,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00133,2011,47,45-54,Male,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.0,low_burden
KE-NRB-2012-00134,2012,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.9,low_burden
KE-NRB-2009-00135,2009,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,52.8,low_burden
KE-NRB-2017-00136,2017,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.4,low_burden
KE-NRB-2016-00137,2016,52,45-54,Female,Other,Other specified,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,17.2,low_burden
KE-NRB-2018-00138,2018,46,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-00139,2013,64,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.6,low_burden
KE-NRB-2013-00140,2013,33,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-00141,2012,18,15-24,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.1,low_burden
KE-NRB-2017-00142,2017,64,55-64,Male,Oesophagus,Other specified,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,13.5,low_burden
KE-NRB-2010-00143,2010,25,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-00144,2014,46,45-54,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,33.8,low_burden
KE-NRB-2010-00145,2010,42,35-44,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.9,low_burden
KE-NRB-2011-00146,2011,57,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,11.5,low_burden
KE-NRB-2017-00147,2017,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.3,low_burden
KE-NRB-2014-00148,2014,49,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00149,2016,64,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,20.4,low_burden
KE-NRB-2014-00150,2014,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2016-00151,2016,81,75+,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,46.8,low_burden
KE-NRB-2012-00152,2012,57,55-64,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.9,low_burden
KE-NRB-2017-00153,2017,36,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-00154,2009,42,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.8,low_burden
KE-NRB-2015-00155,2015,43,35-44,Male,Brain and CNS,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.3,low_burden
KE-NRB-2013-00156,2013,21,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00157,2012,40,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2009-00158,2009,84,75+,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.2,low_burden
KE-NRB-2011-00159,2011,32,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,16.4,low_burden
KE-NRB-2012-00160,2012,90,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,27.7,low_burden
KE-NRB-2012-00161,2012,86,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2015-00162,2015,46,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,0.3,low_burden
KE-NRB-2012-00163,2012,51,45-54,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.0,low_burden
KE-NRB-2014-00164,2014,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,14.0,low_burden
KE-NRB-2018-00165,2018,57,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,27.5,low_burden
KE-NRB-2011-00166,2011,91,75+,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,5.2,low_burden
KE-NRB-2018-00167,2018,55,55-64,Male,Stomach,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,7.3,low_burden
KE-NRB-2017-00168,2017,45,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-00169,2012,48,45-54,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,54.4,low_burden
KE-NRB-2010-00170,2010,72,65-74,Male,Oesophagus,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.8,low_burden
KE-NRB-2015-00171,2015,39,35-44,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.9,low_burden
KE-NRB-2011-00172,2011,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,60.0,low_burden
KE-NRB-2015-00173,2015,65,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,7.2,low_burden
KE-NRB-2016-00174,2016,72,65-74,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.1,low_burden
KE-NRB-2013-00175,2013,66,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.6,low_burden
KE-NRB-2015-00176,2015,67,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-00177,2015,94,75+,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-00178,2010,66,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,21.9,low_burden
KE-NRB-2018-00179,2018,74,65-74,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,50.2,low_burden
KE-NRB-2012-00180,2012,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,1.8,low_burden
KE-NRB-2013-00181,2013,49,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,36.9,low_burden
KE-NRB-2015-00182,2015,47,45-54,Female,Ovary,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,31.5,low_burden
KE-NRB-2014-00183,2014,55,55-64,Male,Skin (melanoma),Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2009-00184,2009,36,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-00185,2017,46,45-54,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00186,2018,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,8.6,low_burden
KE-NRB-2013-00187,2013,46,45-54,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,36.8,low_burden
KE-NRB-2018-00188,2018,37,35-44,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,43.1,low_burden
KE-NRB-2013-00189,2013,28,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,0.9,low_burden
KE-NRB-2009-00190,2009,36,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.1,low_burden
KE-NRB-2014-00191,2014,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.0,low_burden
KE-NRB-2011-00192,2011,61,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2009-00193,2009,33,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.2,low_burden
KE-NRB-2015-00194,2015,70,65-74,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,25.7,low_burden
KE-NRB-2018-00195,2018,54,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.6,low_burden
KE-NRB-2010-00196,2010,59,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,35.0,low_burden
KE-NRB-2018-00197,2018,59,55-64,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.2,low_burden
KE-NRB-2015-00198,2015,59,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.0,low_burden
KE-NRB-2018-00199,2018,28,25-34,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,33.7,low_burden
KE-NRB-2015-00200,2015,30,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,33.0,low_burden
KE-NRB-2013-00201,2013,70,65-74,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,42.6,low_burden
KE-NRB-2012-00202,2012,46,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Dead,22.8,low_burden
KE-NRB-2016-00203,2016,53,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.1,low_burden
KE-NRB-2013-00204,2013,66,65-74,Female,Breast,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,low_burden
KE-NRB-2018-00205,2018,66,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.9,low_burden
KE-NRB-2013-00206,2013,58,55-64,Male,Liver,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.8,low_burden
KE-NRB-2015-00207,2015,57,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,40.2,low_burden
KE-NRB-2017-00208,2017,60,55-64,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Alive,1.1,low_burden
KE-NRB-2014-00209,2014,37,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,24.4,low_burden
KE-NRB-2018-00210,2018,49,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.0,low_burden
KE-NRB-2018-00211,2018,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,13.2,low_burden
KE-NRB-2018-00212,2018,52,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.9,low_burden
KE-NRB-2014-00213,2014,37,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.2,low_burden
KE-NRB-2017-00214,2017,73,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,3.4,low_burden
KE-NRB-2012-00215,2012,54,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Dead,11.1,low_burden
KE-NRB-2013-00216,2013,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,18.0,low_burden
KE-NRB-2012-00217,2012,42,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Dead,10.0,low_burden
KE-NRB-2017-00218,2017,51,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.6,low_burden
KE-NRB-2011-00219,2011,76,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,14.2,low_burden
KE-NRB-2017-00220,2017,47,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,10.3,low_burden
KE-NRB-2013-00221,2013,52,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00222,2011,46,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.2,low_burden
KE-NRB-2016-00223,2016,62,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,1.7,low_burden
KE-NRB-2017-00224,2017,34,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.3,low_burden
KE-NRB-2013-00225,2013,57,55-64,Male,Leukemia,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,22.4,low_burden
KE-NRB-2016-00226,2016,61,55-64,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.8,low_burden
KE-NRB-2011-00227,2011,17,15-24,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.3,low_burden
KE-NRB-2016-00228,2016,93,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.0,low_burden
KE-NRB-2017-00229,2017,64,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.0,low_burden
KE-NRB-2012-00230,2012,71,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Dead,15.9,low_burden
KE-NRB-2017-00231,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,34.7,low_burden
KE-NRB-2014-00232,2014,40,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.6,low_burden
KE-NRB-2013-00233,2013,39,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,37.0,low_burden
KE-NRB-2010-00234,2010,35,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemotherapy only,Dead,52.7,low_burden
KE-NRB-2009-00235,2009,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-00236,2018,42,35-44,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.5,low_burden
KE-NRB-2015-00237,2015,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,4.9,low_burden
KE-NRB-2012-00238,2012,49,45-54,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,11.3,low_burden
KE-NRB-2011-00239,2011,41,35-44,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.7,low_burden
KE-NRB-2011-00240,2011,64,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,28.8,low_burden
KE-NRB-2012-00241,2012,56,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,13.1,low_burden
KE-NRB-2015-00242,2015,55,55-64,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-00243,2015,32,25-34,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.5,low_burden
KE-NRB-2012-00244,2012,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-00245,2010,36,35-44,Male,Kidney,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,21.8,low_burden
KE-NRB-2017-00246,2017,54,45-54,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,5.3,low_burden
KE-NRB-2015-00247,2015,40,35-44,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2014-00248,2014,80,75+,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,10.7,low_burden
KE-NRB-2010-00249,2010,73,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,40.2,low_burden
KE-NRB-2018-00250,2018,32,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,21.3,low_burden
KE-NRB-2016-00251,2016,52,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.7,low_burden
KE-NRB-2016-00252,2016,41,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-00253,2018,70,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,23.8,low_burden
KE-NRB-2018-00254,2018,65,65-74,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,1.4,low_burden
KE-NRB-2011-00255,2011,33,25-34,Male,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.1,low_burden
KE-NRB-2011-00256,2011,55,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,0.5,low_burden
KE-NRB-2014-00257,2014,43,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,13.1,low_burden
KE-NRB-2009-00258,2009,59,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,14.4,low_burden
KE-NRB-2016-00259,2016,45,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-00260,2013,45,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,0.5,low_burden
KE-NRB-2016-00261,2016,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,21.4,low_burden
KE-NRB-2018-00262,2018,66,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,13.2,low_burden
KE-NRB-2012-00263,2012,17,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00264,2012,73,65-74,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.9,low_burden
KE-NRB-2015-00265,2015,31,25-34,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.6,low_burden
KE-NRB-2013-00266,2013,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.6,low_burden
KE-NRB-2012-00267,2012,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2012-00268,2012,55,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.9,low_burden
KE-NRB-2014-00269,2014,50,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.9,low_burden
KE-NRB-2015-00270,2015,67,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.3,low_burden
KE-NRB-2010-00271,2010,47,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.4,low_burden
KE-NRB-2013-00272,2013,59,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-00273,2009,47,45-54,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.3,low_burden
KE-NRB-2012-00274,2012,64,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,1.3,low_burden
KE-NRB-2017-00275,2017,65,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.5,low_burden
KE-NRB-2012-00276,2012,63,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Radiotherapy only,Alive,31.5,low_burden
KE-NRB-2010-00277,2010,69,65-74,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.8,low_burden
KE-NRB-2015-00278,2015,43,35-44,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,33.0,low_burden
KE-NRB-2015-00279,2015,16,15-24,Male,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.7,low_burden
KE-NRB-2017-00280,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,28.4,low_burden
KE-NRB-2017-00281,2017,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.4,low_burden
KE-NRB-2014-00282,2014,8,0-14,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,12.4,low_burden
KE-NRB-2015-00283,2015,64,55-64,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2018-00284,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.9,low_burden
KE-NRB-2014-00285,2014,38,35-44,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.4,low_burden
KE-NRB-2011-00286,2011,73,65-74,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-00287,2017,46,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00288,2011,70,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,56.5,low_burden
KE-NRB-2013-00289,2013,42,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,45.6,low_burden
KE-NRB-2017-00290,2017,72,65-74,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,16.4,low_burden
KE-NRB-2014-00291,2014,35,35-44,Male,Oesophagus,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,low_burden
KE-NRB-2015-00292,2015,60,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,39.8,low_burden
KE-NRB-2017-00293,2017,62,55-64,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-00294,2010,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.3,low_burden
KE-NRB-2013-00295,2013,72,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.8,low_burden
KE-NRB-2012-00296,2012,67,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-00297,2012,72,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,31.3,low_burden
KE-NRB-2010-00298,2010,93,75+,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.2,low_burden
KE-NRB-2009-00299,2009,52,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.4,low_burden
KE-NRB-2017-00300,2017,93,75+,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,40.2,low_burden
KE-NRB-2017-00301,2017,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,12.8,low_burden
KE-NRB-2011-00302,2011,42,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,24.5,low_burden
KE-NRB-2012-00303,2012,40,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,12.9,low_burden
KE-NRB-2011-00304,2011,47,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,10.9,low_burden
KE-NRB-2018-00305,2018,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,25.4,low_burden
KE-NRB-2012-00306,2012,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.2,low_burden
KE-NRB-2016-00307,2016,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.4,low_burden
KE-NRB-2018-00308,2018,59,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2017-00309,2017,50,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.0,low_burden
KE-NRB-2014-00310,2014,35,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,18.3,low_burden
KE-NRB-2018-00311,2018,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-00312,2014,32,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.2,low_burden
KE-NRB-2016-00313,2016,53,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00314,2018,47,45-54,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,51.6,low_burden
KE-NRB-2015-00315,2015,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,32.1,low_burden
KE-NRB-2016-00316,2016,71,65-74,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,54.7,low_burden
KE-NRB-2015-00317,2015,62,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,5.7,low_burden
KE-NRB-2018-00318,2018,59,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.1,low_burden
KE-NRB-2011-00319,2011,63,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Dead,19.3,low_burden
KE-NRB-2010-00320,2010,78,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.0,low_burden
KE-NRB-2014-00321,2014,45,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.0,low_burden
KE-NRB-2016-00322,2016,46,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2014-00323,2014,45,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.4,low_burden
KE-NRB-2015-00324,2015,47,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,31.2,low_burden
KE-NRB-2012-00325,2012,28,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Dead,26.1,low_burden
KE-NRB-2018-00326,2018,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,13.2,low_burden
KE-NRB-2017-00327,2017,90,75+,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,31.1,low_burden
KE-NRB-2017-00328,2017,39,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,4.0,low_burden
KE-NRB-2016-00329,2016,42,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,47.7,low_burden
KE-NRB-2013-00330,2013,58,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-00331,2017,37,35-44,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,47.4,low_burden
KE-NRB-2010-00332,2010,58,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00333,2017,52,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Radiotherapy only,Dead,27.5,low_burden
KE-NRB-2016-00334,2016,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.2,low_burden
KE-NRB-2015-00335,2015,50,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.8,low_burden
KE-NRB-2015-00336,2015,69,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.5,low_burden
KE-NRB-2009-00337,2009,51,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2018-00338,2018,29,25-34,Female,Thyroid,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.6,low_burden
KE-NRB-2016-00339,2016,74,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00340,2017,37,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.7,low_burden
KE-NRB-2016-00341,2016,80,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,45.6,low_burden
KE-NRB-2012-00342,2012,21,15-24,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,20.5,low_burden
KE-NRB-2017-00343,2017,50,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.0,low_burden
KE-NRB-2017-00344,2017,22,15-24,Male,Stomach,Other specified,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,60.0,low_burden
KE-NRB-2015-00345,2015,70,65-74,Female,Other,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,21.2,low_burden
KE-NRB-2017-00346,2017,62,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.1,low_burden
KE-NRB-2018-00347,2018,27,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.8,low_burden
KE-NRB-2016-00348,2016,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,42.1,low_burden
KE-NRB-2012-00349,2012,6,0-14,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.4,low_burden
KE-NRB-2015-00350,2015,71,65-74,Male,Other,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,1.6,low_burden
KE-NRB-2009-00351,2009,73,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,3.2,low_burden
KE-NRB-2017-00352,2017,26,25-34,Male,Pancreas,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,9.7,low_burden
KE-NRB-2012-00353,2012,63,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.0,low_burden
KE-NRB-2011-00354,2011,44,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.0,low_burden
KE-NRB-2018-00355,2018,43,35-44,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2011-00356,2011,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.5,low_burden
KE-NRB-2013-00357,2013,67,65-74,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-00358,2012,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,35.5,low_burden
KE-NRB-2015-00359,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,14.4,low_burden
KE-NRB-2014-00360,2014,17,15-24,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.3,low_burden
KE-NRB-2017-00361,2017,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,6.7,low_burden
KE-NRB-2016-00362,2016,48,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,60.0,low_burden
KE-NRB-2012-00363,2012,38,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,3.0,low_burden
KE-NRB-2013-00364,2013,52,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,51.1,low_burden
KE-NRB-2011-00365,2011,42,35-44,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.7,low_burden
KE-NRB-2010-00366,2010,70,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,9.3,low_burden
KE-NRB-2016-00367,2016,46,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,11.7,low_burden
KE-NRB-2012-00368,2012,35,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.5,low_burden
KE-NRB-2016-00369,2016,61,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,32.2,low_burden
KE-NRB-2013-00370,2013,44,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,14.0,low_burden
KE-NRB-2017-00371,2017,60,55-64,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,6.0,low_burden
KE-NRB-2018-00372,2018,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,15.2,low_burden
KE-NRB-2017-00373,2017,26,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,49.1,low_burden
KE-NRB-2015-00374,2015,95,75+,Male,Kaposi sarcoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.2,low_burden
KE-NRB-2014-00375,2014,42,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.1,low_burden
KE-NRB-2012-00376,2012,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00377,2018,59,55-64,Male,Bladder,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-00378,2012,46,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.4,low_burden
KE-NRB-2009-00379,2009,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,2.9,low_burden
KE-NRB-2013-00380,2013,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,7.4,low_burden
KE-NRB-2010-00381,2010,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,15.7,low_burden
KE-NRB-2011-00382,2011,48,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.5,low_burden
KE-NRB-2018-00383,2018,43,35-44,Male,Skin (melanoma),Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.4,low_burden
KE-NRB-2010-00384,2010,54,45-54,Male,Lung,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.5,low_burden
KE-NRB-2014-00385,2014,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.3,low_burden
KE-NRB-2016-00386,2016,54,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.3,low_burden
KE-NRB-2018-00387,2018,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.8,low_burden
KE-NRB-2013-00388,2013,44,35-44,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,low_burden
KE-NRB-2014-00389,2014,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,53.2,low_burden
KE-NRB-2015-00390,2015,40,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.0,low_burden
KE-NRB-2012-00391,2012,56,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2013-00392,2013,38,35-44,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00393,2014,20,15-24,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2016-00394,2016,37,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.7,low_burden
KE-NRB-2015-00395,2015,52,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.2,low_burden
KE-NRB-2012-00396,2012,53,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,11.5,low_burden
KE-NRB-2015-00397,2015,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.4,low_burden
KE-NRB-2016-00398,2016,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00399,2012,61,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.7,low_burden
KE-NRB-2015-00400,2015,52,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-00401,2012,70,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.8,low_burden
KE-NRB-2013-00402,2013,57,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-00403,2018,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,59.2,low_burden
KE-NRB-2016-00404,2016,58,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.2,low_burden
KE-NRB-2009-00405,2009,71,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00406,2014,51,45-54,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,20.5,low_burden
KE-NRB-2009-00407,2009,65,65-74,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,17.3,low_burden
KE-NRB-2013-00408,2013,35,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-00409,2010,35,35-44,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,low_burden
KE-NRB-2016-00410,2016,40,35-44,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,6.8,low_burden
KE-NRB-2013-00411,2013,39,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.0,low_burden
KE-NRB-2017-00412,2017,50,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.9,low_burden
KE-NRB-2015-00413,2015,53,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,45.6,low_burden
KE-NRB-2015-00414,2015,26,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.2,low_burden
KE-NRB-2018-00415,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,45.7,low_burden
KE-NRB-2015-00416,2015,78,75+,Male,Colorectum,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.3,low_burden
KE-NRB-2014-00417,2014,28,25-34,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,52.3,low_burden
KE-NRB-2016-00418,2016,45,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,4.8,low_burden
KE-NRB-2011-00419,2011,64,55-64,Male,Pancreas,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-00420,2015,60,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,3.4,low_burden
KE-NRB-2011-00421,2011,48,45-54,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2014-00422,2014,46,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-00423,2011,35,35-44,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-00424,2015,47,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.5,low_burden
KE-NRB-2010-00425,2010,69,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-00426,2013,52,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,5.3,low_burden
KE-NRB-2017-00427,2017,62,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,15.7,low_burden
KE-NRB-2013-00428,2013,46,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Alive,5.7,low_burden
KE-NRB-2015-00429,2015,60,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,3.5,low_burden
KE-NRB-2016-00430,2016,48,45-54,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.1,low_burden
KE-NRB-2011-00431,2011,72,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.0,low_burden
KE-NRB-2017-00432,2017,49,45-54,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.5,low_burden
KE-NRB-2018-00433,2018,61,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,8.5,low_burden
KE-NRB-2018-00434,2018,88,75+,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,4.7,low_burden
KE-NRB-2016-00435,2016,56,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,10.6,low_burden
KE-NRB-2014-00436,2014,57,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.9,low_burden
KE-NRB-2016-00437,2016,52,45-54,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.7,low_burden
KE-NRB-2011-00438,2011,46,45-54,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.5,low_burden
KE-NRB-2016-00439,2016,71,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.9,low_burden
KE-NRB-2018-00440,2018,34,25-34,Male,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,31.3,low_burden
KE-NRB-2009-00441,2009,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,5.1,low_burden
KE-NRB-2016-00442,2016,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,57.7,low_burden
KE-NRB-2010-00443,2010,50,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,6.9,low_burden
KE-NRB-2014-00444,2014,40,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemotherapy only,Alive,9.8,low_burden
KE-NRB-2011-00445,2011,29,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.6,low_burden
KE-NRB-2013-00446,2013,88,75+,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.2,low_burden
KE-NRB-2018-00447,2018,36,35-44,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,9.5,low_burden
KE-NRB-2013-00448,2013,95,75+,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,9.1,low_burden
KE-NRB-2012-00449,2012,51,45-54,Male,Pancreas,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.0,low_burden
KE-NRB-2011-00450,2011,36,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,6.1,low_burden
KE-NRB-2010-00451,2010,57,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.1,low_burden
KE-NRB-2014-00452,2014,53,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,3.9,low_burden
KE-NRB-2015-00453,2015,69,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.4,low_burden
KE-NRB-2016-00454,2016,44,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.2,low_burden
KE-NRB-2015-00455,2015,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-00456,2009,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.8,low_burden
KE-NRB-2018-00457,2018,56,55-64,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,34.6,low_burden
KE-NRB-2011-00458,2011,58,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,43.6,low_burden
KE-NRB-2018-00459,2018,57,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.4,low_burden
KE-NRB-2017-00460,2017,62,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,1.5,low_burden
KE-NRB-2017-00461,2017,34,25-34,Male,Leukemia,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2016-00462,2016,42,35-44,Male,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.4,low_burden
KE-NRB-2018-00463,2018,39,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,32.7,low_burden
KE-NRB-2016-00464,2016,54,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,55.1,low_burden
KE-NRB-2018-00465,2018,47,45-54,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.6,low_burden
KE-NRB-2017-00466,2017,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,12.6,low_burden
KE-NRB-2012-00467,2012,61,55-64,Male,Brain and CNS,Adenocarcinoma,Unknown,Other,Malignant,Peri-urban,Surgery only,Dead,4.9,low_burden
KE-NRB-2017-00468,2017,50,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.4,low_burden
KE-NRB-2013-00469,2013,61,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,2.2,low_burden
KE-NRB-2016-00470,2016,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.0,low_burden
KE-NRB-2013-00471,2013,62,55-64,Male,Liver,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.9,low_burden
KE-NRB-2015-00472,2015,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,2.9,low_burden
KE-NRB-2017-00473,2017,66,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.5,low_burden
KE-NRB-2016-00474,2016,55,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.2,low_burden
KE-NRB-2011-00475,2011,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,9.7,low_burden
KE-NRB-2011-00476,2011,26,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,11.9,low_burden
KE-NRB-2010-00477,2010,22,15-24,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,6.5,low_burden
KE-NRB-2015-00478,2015,36,35-44,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,9.9,low_burden
KE-NRB-2015-00479,2015,72,65-74,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.4,low_burden
KE-NRB-2013-00480,2013,73,65-74,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,7.9,low_burden
KE-NRB-2016-00481,2016,50,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.8,low_burden
KE-NRB-2014-00482,2014,59,55-64,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.1,low_burden
KE-NRB-2017-00483,2017,35,35-44,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00484,2014,61,55-64,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,12.2,low_burden
KE-NRB-2010-00485,2010,40,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Dead,0.4,low_burden
KE-NRB-2016-00486,2016,25,25-34,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,37.3,low_burden
KE-NRB-2017-00487,2017,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,60.0,low_burden
KE-NRB-2012-00488,2012,46,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-00489,2014,45,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,14.4,low_burden
KE-NRB-2011-00490,2011,53,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.1,low_burden
KE-NRB-2017-00491,2017,61,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2012-00492,2012,58,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,8.8,low_burden
KE-NRB-2016-00493,2016,62,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,32.0,low_burden
KE-NRB-2010-00494,2010,36,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00495,2016,27,25-34,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,59.0,low_burden
KE-NRB-2012-00496,2012,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,50.2,low_burden
KE-NRB-2013-00497,2013,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00498,2016,53,45-54,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,5.9,low_burden
KE-NRB-2013-00499,2013,47,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.3,low_burden
KE-NRB-2016-00500,2016,44,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-00501,2011,76,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2009-00502,2009,50,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,51.2,low_burden
KE-NRB-2015-00503,2015,61,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.4,low_burden
KE-NRB-2013-00504,2013,46,45-54,Male,Pancreas,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.1,low_burden
KE-NRB-2018-00505,2018,57,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.1,low_burden
KE-NRB-2014-00506,2014,68,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.4,low_burden
KE-NRB-2014-00507,2014,63,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,34.6,low_burden
KE-NRB-2010-00508,2010,55,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Palliative care only,Lost to follow-up,13.6,low_burden
KE-NRB-2017-00509,2017,62,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.9,low_burden
KE-NRB-2013-00510,2013,37,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,28.6,low_burden
KE-NRB-2012-00511,2012,67,65-74,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,low_burden
KE-NRB-2014-00512,2014,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,16.9,low_burden
KE-NRB-2012-00513,2012,83,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,12.2,low_burden
KE-NRB-2018-00514,2018,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,18.7,low_burden
KE-NRB-2015-00515,2015,67,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-00516,2018,55,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,54.1,low_burden
KE-NRB-2013-00517,2013,55,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,4.9,low_burden
KE-NRB-2016-00518,2016,42,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,40.6,low_burden
KE-NRB-2011-00519,2011,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.2,low_burden
KE-NRB-2014-00520,2014,28,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,52.3,low_burden
KE-NRB-2017-00521,2017,35,35-44,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,48.1,low_burden
KE-NRB-2017-00522,2017,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,10.1,low_burden
KE-NRB-2016-00523,2016,72,65-74,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,57.7,low_burden
KE-NRB-2017-00524,2017,69,65-74,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-00525,2017,65,65-74,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.1,low_burden
KE-NRB-2017-00526,2017,75,75+,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,31.0,low_burden
KE-NRB-2016-00527,2016,38,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,41.1,low_burden
KE-NRB-2010-00528,2010,81,75+,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,28.3,low_burden
KE-NRB-2012-00529,2012,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,3.1,low_burden
KE-NRB-2011-00530,2011,67,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,16.4,low_burden
KE-NRB-2015-00531,2015,62,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,40.2,low_burden
KE-NRB-2018-00532,2018,63,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,17.7,low_burden
KE-NRB-2016-00533,2016,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.5,low_burden
KE-NRB-2016-00534,2016,74,65-74,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,9.8,low_burden
KE-NRB-2014-00535,2014,35,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.3,low_burden
KE-NRB-2016-00536,2016,27,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.1,low_burden
KE-NRB-2017-00537,2017,52,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Dead,15.6,low_burden
KE-NRB-2015-00538,2015,61,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.1,low_burden
KE-NRB-2016-00539,2016,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-00540,2009,56,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,1.6,low_burden
KE-NRB-2014-00541,2014,73,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.3,low_burden
KE-NRB-2010-00542,2010,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,28.7,low_burden
KE-NRB-2017-00543,2017,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.5,low_burden
KE-NRB-2017-00544,2017,71,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,60.0,low_burden
KE-NRB-2013-00545,2013,48,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.1,low_burden
KE-NRB-2017-00546,2017,45,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,49.8,low_burden
KE-NRB-2013-00547,2013,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,31.7,low_burden
KE-NRB-2015-00548,2015,59,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,34.7,low_burden
KE-NRB-2017-00549,2017,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00550,2014,72,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.7,low_burden
KE-NRB-2014-00551,2014,60,55-64,Male,Prostate,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,0.7,low_burden
KE-NRB-2017-00552,2017,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,24.3,low_burden
KE-NRB-2018-00553,2018,77,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,42.3,low_burden
KE-NRB-2016-00554,2016,32,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.6,low_burden
KE-NRB-2015-00555,2015,61,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.4,low_burden
KE-NRB-2013-00556,2013,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Alive,15.5,low_burden
KE-NRB-2015-00557,2015,59,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.0,low_burden
KE-NRB-2013-00558,2013,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,34.7,low_burden
KE-NRB-2016-00559,2016,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,22.4,low_burden
KE-NRB-2011-00560,2011,73,65-74,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,38.2,low_burden
KE-NRB-2015-00561,2015,37,35-44,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.1,low_burden
KE-NRB-2015-00562,2015,32,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,37.8,low_burden
KE-NRB-2015-00563,2015,34,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,32.8,low_burden
KE-NRB-2009-00564,2009,40,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Chemotherapy only,Dead,15.5,low_burden
KE-NRB-2009-00565,2009,34,25-34,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,11.7,low_burden
KE-NRB-2017-00566,2017,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,20.1,low_burden
KE-NRB-2016-00567,2016,85,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Other,Benign/uncertain,Urban,N/A,Alive,8.1,low_burden
KE-NRB-2015-00568,2015,38,35-44,Female,Ovary,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.4,low_burden
KE-NRB-2016-00569,2016,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,22.2,low_burden
KE-NRB-2012-00570,2012,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.3,low_burden
KE-NRB-2011-00571,2011,36,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-00572,2015,45,45-54,Female,Breast,Unspecified,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,29.5,low_burden
KE-NRB-2017-00573,2017,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,8.0,low_burden
KE-NRB-2012-00574,2012,46,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.3,low_burden
KE-NRB-2018-00575,2018,55,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,53.9,low_burden
KE-NRB-2017-00576,2017,86,75+,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.7,low_burden
KE-NRB-2016-00577,2016,37,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-00578,2016,62,55-64,Female,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,18.5,low_burden
KE-NRB-2015-00579,2015,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.3,low_burden
KE-NRB-2016-00580,2016,11,0-14,Male,Prostate,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.4,low_burden
KE-NRB-2014-00581,2014,48,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,low_burden
KE-NRB-2016-00582,2016,46,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.5,low_burden
KE-NRB-2015-00583,2015,64,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-00584,2011,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-00585,2017,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,9.7,low_burden
KE-NRB-2017-00586,2017,49,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.2,low_burden
KE-NRB-2018-00587,2018,57,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.8,low_burden
KE-NRB-2009-00588,2009,55,55-64,Male,Multiple myeloma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.1,low_burden
KE-NRB-2018-00589,2018,74,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2010-00590,2010,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.1,low_burden
KE-NRB-2013-00591,2013,36,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,14.0,low_burden
KE-NRB-2009-00592,2009,83,75+,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.0,low_burden
KE-NRB-2016-00593,2016,66,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,1.6,low_burden
KE-NRB-2014-00594,2014,41,35-44,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,29.0,low_burden
KE-NRB-2016-00595,2016,72,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,57.7,low_burden
KE-NRB-2015-00596,2015,63,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.1,low_burden
KE-NRB-2010-00597,2010,62,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,25.9,low_burden
KE-NRB-2013-00598,2013,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,43.9,low_burden
KE-NRB-2012-00599,2012,62,55-64,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.4,low_burden
KE-NRB-2011-00600,2011,45,45-54,Male,Skin (melanoma),Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,18.4,low_burden
KE-NRB-2011-00601,2011,54,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,14.3,low_burden
KE-NRB-2016-00602,2016,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,33.3,low_burden
KE-NRB-2010-00603,2010,46,45-54,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.4,low_burden
KE-NRB-2017-00604,2017,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.7,low_burden
KE-NRB-2017-00605,2017,68,65-74,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,32.6,low_burden
KE-NRB-2017-00606,2017,57,55-64,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,25.6,low_burden
KE-NRB-2017-00607,2017,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.6,low_burden
KE-NRB-2009-00608,2009,51,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,8.2,low_burden
KE-NRB-2013-00609,2013,52,45-54,Male,Liver,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,26.4,low_burden
KE-NRB-2015-00610,2015,64,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,7.8,low_burden
KE-NRB-2012-00611,2012,67,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2018-00612,2018,93,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Other,In situ,Urban,N/A,Alive,13.3,low_burden
KE-NRB-2012-00613,2012,44,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Dead,39.4,low_burden
KE-NRB-2017-00614,2017,72,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,19.9,low_burden
KE-NRB-2018-00615,2018,66,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,4.6,low_burden
KE-NRB-2016-00616,2016,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.9,low_burden
KE-NRB-2017-00617,2017,64,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.1,low_burden
KE-NRB-2018-00618,2018,63,55-64,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-00619,2009,67,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.7,low_burden
KE-NRB-2014-00620,2014,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,34.3,low_burden
KE-NRB-2012-00621,2012,70,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,38.2,low_burden
KE-NRB-2013-00622,2013,54,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.0,low_burden
KE-NRB-2015-00623,2015,55,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.9,low_burden
KE-NRB-2012-00624,2012,59,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-00625,2013,44,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,22.2,low_burden
KE-NRB-2010-00626,2010,51,45-54,Female,Cervix uteri,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-00627,2017,70,65-74,Male,Stomach,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.7,low_burden
KE-NRB-2012-00628,2012,12,0-14,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,36.5,low_burden
KE-NRB-2014-00629,2014,71,65-74,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,15.9,low_burden
KE-NRB-2015-00630,2015,57,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00631,2011,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-00632,2016,59,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,29.8,low_burden
KE-NRB-2018-00633,2018,69,65-74,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,57.1,low_burden
KE-NRB-2016-00634,2016,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.0,low_burden
KE-NRB-2016-00635,2016,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,1.1,low_burden
KE-NRB-2010-00636,2010,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.6,low_burden
KE-NRB-2015-00637,2015,55,55-64,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00638,2012,62,55-64,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-00639,2013,62,55-64,Male,Pancreas,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,20.1,low_burden
KE-NRB-2014-00640,2014,74,65-74,Female,Other,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Dead,24.8,low_burden
KE-NRB-2017-00641,2017,42,35-44,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.8,low_burden
KE-NRB-2012-00642,2012,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,44.0,low_burden
KE-NRB-2018-00643,2018,57,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,46.5,low_burden
KE-NRB-2016-00644,2016,43,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.6,low_burden
KE-NRB-2017-00645,2017,70,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Rural,N/A,Dead,2.3,low_burden
KE-NRB-2018-00646,2018,64,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,9.9,low_burden
KE-NRB-2014-00647,2014,95,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,38.2,low_burden
KE-NRB-2018-00648,2018,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,59.9,low_burden
KE-NRB-2018-00649,2018,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.1,low_burden
KE-NRB-2017-00650,2017,49,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,19.6,low_burden
KE-NRB-2018-00651,2018,64,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,10.2,low_burden
KE-NRB-2016-00652,2016,58,55-64,Male,Multiple myeloma,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.4,low_burden
KE-NRB-2012-00653,2012,77,75+,Female,Breast,Adenocarcinoma,Unknown,Other,Malignant,Urban,Surgery only,Dead,4.8,low_burden
KE-NRB-2017-00654,2017,39,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,1.6,low_burden
KE-NRB-2015-00655,2015,91,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,23.1,low_burden
KE-NRB-2012-00656,2012,79,75+,Male,Brain and CNS,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,19.7,low_burden
KE-NRB-2016-00657,2016,75,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,10.7,low_burden
KE-NRB-2014-00658,2014,28,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.0,low_burden
KE-NRB-2011-00659,2011,30,25-34,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,13.0,low_burden
KE-NRB-2013-00660,2013,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00661,2016,46,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.8,low_burden
KE-NRB-2013-00662,2013,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,28.6,low_burden
KE-NRB-2015-00663,2015,39,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,26.1,low_burden
KE-NRB-2016-00664,2016,49,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,25.9,low_burden
KE-NRB-2013-00665,2013,46,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,26.1,low_burden
KE-NRB-2018-00666,2018,74,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,24.0,low_burden
KE-NRB-2018-00667,2018,42,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-00668,2012,55,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Rural,Palliative care only,Alive,60.0,low_burden
KE-NRB-2013-00669,2013,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2013-00670,2013,34,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.8,low_burden
KE-NRB-2016-00671,2016,55,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-00672,2016,80,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.2,low_burden
KE-NRB-2014-00673,2014,64,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,46.8,low_burden
KE-NRB-2010-00674,2010,35,35-44,Female,Thyroid,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.4,low_burden
KE-NRB-2017-00675,2017,62,55-64,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,25.8,low_burden
KE-NRB-2010-00676,2010,36,35-44,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,27.9,low_burden
KE-NRB-2010-00677,2010,57,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2010-00678,2010,37,35-44,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,6.4,low_burden
KE-NRB-2010-00679,2010,62,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,2.1,low_burden
KE-NRB-2016-00680,2016,62,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,27.4,low_burden
KE-NRB-2010-00681,2010,70,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,0.6,low_burden
KE-NRB-2018-00682,2018,71,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,6.4,low_burden
KE-NRB-2017-00683,2017,51,45-54,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-00684,2018,61,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,46.5,low_burden
KE-NRB-2013-00685,2013,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,9.7,low_burden
KE-NRB-2017-00686,2017,69,65-74,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-00687,2015,36,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,26.3,low_burden
KE-NRB-2012-00688,2012,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2010-00689,2010,52,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,1.9,low_burden
KE-NRB-2011-00690,2011,64,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-00691,2013,64,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,38.9,low_burden
KE-NRB-2016-00692,2016,70,65-74,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,21.8,low_burden
KE-NRB-2017-00693,2017,94,75+,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.2,low_burden
KE-NRB-2015-00694,2015,73,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.0,low_burden
KE-NRB-2010-00695,2010,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,11.9,low_burden
KE-NRB-2017-00696,2017,41,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.9,low_burden
KE-NRB-2016-00697,2016,56,55-64,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,34.2,low_burden
KE-NRB-2015-00698,2015,56,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,5.2,low_burden
KE-NRB-2013-00699,2013,51,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,13.5,low_burden
KE-NRB-2011-00700,2011,51,45-54,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-00701,2014,57,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.8,low_burden
KE-NRB-2016-00702,2016,63,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,29.1,low_burden
KE-NRB-2013-00703,2013,16,15-24,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.8,low_burden
KE-NRB-2014-00704,2014,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,5.7,low_burden
KE-NRB-2011-00705,2011,64,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,23.7,low_burden
KE-NRB-2013-00706,2013,55,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.2,low_burden
KE-NRB-2016-00707,2016,63,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,53.3,low_burden
KE-NRB-2011-00708,2011,40,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.8,low_burden
KE-NRB-2017-00709,2017,61,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,39.7,low_burden
KE-NRB-2012-00710,2012,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.7,low_burden
KE-NRB-2017-00711,2017,70,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.0,low_burden
KE-NRB-2017-00712,2017,20,15-24,Female,Other,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,27.7,low_burden
KE-NRB-2013-00713,2013,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,34.1,low_burden
KE-NRB-2011-00714,2011,32,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00715,2011,43,35-44,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,29.1,low_burden
KE-NRB-2015-00716,2015,40,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.3,low_burden
KE-NRB-2014-00717,2014,49,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.4,low_burden
KE-NRB-2011-00718,2011,59,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,low_burden
KE-NRB-2017-00719,2017,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.3,low_burden
KE-NRB-2013-00720,2013,37,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,46.0,low_burden
KE-NRB-2012-00721,2012,36,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.4,low_burden
KE-NRB-2013-00722,2013,63,55-64,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,33.8,low_burden
KE-NRB-2018-00723,2018,28,25-34,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.4,low_burden
KE-NRB-2013-00724,2013,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,44.2,low_burden
KE-NRB-2013-00725,2013,59,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.7,low_burden
KE-NRB-2018-00726,2018,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,4.4,low_burden
KE-NRB-2013-00727,2013,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,1.7,low_burden
KE-NRB-2014-00728,2014,2,0-14,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,20.4,low_burden
KE-NRB-2018-00729,2018,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Other,In situ,Urban,N/A,Dead,15.2,low_burden
KE-NRB-2017-00730,2017,18,15-24,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-00731,2015,34,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,11.0,low_burden
KE-NRB-2010-00732,2010,66,65-74,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,17.0,low_burden
KE-NRB-2018-00733,2018,68,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.3,low_burden
KE-NRB-2017-00734,2017,66,65-74,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.3,low_burden
KE-NRB-2012-00735,2012,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-00736,2018,59,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-00737,2013,45,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2013-00738,2013,84,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.4,low_burden
KE-NRB-2016-00739,2016,62,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-00740,2013,48,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,39.9,low_burden
KE-NRB-2014-00741,2014,65,65-74,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.5,low_burden
KE-NRB-2009-00742,2009,71,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-00743,2017,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,46.0,low_burden
KE-NRB-2012-00744,2012,51,45-54,Male,Oesophagus,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,17.8,low_burden
KE-NRB-2017-00745,2017,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Other,Benign/uncertain,Peri-urban,N/A,Alive,44.1,low_burden
KE-NRB-2013-00746,2013,56,55-64,Male,Prostate,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,18.1,low_burden
KE-NRB-2018-00747,2018,48,45-54,Male,Bladder,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-00748,2014,58,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,41.5,low_burden
KE-NRB-2013-00749,2013,84,75+,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Dead,1.7,low_burden
KE-NRB-2017-00750,2017,56,55-64,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,60.0,low_burden
KE-NRB-2011-00751,2011,31,25-34,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.5,low_burden
KE-NRB-2013-00752,2013,93,75+,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.3,low_burden
KE-NRB-2018-00753,2018,62,55-64,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,44.6,low_burden
KE-NRB-2010-00754,2010,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.0,low_burden
KE-NRB-2009-00755,2009,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.8,low_burden
KE-NRB-2016-00756,2016,51,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,11.1,low_burden
KE-NRB-2018-00757,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,37.0,low_burden
KE-NRB-2017-00758,2017,25,25-34,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.9,low_burden
KE-NRB-2014-00759,2014,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,37.6,low_burden
KE-NRB-2012-00760,2012,64,55-64,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-00761,2015,28,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,7.6,low_burden
KE-NRB-2016-00762,2016,89,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.7,low_burden
KE-NRB-2017-00763,2017,42,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,39.1,low_burden
KE-NRB-2016-00764,2016,60,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,14.6,low_burden
KE-NRB-2015-00765,2015,35,35-44,Male,Lung,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,19.1,low_burden
KE-NRB-2016-00766,2016,36,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,7.2,low_burden
KE-NRB-2016-00767,2016,54,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,21.4,low_burden
KE-NRB-2018-00768,2018,34,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,low_burden
KE-NRB-2015-00769,2015,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.2,low_burden
KE-NRB-2013-00770,2013,36,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.0,low_burden
KE-NRB-2012-00771,2012,59,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,57.8,low_burden
KE-NRB-2014-00772,2014,64,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.3,low_burden
KE-NRB-2011-00773,2011,47,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.8,low_burden
KE-NRB-2017-00774,2017,61,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.5,low_burden
KE-NRB-2010-00775,2010,34,25-34,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.0,low_burden
KE-NRB-2018-00776,2018,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.4,low_burden
KE-NRB-2011-00777,2011,46,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.0,low_burden
KE-NRB-2010-00778,2010,60,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-00779,2016,89,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.2,low_burden
KE-NRB-2018-00780,2018,67,65-74,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00781,2017,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,7.7,low_burden
KE-NRB-2018-00782,2018,65,65-74,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.1,low_burden
KE-NRB-2014-00783,2014,24,15-24,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,34.8,low_burden
KE-NRB-2011-00784,2011,34,25-34,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-00785,2012,29,25-34,Male,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,59.1,low_burden
KE-NRB-2012-00786,2012,72,65-74,Male,Prostate,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.5,low_burden
KE-NRB-2015-00787,2015,36,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.7,low_burden
KE-NRB-2013-00788,2013,58,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Dead,15.0,low_burden
KE-NRB-2009-00789,2009,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-00790,2012,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,48.1,low_burden
KE-NRB-2016-00791,2016,42,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.8,low_burden
KE-NRB-2010-00792,2010,20,15-24,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,45.7,low_burden
KE-NRB-2016-00793,2016,70,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,20.5,low_burden
KE-NRB-2009-00794,2009,51,45-54,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2014-00795,2014,66,65-74,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2012-00796,2012,57,55-64,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,10.8,low_burden
KE-NRB-2011-00797,2011,34,25-34,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,6.6,low_burden
KE-NRB-2009-00798,2009,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.1,low_burden
KE-NRB-2011-00799,2011,41,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Dead,5.1,low_burden
KE-NRB-2014-00800,2014,66,65-74,Male,Leukemia,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00801,2014,55,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,35.6,low_burden
KE-NRB-2015-00802,2015,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.4,low_burden
KE-NRB-2017-00803,2017,32,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2012-00804,2012,61,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2014-00805,2014,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.4,low_burden
KE-NRB-2013-00806,2013,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Dead,24.1,low_burden
KE-NRB-2010-00807,2010,51,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,43.1,low_burden
KE-NRB-2013-00808,2013,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.3,low_burden
KE-NRB-2009-00809,2009,38,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.3,low_burden
KE-NRB-2016-00810,2016,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,58.1,low_burden
KE-NRB-2011-00811,2011,60,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,In situ,Peri-urban,N/A,Dead,14.9,low_burden
KE-NRB-2015-00812,2015,50,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,0.1,low_burden
KE-NRB-2009-00813,2009,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,24.6,low_burden
KE-NRB-2010-00814,2010,73,65-74,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.2,low_burden
KE-NRB-2017-00815,2017,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,12.7,low_burden
KE-NRB-2017-00816,2017,52,45-54,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-00817,2011,91,75+,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,15.5,low_burden
KE-NRB-2012-00818,2012,72,65-74,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.9,low_burden
KE-NRB-2010-00819,2010,47,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,7.1,low_burden
KE-NRB-2016-00820,2016,45,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.7,low_burden
KE-NRB-2014-00821,2014,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.3,low_burden
KE-NRB-2015-00822,2015,53,45-54,Female,Breast,Other specified,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,16.8,low_burden
KE-NRB-2018-00823,2018,42,35-44,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.3,low_burden
KE-NRB-2009-00824,2009,61,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2010-00825,2010,55,55-64,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.1,low_burden
KE-NRB-2013-00826,2013,53,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.2,low_burden
KE-NRB-2016-00827,2016,62,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.6,low_burden
KE-NRB-2017-00828,2017,72,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.5,low_burden
KE-NRB-2009-00829,2009,21,15-24,Female,Other,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,41.0,low_burden
KE-NRB-2018-00830,2018,94,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00831,2017,49,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,15.7,low_burden
KE-NRB-2018-00832,2018,36,35-44,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,7.1,low_burden
KE-NRB-2016-00833,2016,47,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,20.4,low_burden
KE-NRB-2016-00834,2016,20,15-24,Male,Liver,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,12.4,low_burden
KE-NRB-2017-00835,2017,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,19.2,low_burden
KE-NRB-2009-00836,2009,87,75+,Male,Lung,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Lost to follow-up,19.9,low_burden
KE-NRB-2017-00837,2017,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-00838,2016,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2012-00839,2012,25,25-34,Male,Brain and CNS,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.1,low_burden
KE-NRB-2017-00840,2017,37,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,12.3,low_burden
KE-NRB-2014-00841,2014,51,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,31.8,low_burden
KE-NRB-2016-00842,2016,64,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.0,low_burden
KE-NRB-2016-00843,2016,35,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.0,low_burden
KE-NRB-2012-00844,2012,39,35-44,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,low_burden
KE-NRB-2015-00845,2015,74,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,3.9,low_burden
KE-NRB-2011-00846,2011,55,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,21.6,low_burden
KE-NRB-2012-00847,2012,55,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,2.7,low_burden
KE-NRB-2017-00848,2017,42,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Radiotherapy only,Lost to follow-up,15.7,low_burden
KE-NRB-2018-00849,2018,47,45-54,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.6,low_burden
KE-NRB-2010-00850,2010,71,65-74,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,44.2,low_burden
KE-NRB-2015-00851,2015,71,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,49.1,low_burden
KE-NRB-2016-00852,2016,52,45-54,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,6.4,low_burden
KE-NRB-2011-00853,2011,43,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.3,low_burden
KE-NRB-2017-00854,2017,53,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,28.9,low_burden
KE-NRB-2011-00855,2011,47,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,38.3,low_burden
KE-NRB-2010-00856,2010,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,1.0,low_burden
KE-NRB-2017-00857,2017,48,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,44.1,low_burden
KE-NRB-2017-00858,2017,33,25-34,Female,Cervix uteri,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,57.1,low_burden
KE-NRB-2013-00859,2013,59,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,2.1,low_burden
KE-NRB-2017-00860,2017,44,35-44,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,11.2,low_burden
KE-NRB-2016-00861,2016,70,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,49.0,low_burden
KE-NRB-2011-00862,2011,44,35-44,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,10.7,low_burden
KE-NRB-2016-00863,2016,16,15-24,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-00864,2010,46,45-54,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-00865,2015,35,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,46.7,low_burden
KE-NRB-2011-00866,2011,91,75+,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,9.1,low_burden
KE-NRB-2014-00867,2014,18,15-24,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,31.4,low_burden
KE-NRB-2017-00868,2017,50,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.4,low_burden
KE-NRB-2018-00869,2018,20,15-24,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,36.3,low_burden
KE-NRB-2011-00870,2011,53,45-54,Female,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,11.2,low_burden
KE-NRB-2012-00871,2012,50,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,35.0,low_burden
KE-NRB-2017-00872,2017,53,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,In situ,Urban,N/A,Alive,3.5,low_burden
KE-NRB-2011-00873,2011,74,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,7.3,low_burden
KE-NRB-2015-00874,2015,60,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.2,low_burden
KE-NRB-2016-00875,2016,31,25-34,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-00876,2016,62,55-64,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.3,low_burden
KE-NRB-2010-00877,2010,69,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,36.8,low_burden
KE-NRB-2014-00878,2014,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.3,low_burden
KE-NRB-2011-00879,2011,37,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,12.4,low_burden
KE-NRB-2012-00880,2012,45,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-00881,2017,32,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.5,low_burden
KE-NRB-2010-00882,2010,47,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.8,low_burden
KE-NRB-2015-00883,2015,64,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,11.9,low_burden
KE-NRB-2012-00884,2012,64,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.4,low_burden
KE-NRB-2015-00885,2015,66,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Rural,N/A,Dead,23.5,low_burden
KE-NRB-2012-00886,2012,88,75+,Female,Cervix uteri,Sarcoma,Unknown,Death certificate only,In situ,Urban,N/A,Alive,12.4,low_burden
KE-NRB-2018-00887,2018,51,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,40.1,low_burden
KE-NRB-2012-00888,2012,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,5.0,low_burden
KE-NRB-2018-00889,2018,70,65-74,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00890,2017,71,65-74,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,30.4,low_burden
KE-NRB-2016-00891,2016,79,75+,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,4.4,low_burden
KE-NRB-2016-00892,2016,70,65-74,Male,Liver,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,51.9,low_burden
KE-NRB-2015-00893,2015,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,27.1,low_burden
KE-NRB-2012-00894,2012,53,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-00895,2015,48,45-54,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,13.9,low_burden
KE-NRB-2018-00896,2018,27,25-34,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-00897,2017,63,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-00898,2010,57,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.9,low_burden
KE-NRB-2014-00899,2014,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,45.4,low_burden
KE-NRB-2013-00900,2013,26,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,49.5,low_burden
KE-NRB-2018-00901,2018,42,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.7,low_burden
KE-NRB-2011-00902,2011,38,35-44,Male,Skin (melanoma),Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,10.4,low_burden
KE-NRB-2016-00903,2016,86,75+,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,19.9,low_burden
KE-NRB-2015-00904,2015,53,45-54,Female,Thyroid,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.6,low_burden
KE-NRB-2018-00905,2018,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.0,low_burden
KE-NRB-2010-00906,2010,28,25-34,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,51.3,low_burden
KE-NRB-2017-00907,2017,28,25-34,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.4,low_burden
KE-NRB-2010-00908,2010,46,45-54,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,15.5,low_burden
KE-NRB-2015-00909,2015,62,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,46.9,low_burden
KE-NRB-2012-00910,2012,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.0,low_burden
KE-NRB-2015-00911,2015,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.4,low_burden
KE-NRB-2010-00912,2010,37,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.6,low_burden
KE-NRB-2018-00913,2018,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,56.4,low_burden
KE-NRB-2016-00914,2016,79,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,56.1,low_burden
KE-NRB-2015-00915,2015,43,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.1,low_burden
KE-NRB-2011-00916,2011,56,55-64,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.3,low_burden
KE-NRB-2009-00917,2009,50,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.8,low_burden
KE-NRB-2014-00918,2014,30,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,10.3,low_burden
KE-NRB-2017-00919,2017,66,65-74,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,4.2,low_burden
KE-NRB-2018-00920,2018,28,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.8,low_burden
KE-NRB-2012-00921,2012,61,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,10.9,low_burden
KE-NRB-2011-00922,2011,66,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-00923,2011,66,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-00924,2010,60,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,19.3,low_burden
KE-NRB-2015-00925,2015,37,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.5,low_burden
KE-NRB-2016-00926,2016,72,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,0.4,low_burden
KE-NRB-2014-00927,2014,61,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,6.5,low_burden
KE-NRB-2010-00928,2010,17,15-24,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,13.4,low_burden
KE-NRB-2015-00929,2015,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,49.3,low_burden
KE-NRB-2015-00930,2015,47,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,4.2,low_burden
KE-NRB-2012-00931,2012,87,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.3,low_burden
KE-NRB-2010-00932,2010,69,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.2,low_burden
KE-NRB-2017-00933,2017,71,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.0,low_burden
KE-NRB-2017-00934,2017,25,25-34,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00935,2011,52,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,19.4,low_burden
KE-NRB-2010-00936,2010,39,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,54.6,low_burden
KE-NRB-2012-00937,2012,42,35-44,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.1,low_burden
KE-NRB-2017-00938,2017,39,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.6,low_burden
KE-NRB-2017-00939,2017,44,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,12.3,low_burden
KE-NRB-2011-00940,2011,38,35-44,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2018-00941,2018,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.3,low_burden
KE-NRB-2015-00942,2015,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,24.3,low_burden
KE-NRB-2013-00943,2013,63,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.8,low_burden
KE-NRB-2012-00944,2012,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,5.2,low_burden
KE-NRB-2012-00945,2012,61,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.7,low_burden
KE-NRB-2013-00946,2013,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.9,low_burden
KE-NRB-2010-00947,2010,73,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,8.3,low_burden
KE-NRB-2009-00948,2009,63,55-64,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,4.5,low_burden
KE-NRB-2017-00949,2017,46,45-54,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,25.0,low_burden
KE-NRB-2017-00950,2017,32,25-34,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-00951,2014,34,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,15.9,low_burden
KE-NRB-2016-00952,2016,16,15-24,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.9,low_burden
KE-NRB-2009-00953,2009,35,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.0,low_burden
KE-NRB-2011-00954,2011,72,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-00955,2018,77,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,50.0,low_burden
KE-NRB-2016-00956,2016,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.4,low_burden
KE-NRB-2017-00957,2017,65,65-74,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.1,low_burden
KE-NRB-2011-00958,2011,31,25-34,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2018-00959,2018,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,14.7,low_burden
KE-NRB-2009-00960,2009,53,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,14.7,low_burden
KE-NRB-2013-00961,2013,27,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.3,low_burden
KE-NRB-2013-00962,2013,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,43.7,low_burden
KE-NRB-2018-00963,2018,66,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.3,low_burden
KE-NRB-2016-00964,2016,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,51.3,low_burden
KE-NRB-2018-00965,2018,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.6,low_burden
KE-NRB-2014-00966,2014,54,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-00967,2011,35,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,13.0,low_burden
KE-NRB-2018-00968,2018,32,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.3,low_burden
KE-NRB-2011-00969,2011,47,45-54,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,9.8,low_burden
KE-NRB-2009-00970,2009,66,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,10.5,low_burden
KE-NRB-2018-00971,2018,51,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,2.1,low_burden
KE-NRB-2012-00972,2012,44,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,24.0,low_burden
KE-NRB-2017-00973,2017,53,45-54,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,12.8,low_burden
KE-NRB-2016-00974,2016,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.2,low_burden
KE-NRB-2018-00975,2018,45,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2016-00976,2016,46,45-54,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2018-00977,2018,63,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-00978,2014,53,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.6,low_burden
KE-NRB-2016-00979,2016,45,45-54,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.2,low_burden
KE-NRB-2013-00980,2013,55,55-64,Female,Breast,Other specified,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,31.1,low_burden
KE-NRB-2011-00981,2011,67,65-74,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,3.2,low_burden
KE-NRB-2013-00982,2013,53,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,18.9,low_burden
KE-NRB-2010-00983,2010,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-00984,2015,66,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,8.2,low_burden
KE-NRB-2017-00985,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.8,low_burden
KE-NRB-2012-00986,2012,41,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,50.8,low_burden
KE-NRB-2014-00987,2014,48,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-00988,2016,46,45-54,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.8,low_burden
KE-NRB-2018-00989,2018,28,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,53.8,low_burden
KE-NRB-2017-00990,2017,54,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,19.3,low_burden
KE-NRB-2016-00991,2016,51,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.2,low_burden
KE-NRB-2011-00992,2011,42,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2009-00993,2009,86,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,8.3,low_burden
KE-NRB-2012-00994,2012,57,55-64,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,6.8,low_burden
KE-NRB-2016-00995,2016,35,35-44,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-00996,2015,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-00997,2015,58,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.6,low_burden
KE-NRB-2010-00998,2010,71,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,8.1,low_burden
KE-NRB-2012-00999,2012,75,75+,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.7,low_burden
KE-NRB-2012-01000,2012,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.3,low_burden
KE-NRB-2012-01001,2012,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,25.8,low_burden
KE-NRB-2017-01002,2017,32,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.0,low_burden
KE-NRB-2018-01003,2018,54,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Rural,N/A,Dead,21.8,low_burden
KE-NRB-2018-01004,2018,57,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2018-01005,2018,35,35-44,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-01006,2016,43,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.9,low_burden
KE-NRB-2016-01007,2016,66,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,14.5,low_burden
KE-NRB-2012-01008,2012,37,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.7,low_burden
KE-NRB-2018-01009,2018,74,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.0,low_burden
KE-NRB-2012-01010,2012,71,65-74,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.9,low_burden
KE-NRB-2018-01011,2018,31,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-01012,2015,32,25-34,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,0.4,low_burden
KE-NRB-2016-01013,2016,40,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,16.7,low_burden
KE-NRB-2015-01014,2015,60,55-64,Male,Stomach,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.9,low_burden
KE-NRB-2014-01015,2014,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,15.7,low_burden
KE-NRB-2014-01016,2014,76,75+,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,43.6,low_burden
KE-NRB-2012-01017,2012,37,35-44,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.7,low_burden
KE-NRB-2018-01018,2018,46,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,34.7,low_burden
KE-NRB-2011-01019,2011,70,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-01020,2015,41,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,17.9,low_burden
KE-NRB-2012-01021,2012,51,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,43.3,low_burden
KE-NRB-2015-01022,2015,52,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,low_burden
KE-NRB-2016-01023,2016,46,45-54,Male,Brain and CNS,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,8.6,low_burden
KE-NRB-2010-01024,2010,46,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,59.6,low_burden
KE-NRB-2012-01025,2012,93,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,low_burden
KE-NRB-2015-01026,2015,38,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,8.9,low_burden
KE-NRB-2016-01027,2016,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.6,low_burden
KE-NRB-2015-01028,2015,47,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-01029,2016,58,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,5.0,low_burden
KE-NRB-2016-01030,2016,44,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.1,low_burden
KE-NRB-2018-01031,2018,60,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.7,low_burden
KE-NRB-2016-01032,2016,26,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,1.4,low_burden
KE-NRB-2013-01033,2013,51,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.9,low_burden
KE-NRB-2012-01034,2012,42,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.6,low_burden
KE-NRB-2018-01035,2018,31,25-34,Female,Corpus uteri,Adenocarcinoma,Unknown,Clinical only,In situ,Urban,N/A,Dead,44.1,low_burden
KE-NRB-2009-01036,2009,36,35-44,Male,Non-Hodgkin lymphoma,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,35.9,low_burden
KE-NRB-2016-01037,2016,74,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-01038,2012,78,75+,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.3,low_burden
KE-NRB-2015-01039,2015,95,75+,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,18.3,low_burden
KE-NRB-2012-01040,2012,56,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-01041,2013,67,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,17.2,low_burden
KE-NRB-2012-01042,2012,46,45-54,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.7,low_burden
KE-NRB-2013-01043,2013,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-01044,2012,42,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.7,low_burden
KE-NRB-2018-01045,2018,60,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,9.8,low_burden
KE-NRB-2013-01046,2013,45,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,12.4,low_burden
KE-NRB-2017-01047,2017,30,25-34,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,56.2,low_burden
KE-NRB-2017-01048,2017,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.9,low_burden
KE-NRB-2009-01049,2009,63,55-64,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.8,low_burden
KE-NRB-2009-01050,2009,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-01051,2015,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-01052,2018,42,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,3.7,low_burden
KE-NRB-2010-01053,2010,46,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.1,low_burden
KE-NRB-2016-01054,2016,84,75+,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,20.4,low_burden
KE-NRB-2018-01055,2018,37,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.9,low_burden
KE-NRB-2018-01056,2018,92,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,6.2,low_burden
KE-NRB-2012-01057,2012,65,65-74,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.4,low_burden
KE-NRB-2013-01058,2013,69,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.1,low_burden
KE-NRB-2017-01059,2017,22,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,6.2,low_burden
KE-NRB-2014-01060,2014,26,25-34,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.3,low_burden
KE-NRB-2015-01061,2015,92,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.7,low_burden
KE-NRB-2010-01062,2010,34,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,4.9,low_burden
KE-NRB-2018-01063,2018,59,55-64,Male,Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,41.6,low_burden
KE-NRB-2018-01064,2018,17,15-24,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.1,low_burden
KE-NRB-2018-01065,2018,66,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,2.7,low_burden
KE-NRB-2011-01066,2011,39,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Alive,19.2,low_burden
KE-NRB-2014-01067,2014,69,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-01068,2015,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,7.7,low_burden
KE-NRB-2015-01069,2015,57,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.3,low_burden
KE-NRB-2016-01070,2016,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,43.3,low_burden
KE-NRB-2018-01071,2018,40,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,57.6,low_burden
KE-NRB-2009-01072,2009,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2013-01073,2013,71,65-74,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-01074,2018,67,65-74,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,12.6,low_burden
KE-NRB-2014-01075,2014,59,55-64,Male,Pancreas,Lymphoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Alive,9.9,low_burden
KE-NRB-2013-01076,2013,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.9,low_burden
KE-NRB-2009-01077,2009,79,75+,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,35.6,low_burden
KE-NRB-2014-01078,2014,31,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.4,low_burden
KE-NRB-2017-01079,2017,64,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,32.1,low_burden
KE-NRB-2010-01080,2010,22,15-24,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.1,low_burden
KE-NRB-2015-01081,2015,58,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,19.0,low_burden
KE-NRB-2009-01082,2009,54,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.4,low_burden
KE-NRB-2018-01083,2018,46,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-01084,2010,71,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,55.6,low_burden
KE-NRB-2013-01085,2013,78,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,52.4,low_burden
KE-NRB-2016-01086,2016,50,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.9,low_burden
KE-NRB-2012-01087,2012,26,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.4,low_burden
KE-NRB-2015-01088,2015,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.7,low_burden
KE-NRB-2016-01089,2016,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-01090,2011,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,59.3,low_burden
KE-NRB-2014-01091,2014,49,45-54,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.0,low_burden
KE-NRB-2012-01092,2012,45,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,38.6,low_burden
KE-NRB-2015-01093,2015,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,low_burden
KE-NRB-2011-01094,2011,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,16.1,low_burden
KE-NRB-2012-01095,2012,66,65-74,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.9,low_burden
KE-NRB-2015-01096,2015,74,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,53.0,low_burden
KE-NRB-2013-01097,2013,45,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,24.9,low_burden
KE-NRB-2012-01098,2012,55,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,3.6,low_burden
KE-NRB-2010-01099,2010,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-01100,2009,48,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,57.1,low_burden
KE-NRB-2016-01101,2016,64,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-01102,2018,72,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,17.2,low_burden
KE-NRB-2012-01103,2012,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-01104,2014,32,25-34,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.9,low_burden
KE-NRB-2016-01105,2016,70,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.5,low_burden
KE-NRB-2009-01106,2009,47,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.6,low_burden
KE-NRB-2011-01107,2011,41,35-44,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.6,low_burden
KE-NRB-2014-01108,2014,38,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.1,low_burden
KE-NRB-2010-01109,2010,36,35-44,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,36.7,low_burden
KE-NRB-2014-01110,2014,71,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,45.8,low_burden
KE-NRB-2015-01111,2015,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,37.7,low_burden
KE-NRB-2018-01112,2018,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.2,low_burden
KE-NRB-2013-01113,2013,94,75+,Male,Lung,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,15.8,low_burden
KE-NRB-2018-01114,2018,5,0-14,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.9,low_burden
KE-NRB-2016-01115,2016,57,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,low_burden
KE-NRB-2009-01116,2009,55,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2012-01117,2012,75,75+,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,36.5,low_burden
KE-NRB-2009-01118,2009,74,65-74,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.8,low_burden
KE-NRB-2015-01119,2015,28,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.9,low_burden
KE-NRB-2018-01120,2018,62,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,46.7,low_burden
KE-NRB-2011-01121,2011,48,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.4,low_burden
KE-NRB-2011-01122,2011,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Dead,36.8,low_burden
KE-NRB-2014-01123,2014,69,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.8,low_burden
KE-NRB-2014-01124,2014,58,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-01125,2017,51,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,29.1,low_burden
KE-NRB-2014-01126,2014,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,7.2,low_burden
KE-NRB-2017-01127,2017,23,15-24,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,16.0,low_burden
KE-NRB-2017-01128,2017,94,75+,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,16.9,low_burden
KE-NRB-2017-01129,2017,38,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,20.7,low_burden
KE-NRB-2012-01130,2012,55,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,33.5,low_burden
KE-NRB-2013-01131,2013,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.3,low_burden
KE-NRB-2018-01132,2018,80,75+,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,56.8,low_burden
KE-NRB-2012-01133,2012,72,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,29.7,low_burden
KE-NRB-2013-01134,2013,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,17.2,low_burden
KE-NRB-2016-01135,2016,68,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,2.1,low_burden
KE-NRB-2009-01136,2009,47,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,20.3,low_burden
KE-NRB-2017-01137,2017,59,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,55.0,low_burden
KE-NRB-2014-01138,2014,52,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.7,low_burden
KE-NRB-2018-01139,2018,21,15-24,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,44.2,low_burden
KE-NRB-2013-01140,2013,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,50.2,low_burden
KE-NRB-2009-01141,2009,43,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,30.1,low_burden
KE-NRB-2012-01142,2012,84,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,7.0,low_burden
KE-NRB-2011-01143,2011,69,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,6.4,low_burden
KE-NRB-2014-01144,2014,60,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,31.0,low_burden
KE-NRB-2015-01145,2015,52,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.2,low_burden
KE-NRB-2010-01146,2010,72,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.7,low_burden
KE-NRB-2017-01147,2017,70,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Dead,30.2,low_burden
KE-NRB-2018-01148,2018,74,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,15.5,low_burden
KE-NRB-2018-01149,2018,64,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Rural,Surgery only,Alive,43.3,low_burden
KE-NRB-2013-01150,2013,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.4,low_burden
KE-NRB-2009-01151,2009,74,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-01152,2009,79,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-01153,2016,68,65-74,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Dead,6.0,low_burden
KE-NRB-2011-01154,2011,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01155,2013,48,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,39.8,low_burden
KE-NRB-2016-01156,2016,87,75+,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.1,low_burden
KE-NRB-2018-01157,2018,58,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-01158,2013,90,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-01159,2013,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,0.1,low_burden
KE-NRB-2017-01160,2017,28,25-34,Female,Other,Sarcoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,54.8,low_burden
KE-NRB-2017-01161,2017,74,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,29.3,low_burden
KE-NRB-2018-01162,2018,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.4,low_burden
KE-NRB-2016-01163,2016,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.4,low_burden
KE-NRB-2016-01164,2016,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,low_burden
KE-NRB-2015-01165,2015,61,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,8.0,low_burden
KE-NRB-2010-01166,2010,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery only,Dead,13.1,low_burden
KE-NRB-2016-01167,2016,56,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2010-01168,2010,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.8,low_burden
KE-NRB-2017-01169,2017,31,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.1,low_burden
KE-NRB-2017-01170,2017,47,45-54,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.6,low_burden
KE-NRB-2010-01171,2010,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2014-01172,2014,63,55-64,Female,Thyroid,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Lost to follow-up,13.3,low_burden
KE-NRB-2016-01173,2016,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2018-01174,2018,41,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,50.9,low_burden
KE-NRB-2017-01175,2017,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,43.8,low_burden
KE-NRB-2017-01176,2017,63,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,60.0,low_burden
KE-NRB-2015-01177,2015,35,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.7,low_burden
KE-NRB-2010-01178,2010,67,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,18.0,low_burden
KE-NRB-2018-01179,2018,67,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.3,low_burden
KE-NRB-2018-01180,2018,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,47.4,low_burden
KE-NRB-2009-01181,2009,60,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Rural,Surgery only,Dead,16.8,low_burden
KE-NRB-2016-01182,2016,39,35-44,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.0,low_burden
KE-NRB-2016-01183,2016,59,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,1.0,low_burden
KE-NRB-2014-01184,2014,32,25-34,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.4,low_burden
KE-NRB-2009-01185,2009,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2016-01186,2016,63,55-64,Male,Other,Sarcoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,47.1,low_burden
KE-NRB-2018-01187,2018,32,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2015-01188,2015,42,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.6,low_burden
KE-NRB-2016-01189,2016,64,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.6,low_burden
KE-NRB-2010-01190,2010,52,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,18.4,low_burden
KE-NRB-2017-01191,2017,53,45-54,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,22.8,low_burden
KE-NRB-2013-01192,2013,72,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.4,low_burden
KE-NRB-2011-01193,2011,34,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,12.5,low_burden
KE-NRB-2012-01194,2012,7,0-14,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,3.2,low_burden
KE-NRB-2015-01195,2015,70,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,58.0,low_burden
KE-NRB-2012-01196,2012,63,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.3,low_burden
KE-NRB-2010-01197,2010,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,8.3,low_burden
KE-NRB-2010-01198,2010,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.8,low_burden
KE-NRB-2015-01199,2015,29,25-34,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-01200,2017,39,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.1,low_burden
KE-NRB-2011-01201,2011,30,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.0,low_burden
KE-NRB-2016-01202,2016,49,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,10.6,low_burden
KE-NRB-2017-01203,2017,54,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.7,low_burden
KE-NRB-2015-01204,2015,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.6,low_burden
KE-NRB-2014-01205,2014,50,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,3.5,low_burden
KE-NRB-2010-01206,2010,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.4,low_burden
KE-NRB-2015-01207,2015,65,65-74,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-01208,2014,57,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.1,low_burden
KE-NRB-2011-01209,2011,82,75+,Male,Brain and CNS,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,14.1,low_burden
KE-NRB-2017-01210,2017,70,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,44.5,low_burden
KE-NRB-2017-01211,2017,53,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.5,low_burden
KE-NRB-2013-01212,2013,49,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.6,low_burden
KE-NRB-2011-01213,2011,67,65-74,Male,Stomach,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,22.2,low_burden
KE-NRB-2016-01214,2016,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.4,low_burden
KE-NRB-2017-01215,2017,72,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.8,low_burden
KE-NRB-2013-01216,2013,76,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.9,low_burden
KE-NRB-2018-01217,2018,50,45-54,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,2.5,low_burden
KE-NRB-2018-01218,2018,64,55-64,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,3.0,low_burden
KE-NRB-2017-01219,2017,73,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,36.1,low_burden
KE-NRB-2016-01220,2016,66,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,22.6,low_burden
KE-NRB-2014-01221,2014,42,35-44,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,22.2,low_burden
KE-NRB-2015-01222,2015,68,65-74,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2014-01223,2014,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.7,low_burden
KE-NRB-2010-01224,2010,76,75+,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,9.9,low_burden
KE-NRB-2013-01225,2013,42,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,39.8,low_burden
KE-NRB-2014-01226,2014,46,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,44.0,low_burden
KE-NRB-2017-01227,2017,86,75+,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.5,low_burden
KE-NRB-2017-01228,2017,29,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,30.0,low_burden
KE-NRB-2017-01229,2017,68,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,36.7,low_burden
KE-NRB-2011-01230,2011,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,37.3,low_burden
KE-NRB-2012-01231,2012,17,15-24,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,53.6,low_burden
KE-NRB-2018-01232,2018,44,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.4,low_burden
KE-NRB-2016-01233,2016,43,35-44,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.5,low_burden
KE-NRB-2010-01234,2010,66,65-74,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2010-01235,2010,68,65-74,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.4,low_burden
KE-NRB-2018-01236,2018,27,25-34,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-01237,2013,56,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,17.4,low_burden
KE-NRB-2010-01238,2010,57,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-01239,2016,55,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,32.4,low_burden
KE-NRB-2015-01240,2015,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-01241,2009,62,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,12.6,low_burden
KE-NRB-2012-01242,2012,27,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-01243,2012,65,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-01244,2015,92,75+,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.4,low_burden
KE-NRB-2018-01245,2018,36,35-44,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-01246,2013,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-01247,2017,90,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,55.1,low_burden
KE-NRB-2016-01248,2016,73,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,1.4,low_burden
KE-NRB-2011-01249,2011,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-01250,2009,38,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,2.4,low_burden
KE-NRB-2013-01251,2013,35,35-44,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.4,low_burden
KE-NRB-2018-01252,2018,40,35-44,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,31.3,low_burden
KE-NRB-2017-01253,2017,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Dead,49.5,low_burden
KE-NRB-2012-01254,2012,26,25-34,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,40.1,low_burden
KE-NRB-2018-01255,2018,34,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,6.6,low_burden
KE-NRB-2015-01256,2015,44,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,50.8,low_burden
KE-NRB-2015-01257,2015,37,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.5,low_burden
KE-NRB-2015-01258,2015,0,0-14,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,22.0,low_burden
KE-NRB-2014-01259,2014,39,35-44,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.1,low_burden
KE-NRB-2015-01260,2015,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,low_burden
KE-NRB-2015-01261,2015,43,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2011-01262,2011,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,28.2,low_burden
KE-NRB-2013-01263,2013,48,45-54,Female,Other,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,30.7,low_burden
KE-NRB-2013-01264,2013,66,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,31.4,low_burden
KE-NRB-2009-01265,2009,36,35-44,Female,Thyroid,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.6,low_burden
KE-NRB-2016-01266,2016,42,35-44,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.5,low_burden
KE-NRB-2017-01267,2017,55,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-01268,2010,49,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,48.8,low_burden
KE-NRB-2013-01269,2013,64,55-64,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,53.4,low_burden
KE-NRB-2015-01270,2015,26,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,11.9,low_burden
KE-NRB-2013-01271,2013,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,5.1,low_burden
KE-NRB-2014-01272,2014,54,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.1,low_burden
KE-NRB-2017-01273,2017,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,No treatment,Alive,20.7,low_burden
KE-NRB-2013-01274,2013,7,0-14,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,11.1,low_burden
KE-NRB-2010-01275,2010,56,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-01276,2017,68,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.5,low_burden
KE-NRB-2015-01277,2015,93,75+,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-01278,2010,52,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-01279,2014,63,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.0,low_burden
KE-NRB-2016-01280,2016,56,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,13.7,low_burden
KE-NRB-2012-01281,2012,50,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,2.6,low_burden
KE-NRB-2018-01282,2018,34,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Dead,23.1,low_burden
KE-NRB-2016-01283,2016,95,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,low_burden
KE-NRB-2018-01284,2018,51,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,35.9,low_burden
KE-NRB-2011-01285,2011,65,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.0,low_burden
KE-NRB-2016-01286,2016,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,41.7,low_burden
KE-NRB-2017-01287,2017,59,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.8,low_burden
KE-NRB-2015-01288,2015,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,9.1,low_burden
KE-NRB-2017-01289,2017,41,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,13.1,low_burden
KE-NRB-2016-01290,2016,50,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.9,low_burden
KE-NRB-2015-01291,2015,45,45-54,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,35.2,low_burden
KE-NRB-2015-01292,2015,53,45-54,Male,Oesophagus,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2014-01293,2014,52,45-54,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-01294,2016,57,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,35.8,low_burden
KE-NRB-2016-01295,2016,80,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-01296,2012,63,55-64,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,13.1,low_burden
KE-NRB-2018-01297,2018,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,24.4,low_burden
KE-NRB-2014-01298,2014,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.1,low_burden
KE-NRB-2014-01299,2014,64,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,17.0,low_burden
KE-NRB-2015-01300,2015,7,0-14,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,50.8,low_burden
KE-NRB-2010-01301,2010,93,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,49.1,low_burden
KE-NRB-2017-01302,2017,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,8.9,low_burden
KE-NRB-2018-01303,2018,36,35-44,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,27.5,low_burden
KE-NRB-2014-01304,2014,71,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,9.5,low_burden
KE-NRB-2010-01305,2010,41,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2018-01306,2018,36,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,41.3,low_burden
KE-NRB-2010-01307,2010,27,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,36.6,low_burden
KE-NRB-2009-01308,2009,44,35-44,Male,Lung,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,27.9,low_burden
KE-NRB-2015-01309,2015,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,13.7,low_burden
KE-NRB-2016-01310,2016,56,55-64,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,29.0,low_burden
KE-NRB-2012-01311,2012,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Dead,11.8,low_burden
KE-NRB-2014-01312,2014,33,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,39.1,low_burden
KE-NRB-2013-01313,2013,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.2,low_burden
KE-NRB-2017-01314,2017,28,25-34,Female,Other,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,51.8,low_burden
KE-NRB-2018-01315,2018,29,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,No treatment,Dead,12.0,low_burden
KE-NRB-2014-01316,2014,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.1,low_burden
KE-NRB-2014-01317,2014,80,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,59.5,low_burden
KE-NRB-2018-01318,2018,57,55-64,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,12.1,low_burden
KE-NRB-2013-01319,2013,57,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.8,low_burden
KE-NRB-2018-01320,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.6,low_burden
KE-NRB-2016-01321,2016,48,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01322,2013,73,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,21.0,low_burden
KE-NRB-2012-01323,2012,63,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,25.8,low_burden
KE-NRB-2017-01324,2017,53,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,36.6,low_burden
KE-NRB-2010-01325,2010,48,45-54,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,low_burden
KE-NRB-2013-01326,2013,50,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,18.5,low_burden
KE-NRB-2011-01327,2011,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.3,low_burden
KE-NRB-2017-01328,2017,41,35-44,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-01329,2011,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,49.4,low_burden
KE-NRB-2018-01330,2018,46,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,32.2,low_burden
KE-NRB-2012-01331,2012,70,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,15.5,low_burden
KE-NRB-2015-01332,2015,79,75+,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.4,low_burden
KE-NRB-2010-01333,2010,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.9,low_burden
KE-NRB-2012-01334,2012,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,38.2,low_burden
KE-NRB-2016-01335,2016,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.8,low_burden
KE-NRB-2017-01336,2017,43,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-01337,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,4.6,low_burden
KE-NRB-2015-01338,2015,7,0-14,Male,Skin (melanoma),Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.9,low_burden
KE-NRB-2018-01339,2018,60,55-64,Male,Kidney,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2017-01340,2017,72,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Dead,23.6,low_burden
KE-NRB-2012-01341,2012,50,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,low_burden
KE-NRB-2018-01342,2018,18,15-24,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2016-01343,2016,57,55-64,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,low_burden
KE-NRB-2011-01344,2011,39,35-44,Male,Leukemia,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-01345,2016,51,45-54,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-01346,2014,62,55-64,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.9,low_burden
KE-NRB-2014-01347,2014,76,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-01348,2015,64,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.3,low_burden
KE-NRB-2011-01349,2011,50,45-54,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01350,2013,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.0,low_burden
KE-NRB-2016-01351,2016,36,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,46.9,low_burden
KE-NRB-2010-01352,2010,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,4.4,low_burden
KE-NRB-2016-01353,2016,62,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-01354,2015,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2016-01355,2016,41,35-44,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.9,low_burden
KE-NRB-2009-01356,2009,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.7,low_burden
KE-NRB-2015-01357,2015,63,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,47.8,low_burden
KE-NRB-2011-01358,2011,61,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Peri-urban,N/A,Dead,34.7,low_burden
KE-NRB-2016-01359,2016,43,35-44,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,34.5,low_burden
KE-NRB-2009-01360,2009,64,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-01361,2013,36,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.4,low_burden
KE-NRB-2015-01362,2015,59,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.3,low_burden
KE-NRB-2010-01363,2010,47,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,2.7,low_burden
KE-NRB-2016-01364,2016,48,45-54,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.3,low_burden
KE-NRB-2010-01365,2010,44,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,8.1,low_burden
KE-NRB-2009-01366,2009,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,37.5,low_burden
KE-NRB-2017-01367,2017,45,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,4.0,low_burden
KE-NRB-2011-01368,2011,67,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.4,low_burden
KE-NRB-2017-01369,2017,38,35-44,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.8,low_burden
KE-NRB-2011-01370,2011,54,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,8.8,low_burden
KE-NRB-2013-01371,2013,64,55-64,Male,Other,Lymphoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Dead,11.8,low_burden
KE-NRB-2017-01372,2017,42,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.3,low_burden
KE-NRB-2016-01373,2016,44,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2011-01374,2011,45,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.5,low_burden
KE-NRB-2017-01375,2017,60,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,34.1,low_burden
KE-NRB-2017-01376,2017,28,25-34,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,31.2,low_burden
KE-NRB-2014-01377,2014,30,25-34,Female,Thyroid,Unspecified,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-01378,2012,35,35-44,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,57.9,low_burden
KE-NRB-2018-01379,2018,47,45-54,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.7,low_burden
KE-NRB-2017-01380,2017,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,39.2,low_burden
KE-NRB-2015-01381,2015,29,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,12.5,low_burden
KE-NRB-2016-01382,2016,94,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.0,low_burden
KE-NRB-2017-01383,2017,70,65-74,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,12.4,low_burden
KE-NRB-2016-01384,2016,29,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,51.9,low_burden
KE-NRB-2011-01385,2011,26,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.8,low_burden
KE-NRB-2016-01386,2016,86,75+,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.4,low_burden
KE-NRB-2016-01387,2016,32,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,49.8,low_burden
KE-NRB-2017-01388,2017,17,15-24,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,2.0,low_burden
KE-NRB-2011-01389,2011,54,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.0,low_burden
KE-NRB-2016-01390,2016,37,35-44,Male,Other,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-01391,2011,35,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,38.8,low_burden
KE-NRB-2015-01392,2015,73,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,26.2,low_burden
KE-NRB-2009-01393,2009,59,55-64,Male,Pancreas,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,51.3,low_burden
KE-NRB-2018-01394,2018,56,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.0,low_burden
KE-NRB-2016-01395,2016,3,0-14,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2013-01396,2013,17,15-24,Male,Prostate,Leukemia,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.7,low_burden
KE-NRB-2013-01397,2013,61,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,33.3,low_burden
KE-NRB-2013-01398,2013,46,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,10.3,low_burden
KE-NRB-2011-01399,2011,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Alive,11.7,low_burden
KE-NRB-2015-01400,2015,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,55.1,low_burden
KE-NRB-2016-01401,2016,38,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.0,low_burden
KE-NRB-2012-01402,2012,50,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.2,low_burden
KE-NRB-2011-01403,2011,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,52.7,low_burden
KE-NRB-2016-01404,2016,65,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,2.2,low_burden
KE-NRB-2017-01405,2017,62,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,37.0,low_burden
KE-NRB-2010-01406,2010,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.9,low_burden
KE-NRB-2018-01407,2018,40,35-44,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.5,low_burden
KE-NRB-2018-01408,2018,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,35.1,low_burden
KE-NRB-2014-01409,2014,38,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,13.5,low_burden
KE-NRB-2013-01410,2013,13,0-14,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,4.1,low_burden
KE-NRB-2018-01411,2018,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,38.9,low_burden
KE-NRB-2014-01412,2014,60,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.2,low_burden
KE-NRB-2015-01413,2015,61,55-64,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.9,low_burden
KE-NRB-2012-01414,2012,90,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-01415,2012,46,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.2,low_burden
KE-NRB-2017-01416,2017,87,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,53.5,low_burden
KE-NRB-2016-01417,2016,55,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.4,low_burden
KE-NRB-2011-01418,2011,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-01419,2010,70,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2017-01420,2017,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,41.0,low_burden
KE-NRB-2018-01421,2018,30,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-01422,2011,50,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.0,low_burden
KE-NRB-2009-01423,2009,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.0,low_burden
KE-NRB-2017-01424,2017,87,75+,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-01425,2018,39,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,26.8,low_burden
KE-NRB-2013-01426,2013,66,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,13.8,low_burden
KE-NRB-2009-01427,2009,40,35-44,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.3,low_burden
KE-NRB-2013-01428,2013,56,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-01429,2015,40,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-01430,2013,57,55-64,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,5.6,low_burden
KE-NRB-2017-01431,2017,93,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-01432,2009,39,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,16.7,low_burden
KE-NRB-2017-01433,2017,84,75+,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.9,low_burden
KE-NRB-2016-01434,2016,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-01435,2013,35,35-44,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.7,low_burden
KE-NRB-2015-01436,2015,45,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.0,low_burden
KE-NRB-2018-01437,2018,89,75+,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,9.5,low_burden
KE-NRB-2016-01438,2016,85,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,39.5,low_burden
KE-NRB-2012-01439,2012,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,58.3,low_burden
KE-NRB-2011-01440,2011,73,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.7,low_burden
KE-NRB-2011-01441,2011,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,14.2,low_burden
KE-NRB-2018-01442,2018,25,25-34,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.6,low_burden
KE-NRB-2010-01443,2010,72,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,21.6,low_burden
KE-NRB-2018-01444,2018,63,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2009-01445,2009,49,45-54,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-01446,2018,73,65-74,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,20.8,low_burden
KE-NRB-2017-01447,2017,56,55-64,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.4,low_burden
KE-NRB-2018-01448,2018,52,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,3.3,low_burden
KE-NRB-2018-01449,2018,48,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,52.1,low_burden
KE-NRB-2013-01450,2013,36,35-44,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,42.7,low_burden
KE-NRB-2017-01451,2017,47,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,2.6,low_burden
KE-NRB-2017-01452,2017,44,35-44,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-01453,2015,71,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,47.4,low_burden
KE-NRB-2012-01454,2012,31,25-34,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-01455,2017,47,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.2,low_burden
KE-NRB-2016-01456,2016,66,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,15.3,low_burden
KE-NRB-2016-01457,2016,85,75+,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-01458,2015,67,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,1.5,low_burden
KE-NRB-2010-01459,2010,33,25-34,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,38.9,low_burden
KE-NRB-2011-01460,2011,69,65-74,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,54.2,low_burden
KE-NRB-2012-01461,2012,72,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-01462,2016,51,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.3,low_burden
KE-NRB-2013-01463,2013,58,55-64,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,4.5,low_burden
KE-NRB-2009-01464,2009,36,35-44,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.0,low_burden
KE-NRB-2012-01465,2012,49,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2016-01466,2016,86,75+,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.8,low_burden
KE-NRB-2009-01467,2009,52,45-54,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,28.0,low_burden
KE-NRB-2009-01468,2009,58,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,4.3,low_burden
KE-NRB-2009-01469,2009,65,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,9.8,low_burden
KE-NRB-2017-01470,2017,33,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.4,low_burden
KE-NRB-2013-01471,2013,32,25-34,Male,Non-Hodgkin lymphoma,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,59.0,low_burden
KE-NRB-2018-01472,2018,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.6,low_burden
KE-NRB-2009-01473,2009,2,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,26.9,low_burden
KE-NRB-2009-01474,2009,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,41.7,low_burden
KE-NRB-2011-01475,2011,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.4,low_burden
KE-NRB-2014-01476,2014,53,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.7,low_burden
KE-NRB-2012-01477,2012,62,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2009-01478,2009,46,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-01479,2011,27,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.7,low_burden
KE-NRB-2015-01480,2015,17,15-24,Male,Bladder,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,17.0,low_burden
KE-NRB-2013-01481,2013,47,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,8.4,low_burden
KE-NRB-2016-01482,2016,50,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.5,low_burden
KE-NRB-2013-01483,2013,66,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.6,low_burden
KE-NRB-2009-01484,2009,40,35-44,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,25.1,low_burden
KE-NRB-2009-01485,2009,62,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01486,2013,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,26.8,low_burden
KE-NRB-2014-01487,2014,45,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,43.6,low_burden
KE-NRB-2018-01488,2018,1,0-14,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,10.6,low_burden
KE-NRB-2016-01489,2016,87,75+,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.2,low_burden
KE-NRB-2018-01490,2018,44,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01491,2013,83,75+,Male,Other,Leukemia,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,32.8,low_burden
KE-NRB-2013-01492,2013,71,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,29.9,low_burden
KE-NRB-2016-01493,2016,75,75+,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-01494,2012,40,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,38.3,low_burden
KE-NRB-2015-01495,2015,72,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,16.2,low_burden
KE-NRB-2018-01496,2018,52,45-54,Male,Multiple myeloma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.8,low_burden
KE-NRB-2015-01497,2015,27,25-34,Female,Corpus uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,42.2,low_burden
KE-NRB-2017-01498,2017,37,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.0,low_burden
KE-NRB-2016-01499,2016,50,45-54,Female,Thyroid,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01500,2013,56,55-64,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-01501,2015,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,2.3,low_burden
KE-NRB-2009-01502,2009,1,0-14,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.4,low_burden
KE-NRB-2013-01503,2013,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Dead,4.8,low_burden
KE-NRB-2014-01504,2014,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.4,low_burden
KE-NRB-2013-01505,2013,53,45-54,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,38.8,low_burden
KE-NRB-2017-01506,2017,79,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.6,low_burden
KE-NRB-2011-01507,2011,68,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,3.7,low_burden
KE-NRB-2015-01508,2015,53,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-01509,2018,63,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,17.0,low_burden
KE-NRB-2016-01510,2016,26,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,16.8,low_burden
KE-NRB-2014-01511,2014,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,37.5,low_burden
KE-NRB-2009-01512,2009,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,33.4,low_burden
KE-NRB-2010-01513,2010,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,0.1,low_burden
KE-NRB-2012-01514,2012,37,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,30.5,low_burden
KE-NRB-2013-01515,2013,53,45-54,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.8,low_burden
KE-NRB-2015-01516,2015,58,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.7,low_burden
KE-NRB-2014-01517,2014,60,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,2.8,low_burden
KE-NRB-2012-01518,2012,60,55-64,Male,Prostate,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,12.8,low_burden
KE-NRB-2018-01519,2018,47,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.4,low_burden
KE-NRB-2017-01520,2017,64,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,42.9,low_burden
KE-NRB-2017-01521,2017,55,55-64,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.0,low_burden
KE-NRB-2017-01522,2017,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.3,low_burden
KE-NRB-2013-01523,2013,65,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-01524,2018,73,65-74,Male,Kidney,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,2.0,low_burden
KE-NRB-2010-01525,2010,10,0-14,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01526,2013,52,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.3,low_burden
KE-NRB-2018-01527,2018,61,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,4.8,low_burden
KE-NRB-2012-01528,2012,63,55-64,Male,Prostate,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,0.4,low_burden
KE-NRB-2014-01529,2014,29,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Dead,4.5,low_burden
KE-NRB-2015-01530,2015,74,65-74,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.8,low_burden
KE-NRB-2015-01531,2015,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2014-01532,2014,61,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,18.1,low_burden
KE-NRB-2015-01533,2015,52,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.0,low_burden
KE-NRB-2015-01534,2015,2,0-14,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-01535,2017,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2017-01536,2017,59,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-01537,2013,37,35-44,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,46.5,low_burden
KE-NRB-2016-01538,2016,63,55-64,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,low_burden
KE-NRB-2016-01539,2016,37,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.0,low_burden
KE-NRB-2015-01540,2015,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,19.4,low_burden
KE-NRB-2017-01541,2017,54,45-54,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.4,low_burden
KE-NRB-2015-01542,2015,59,55-64,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,33.8,low_burden
KE-NRB-2009-01543,2009,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.5,low_burden
KE-NRB-2010-01544,2010,49,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-01545,2012,43,35-44,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.5,low_burden
KE-NRB-2017-01546,2017,48,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,1.5,low_burden
KE-NRB-2017-01547,2017,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2016-01548,2016,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.0,low_burden
KE-NRB-2017-01549,2017,67,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,58.1,low_burden
KE-NRB-2015-01550,2015,52,45-54,Male,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Alive,33.3,low_burden
KE-NRB-2017-01551,2017,51,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2009-01552,2009,36,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Dead,21.3,low_burden
KE-NRB-2018-01553,2018,43,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.8,low_burden
KE-NRB-2017-01554,2017,65,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,48.6,low_burden
KE-NRB-2017-01555,2017,30,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.2,low_burden
KE-NRB-2013-01556,2013,65,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,7.8,low_burden
KE-NRB-2015-01557,2015,21,15-24,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.3,low_burden
KE-NRB-2014-01558,2014,35,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.9,low_burden
KE-NRB-2009-01559,2009,42,35-44,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Dead,9.2,low_burden
KE-NRB-2011-01560,2011,57,55-64,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,6.6,low_burden
KE-NRB-2015-01561,2015,42,35-44,Male,Leukemia,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-01562,2016,69,65-74,Female,Breast,Sarcoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,33.2,low_burden
KE-NRB-2016-01563,2016,66,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.5,low_burden
KE-NRB-2009-01564,2009,55,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,16.7,low_burden
KE-NRB-2016-01565,2016,84,75+,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.6,low_burden
KE-NRB-2017-01566,2017,62,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,59.4,low_burden
KE-NRB-2014-01567,2014,60,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-01568,2017,39,35-44,Female,Corpus uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.2,low_burden
KE-NRB-2012-01569,2012,68,65-74,Male,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,53.0,low_burden
KE-NRB-2013-01570,2013,63,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.8,low_burden
KE-NRB-2013-01571,2013,29,25-34,Female,Breast,Adenocarcinoma,Unknown,Other,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-01572,2018,70,65-74,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,1.9,low_burden
KE-NRB-2018-01573,2018,39,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,42.1,low_burden
KE-NRB-2014-01574,2014,28,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,8.7,low_burden
KE-NRB-2017-01575,2017,53,45-54,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2018-01576,2018,54,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.0,low_burden
KE-NRB-2012-01577,2012,41,35-44,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,31.2,low_burden
KE-NRB-2016-01578,2016,44,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Alive,6.1,low_burden
KE-NRB-2015-01579,2015,57,55-64,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.4,low_burden
KE-NRB-2015-01580,2015,42,35-44,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,56.4,low_burden
KE-NRB-2010-01581,2010,84,75+,Female,Other,Lymphoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,13.9,low_burden
KE-NRB-2017-01582,2017,26,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.1,low_burden
KE-NRB-2013-01583,2013,19,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,43.5,low_burden
KE-NRB-2018-01584,2018,64,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,9.8,low_burden
KE-NRB-2013-01585,2013,41,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.8,low_burden
KE-NRB-2016-01586,2016,53,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.8,low_burden
KE-NRB-2013-01587,2013,39,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,0.2,low_burden
KE-NRB-2014-01588,2014,59,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,42.7,low_burden
KE-NRB-2014-01589,2014,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-01590,2011,58,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,41.7,low_burden
KE-NRB-2014-01591,2014,47,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,55.9,low_burden
KE-NRB-2011-01592,2011,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,0.3,low_burden
KE-NRB-2015-01593,2015,31,25-34,Male,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,18.0,low_burden
KE-NRB-2015-01594,2015,37,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,47.7,low_burden
KE-NRB-2018-01595,2018,52,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,35.6,low_burden
KE-NRB-2009-01596,2009,38,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.9,low_burden
KE-NRB-2015-01597,2015,48,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.2,low_burden
KE-NRB-2011-01598,2011,53,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,36.4,low_burden
KE-NRB-2018-01599,2018,45,45-54,Female,Corpus uteri,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.5,low_burden
KE-NRB-2015-01600,2015,56,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2010-01601,2010,40,35-44,Female,Cervix uteri,Sarcoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-01602,2018,47,45-54,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,16.5,low_burden
KE-NRB-2014-01603,2014,42,35-44,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,27.2,low_burden
KE-NRB-2017-01604,2017,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2018-01605,2018,73,65-74,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.4,low_burden
KE-NRB-2016-01606,2016,59,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,49.2,low_burden
KE-NRB-2016-01607,2016,37,35-44,Male,Skin (melanoma),Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01608,2013,86,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-01609,2012,35,35-44,Female,Breast,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,2.5,low_burden
KE-NRB-2016-01610,2016,63,55-64,Female,Corpus uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,52.5,low_burden
KE-NRB-2010-01611,2010,48,45-54,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-01612,2017,54,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.9,low_burden
KE-NRB-2018-01613,2018,40,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,25.1,low_burden
KE-NRB-2011-01614,2011,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.2,low_burden
KE-NRB-2017-01615,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,32.0,low_burden
KE-NRB-2016-01616,2016,69,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.5,low_burden
KE-NRB-2014-01617,2014,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,12.4,low_burden
KE-NRB-2009-01618,2009,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.6,low_burden
KE-NRB-2014-01619,2014,54,45-54,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.3,low_burden
KE-NRB-2011-01620,2011,36,35-44,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,36.6,low_burden
KE-NRB-2017-01621,2017,13,0-14,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,34.3,low_burden
KE-NRB-2013-01622,2013,75,75+,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-01623,2015,38,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.1,low_burden
KE-NRB-2010-01624,2010,29,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.2,low_burden
KE-NRB-2018-01625,2018,53,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,46.3,low_burden
KE-NRB-2016-01626,2016,83,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-01627,2012,33,25-34,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.7,low_burden
KE-NRB-2009-01628,2009,50,45-54,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01629,2013,45,45-54,Male,Liver,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,54.9,low_burden
KE-NRB-2014-01630,2014,72,65-74,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,5.8,low_burden
KE-NRB-2017-01631,2017,53,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,1.6,low_burden
KE-NRB-2015-01632,2015,41,35-44,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-01633,2018,21,15-24,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Surgery only,Dead,10.5,low_burden
KE-NRB-2017-01634,2017,74,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.6,low_burden
KE-NRB-2015-01635,2015,88,75+,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-01636,2010,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2017-01637,2017,38,35-44,Male,Bladder,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,0.1,low_burden
KE-NRB-2011-01638,2011,33,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01639,2013,74,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.3,low_burden
KE-NRB-2018-01640,2018,91,75+,Male,Kidney,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,10.3,low_burden
KE-NRB-2009-01641,2009,50,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.8,low_burden
KE-NRB-2014-01642,2014,68,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,5.9,low_burden
KE-NRB-2016-01643,2016,44,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,11.6,low_burden
KE-NRB-2012-01644,2012,70,65-74,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,59.3,low_burden
KE-NRB-2009-01645,2009,74,65-74,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.5,low_burden
KE-NRB-2012-01646,2012,56,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,53.5,low_burden
KE-NRB-2014-01647,2014,89,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,0.3,low_burden
KE-NRB-2018-01648,2018,55,55-64,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,10.0,low_burden
KE-NRB-2013-01649,2013,31,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,13.1,low_burden
KE-NRB-2014-01650,2014,39,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,6.2,low_burden
KE-NRB-2018-01651,2018,54,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,8.2,low_burden
KE-NRB-2011-01652,2011,73,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,26.6,low_burden
KE-NRB-2017-01653,2017,69,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2018-01654,2018,70,65-74,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.1,low_burden
KE-NRB-2013-01655,2013,87,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2018-01656,2018,44,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,1.2,low_burden
KE-NRB-2014-01657,2014,50,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2018-01658,2018,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,13.7,low_burden
KE-NRB-2013-01659,2013,52,45-54,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.8,low_burden
KE-NRB-2014-01660,2014,49,45-54,Female,Thyroid,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.8,low_burden
KE-NRB-2017-01661,2017,45,45-54,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,11.1,low_burden
KE-NRB-2014-01662,2014,54,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-01663,2011,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,21.2,low_burden
KE-NRB-2015-01664,2015,46,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,23.1,low_burden
KE-NRB-2012-01665,2012,89,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,30.5,low_burden
KE-NRB-2013-01666,2013,61,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.9,low_burden
KE-NRB-2015-01667,2015,71,65-74,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,8.0,low_burden
KE-NRB-2017-01668,2017,67,65-74,Male,Multiple myeloma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,29.9,low_burden
KE-NRB-2017-01669,2017,34,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,48.4,low_burden
KE-NRB-2013-01670,2013,61,55-64,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,7.5,low_burden
KE-NRB-2015-01671,2015,54,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,16.3,low_burden
KE-NRB-2017-01672,2017,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,26.2,low_burden
KE-NRB-2016-01673,2016,63,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.6,low_burden
KE-NRB-2017-01674,2017,1,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2014-01675,2014,39,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,22.3,low_burden
KE-NRB-2011-01676,2011,92,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,31.6,low_burden
KE-NRB-2013-01677,2013,59,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,44.8,low_burden
KE-NRB-2010-01678,2010,67,65-74,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,14.3,low_burden
KE-NRB-2017-01679,2017,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,2.2,low_burden
KE-NRB-2018-01680,2018,34,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,29.7,low_burden
KE-NRB-2011-01681,2011,56,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2018-01682,2018,74,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.1,low_burden
KE-NRB-2018-01683,2018,28,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,2.5,low_burden
KE-NRB-2012-01684,2012,46,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,31.2,low_burden
KE-NRB-2016-01685,2016,18,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.6,low_burden
KE-NRB-2009-01686,2009,79,75+,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,35.1,low_burden
KE-NRB-2012-01687,2012,44,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.2,low_burden
KE-NRB-2009-01688,2009,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,47.6,low_burden
KE-NRB-2012-01689,2012,71,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2009-01690,2009,53,45-54,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,13.4,low_burden
KE-NRB-2010-01691,2010,69,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-01692,2015,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,45.5,low_burden
KE-NRB-2010-01693,2010,68,65-74,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.6,low_burden
KE-NRB-2015-01694,2015,35,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2014-01695,2014,76,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.5,low_burden
KE-NRB-2018-01696,2018,72,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,21.0,low_burden
KE-NRB-2017-01697,2017,36,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-01698,2013,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,54.9,low_burden
KE-NRB-2015-01699,2015,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,51.9,low_burden
KE-NRB-2015-01700,2015,74,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.3,low_burden
KE-NRB-2017-01701,2017,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.2,low_burden
KE-NRB-2013-01702,2013,5,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.1,low_burden
KE-NRB-2013-01703,2013,70,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-01704,2014,85,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,15.2,low_burden
KE-NRB-2010-01705,2010,43,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.8,low_burden
KE-NRB-2016-01706,2016,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,31.1,low_burden
KE-NRB-2017-01707,2017,51,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-01708,2010,49,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,0.3,low_burden
KE-NRB-2015-01709,2015,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,22.5,low_burden
KE-NRB-2014-01710,2014,37,35-44,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,25.9,low_burden
KE-NRB-2009-01711,2009,27,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.5,low_burden
KE-NRB-2017-01712,2017,73,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,low_burden
KE-NRB-2016-01713,2016,4,0-14,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.0,low_burden
KE-NRB-2012-01714,2012,62,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,48.1,low_burden
KE-NRB-2017-01715,2017,57,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.9,low_burden
KE-NRB-2014-01716,2014,80,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,32.9,low_burden
KE-NRB-2017-01717,2017,60,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,6.6,low_burden
KE-NRB-2013-01718,2013,43,35-44,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,45.2,low_burden
KE-NRB-2017-01719,2017,47,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,31.1,low_burden
KE-NRB-2010-01720,2010,53,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,35.0,low_burden
KE-NRB-2012-01721,2012,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,22.5,low_burden
KE-NRB-2018-01722,2018,65,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.7,low_burden
KE-NRB-2016-01723,2016,53,45-54,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,15.2,low_burden
KE-NRB-2018-01724,2018,52,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.8,low_burden
KE-NRB-2015-01725,2015,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.8,low_burden
KE-NRB-2010-01726,2010,67,65-74,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,low_burden
KE-NRB-2015-01727,2015,44,35-44,Female,Corpus uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.9,low_burden
KE-NRB-2011-01728,2011,39,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,46.8,low_burden
KE-NRB-2011-01729,2011,49,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-01730,2014,93,75+,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,48.8,low_burden
KE-NRB-2018-01731,2018,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,24.2,low_burden
KE-NRB-2010-01732,2010,52,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-01733,2016,36,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,27.9,low_burden
KE-NRB-2018-01734,2018,31,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,22.7,low_burden
KE-NRB-2010-01735,2010,58,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Dead,53.5,low_burden
KE-NRB-2012-01736,2012,64,55-64,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,25.8,low_burden
KE-NRB-2018-01737,2018,40,35-44,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.7,low_burden
KE-NRB-2013-01738,2013,71,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,17.0,low_burden
KE-NRB-2012-01739,2012,73,65-74,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,59.0,low_burden
KE-NRB-2016-01740,2016,54,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.4,low_burden
KE-NRB-2011-01741,2011,87,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-01742,2011,60,55-64,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,44.6,low_burden
KE-NRB-2016-01743,2016,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.1,low_burden
KE-NRB-2017-01744,2017,49,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.7,low_burden
KE-NRB-2009-01745,2009,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,20.9,low_burden
KE-NRB-2017-01746,2017,82,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.2,low_burden
KE-NRB-2014-01747,2014,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,24.4,low_burden
KE-NRB-2010-01748,2010,72,65-74,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.1,low_burden
KE-NRB-2015-01749,2015,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,5.3,low_burden
KE-NRB-2012-01750,2012,49,45-54,Male,Kaposi sarcoma,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-01751,2016,46,45-54,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,15.2,low_burden
KE-NRB-2014-01752,2014,68,65-74,Male,Liver,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Palliative care only,Alive,7.5,low_burden
KE-NRB-2014-01753,2014,67,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,32.6,low_burden
KE-NRB-2011-01754,2011,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,23.8,low_burden
KE-NRB-2012-01755,2012,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2014-01756,2014,70,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.4,low_burden
KE-NRB-2016-01757,2016,65,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,0.3,low_burden
KE-NRB-2016-01758,2016,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-01759,2014,49,45-54,Male,Leukemia,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.3,low_burden
KE-NRB-2017-01760,2017,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,46.7,low_burden
KE-NRB-2015-01761,2015,70,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,8.7,low_burden
KE-NRB-2011-01762,2011,74,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.7,low_burden
KE-NRB-2018-01763,2018,70,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,low_burden
KE-NRB-2016-01764,2016,26,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.6,low_burden
KE-NRB-2018-01765,2018,62,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,36.0,low_burden
KE-NRB-2012-01766,2012,72,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,57.5,low_burden
KE-NRB-2011-01767,2011,62,55-64,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,low_burden
KE-NRB-2016-01768,2016,58,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,59.5,low_burden
KE-NRB-2011-01769,2011,50,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,In situ,Peri-urban,N/A,Alive,8.0,low_burden
KE-NRB-2017-01770,2017,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.7,low_burden
KE-NRB-2011-01771,2011,48,45-54,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,22.5,low_burden
KE-NRB-2012-01772,2012,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,1.2,low_burden
KE-NRB-2015-01773,2015,51,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,48.7,low_burden
KE-NRB-2018-01774,2018,29,25-34,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.0,low_burden
KE-NRB-2015-01775,2015,59,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.6,low_burden
KE-NRB-2010-01776,2010,37,35-44,Male,Stomach,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,33.8,low_burden
KE-NRB-2010-01777,2010,25,25-34,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,43.5,low_burden
KE-NRB-2013-01778,2013,61,55-64,Male,Lung,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,48.5,low_burden
KE-NRB-2012-01779,2012,57,55-64,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,9.3,low_burden
KE-NRB-2013-01780,2013,65,65-74,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,16.3,low_burden
KE-NRB-2014-01781,2014,47,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2013-01782,2013,38,35-44,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,10.7,low_burden
KE-NRB-2011-01783,2011,49,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,33.2,low_burden
KE-NRB-2017-01784,2017,93,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,4.5,low_burden
KE-NRB-2011-01785,2011,55,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,60.0,low_burden
KE-NRB-2010-01786,2010,64,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.7,low_burden
KE-NRB-2013-01787,2013,39,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,38.7,low_burden
KE-NRB-2011-01788,2011,49,45-54,Male,Lung,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-01789,2010,43,35-44,Female,Other,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,36.4,low_burden
KE-NRB-2017-01790,2017,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.8,low_burden
KE-NRB-2010-01791,2010,36,35-44,Female,Corpus uteri,Leukemia,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.4,low_burden
KE-NRB-2009-01792,2009,68,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,1.3,low_burden
KE-NRB-2012-01793,2012,44,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.9,low_burden
KE-NRB-2017-01794,2017,71,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,16.0,low_burden
KE-NRB-2017-01795,2017,72,65-74,Male,Pancreas,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.1,low_burden
KE-NRB-2012-01796,2012,36,35-44,Male,Brain and CNS,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,20.8,low_burden
KE-NRB-2016-01797,2016,61,55-64,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.2,low_burden
KE-NRB-2016-01798,2016,66,65-74,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,53.5,low_burden
KE-NRB-2018-01799,2018,67,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.1,low_burden
KE-NRB-2012-01800,2012,51,45-54,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,6.9,low_burden
KE-NRB-2014-01801,2014,26,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.5,low_burden
KE-NRB-2012-01802,2012,65,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,3.4,low_burden
KE-NRB-2016-01803,2016,61,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.8,low_burden
KE-NRB-2010-01804,2010,91,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-01805,2014,52,45-54,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.5,low_burden
KE-NRB-2018-01806,2018,37,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Dead,1.2,low_burden
KE-NRB-2018-01807,2018,70,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.9,low_burden
KE-NRB-2012-01808,2012,61,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,low_burden
KE-NRB-2009-01809,2009,64,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.8,low_burden
KE-NRB-2015-01810,2015,45,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,36.2,low_burden
KE-NRB-2014-01811,2014,65,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.6,low_burden
KE-NRB-2015-01812,2015,73,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Dead,7.9,low_burden
KE-NRB-2012-01813,2012,37,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-01814,2010,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.6,low_burden
KE-NRB-2018-01815,2018,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,9.9,low_burden
KE-NRB-2014-01816,2014,60,55-64,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,31.7,low_burden
KE-NRB-2016-01817,2016,32,25-34,Male,Brain and CNS,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,3.8,low_burden
KE-NRB-2016-01818,2016,50,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2017-01819,2017,75,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-01820,2011,59,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,55.3,low_burden
KE-NRB-2014-01821,2014,39,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,4.4,low_burden
KE-NRB-2018-01822,2018,72,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,35.4,low_burden
KE-NRB-2017-01823,2017,50,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,16.3,low_burden
KE-NRB-2011-01824,2011,66,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.1,low_burden
KE-NRB-2009-01825,2009,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.9,low_burden
KE-NRB-2018-01826,2018,60,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.8,low_burden
KE-NRB-2012-01827,2012,32,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.2,low_burden
KE-NRB-2011-01828,2011,39,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.8,low_burden
KE-NRB-2015-01829,2015,48,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,38.7,low_burden
KE-NRB-2012-01830,2012,39,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,18.0,low_burden
KE-NRB-2017-01831,2017,59,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,39.7,low_burden
KE-NRB-2011-01832,2011,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,7.1,low_burden
KE-NRB-2015-01833,2015,50,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,19.3,low_burden
KE-NRB-2009-01834,2009,74,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,4.4,low_burden
KE-NRB-2012-01835,2012,79,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.7,low_burden
KE-NRB-2011-01836,2011,76,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.1,low_burden
KE-NRB-2018-01837,2018,36,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,19.0,low_burden
KE-NRB-2014-01838,2014,45,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-01839,2015,56,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,17.2,low_burden
KE-NRB-2010-01840,2010,13,0-14,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-01841,2009,58,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.6,low_burden
KE-NRB-2009-01842,2009,58,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,41.1,low_burden
KE-NRB-2018-01843,2018,47,45-54,Male,Pancreas,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,10.4,low_burden
KE-NRB-2013-01844,2013,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.8,low_burden
KE-NRB-2009-01845,2009,80,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,5.4,low_burden
KE-NRB-2016-01846,2016,57,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,6.9,low_burden
KE-NRB-2017-01847,2017,46,45-54,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.3,low_burden
KE-NRB-2018-01848,2018,74,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,52.7,low_burden
KE-NRB-2013-01849,2013,32,25-34,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.5,low_burden
KE-NRB-2013-01850,2013,30,25-34,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,34.8,low_burden
KE-NRB-2013-01851,2013,45,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,22.7,low_burden
KE-NRB-2018-01852,2018,70,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-01853,2016,52,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.0,low_burden
KE-NRB-2014-01854,2014,58,55-64,Female,Ovary,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.2,low_burden
KE-NRB-2011-01855,2011,65,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.9,low_burden
KE-NRB-2009-01856,2009,60,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.5,low_burden
KE-NRB-2017-01857,2017,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01858,2013,73,65-74,Male,Stomach,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.6,low_burden
KE-NRB-2013-01859,2013,72,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.9,low_burden
KE-NRB-2017-01860,2017,57,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,44.4,low_burden
KE-NRB-2010-01861,2010,56,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.4,low_burden
KE-NRB-2018-01862,2018,46,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Radiotherapy only,Dead,32.7,low_burden
KE-NRB-2014-01863,2014,68,65-74,Male,Lung,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,11.7,low_burden
KE-NRB-2017-01864,2017,48,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,52.9,low_burden
KE-NRB-2013-01865,2013,33,25-34,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,17.8,low_burden
KE-NRB-2011-01866,2011,65,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,50.8,low_burden
KE-NRB-2009-01867,2009,34,25-34,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,31.3,low_burden
KE-NRB-2011-01868,2011,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.4,low_burden
KE-NRB-2017-01869,2017,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.6,low_burden
KE-NRB-2017-01870,2017,50,45-54,Male,Multiple myeloma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.3,low_burden
KE-NRB-2017-01871,2017,51,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2009-01872,2009,47,45-54,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,29.6,low_burden
KE-NRB-2017-01873,2017,36,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,34.1,low_burden
KE-NRB-2012-01874,2012,38,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-01875,2017,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.1,low_burden
KE-NRB-2018-01876,2018,43,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-01877,2011,64,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.5,low_burden
KE-NRB-2016-01878,2016,44,35-44,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2010-01879,2010,48,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-01880,2015,93,75+,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,13.9,low_burden
KE-NRB-2012-01881,2012,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-01882,2017,31,25-34,Male,Multiple myeloma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,16.3,low_burden
KE-NRB-2010-01883,2010,65,65-74,Male,Lung,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.0,low_burden
KE-NRB-2013-01884,2013,30,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,7.9,low_burden
KE-NRB-2011-01885,2011,33,25-34,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.9,low_burden
KE-NRB-2009-01886,2009,64,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,17.2,low_burden
KE-NRB-2009-01887,2009,23,15-24,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,41.0,low_burden
KE-NRB-2017-01888,2017,51,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-01889,2013,59,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-01890,2014,71,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2009-01891,2009,50,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,48.3,low_burden
KE-NRB-2011-01892,2011,58,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,16.0,low_burden
KE-NRB-2009-01893,2009,34,25-34,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2013-01894,2013,91,75+,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.6,low_burden
KE-NRB-2009-01895,2009,36,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemotherapy only,Dead,13.3,low_burden
KE-NRB-2017-01896,2017,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,5.0,low_burden
KE-NRB-2010-01897,2010,47,45-54,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,low_burden
KE-NRB-2010-01898,2010,43,35-44,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.0,low_burden
KE-NRB-2015-01899,2015,51,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,10.2,low_burden
KE-NRB-2010-01900,2010,54,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,13.5,low_burden
KE-NRB-2018-01901,2018,61,55-64,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,0.0,low_burden
KE-NRB-2018-01902,2018,85,75+,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,20.5,low_burden
KE-NRB-2011-01903,2011,42,35-44,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.7,low_burden
KE-NRB-2010-01904,2010,19,15-24,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,59.6,low_burden
KE-NRB-2009-01905,2009,49,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.4,low_burden
KE-NRB-2015-01906,2015,45,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-01907,2014,58,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.3,low_burden
KE-NRB-2018-01908,2018,70,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.7,low_burden
KE-NRB-2014-01909,2014,12,0-14,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-01910,2012,55,55-64,Female,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Alive,55.7,low_burden
KE-NRB-2011-01911,2011,10,0-14,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,31.4,low_burden
KE-NRB-2017-01912,2017,50,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-01913,2018,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,8.4,low_burden
KE-NRB-2018-01914,2018,89,75+,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,51.5,low_burden
KE-NRB-2016-01915,2016,41,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,47.2,low_burden
KE-NRB-2013-01916,2013,80,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,41.9,low_burden
KE-NRB-2015-01917,2015,35,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,20.2,low_burden
KE-NRB-2018-01918,2018,30,25-34,Male,Prostate,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.4,low_burden
KE-NRB-2013-01919,2013,77,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,27.9,low_burden
KE-NRB-2013-01920,2013,36,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,15.6,low_burden
KE-NRB-2010-01921,2010,2,0-14,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,60.0,low_burden
KE-NRB-2015-01922,2015,36,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.2,low_burden
KE-NRB-2011-01923,2011,55,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,17.2,low_burden
KE-NRB-2017-01924,2017,45,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,12.0,low_burden
KE-NRB-2009-01925,2009,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,57.1,low_burden
KE-NRB-2014-01926,2014,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.2,low_burden
KE-NRB-2009-01927,2009,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,41.5,low_burden
KE-NRB-2009-01928,2009,65,65-74,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,23.2,low_burden
KE-NRB-2014-01929,2014,71,65-74,Female,Corpus uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01930,2013,43,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,8.5,low_burden
KE-NRB-2010-01931,2010,36,35-44,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2017-01932,2017,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,6.9,low_burden
KE-NRB-2013-01933,2013,65,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,49.9,low_burden
KE-NRB-2013-01934,2013,54,45-54,Female,Ovary,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.8,low_burden
KE-NRB-2015-01935,2015,29,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.0,low_burden
KE-NRB-2016-01936,2016,58,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,12.0,low_burden
KE-NRB-2017-01937,2017,74,65-74,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,26.4,low_burden
KE-NRB-2012-01938,2012,56,55-64,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.6,low_burden
KE-NRB-2013-01939,2013,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,8.0,low_burden
KE-NRB-2018-01940,2018,60,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,40.5,low_burden
KE-NRB-2013-01941,2013,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.9,low_burden
KE-NRB-2017-01942,2017,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,4.8,low_burden
KE-NRB-2013-01943,2013,38,35-44,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.4,low_burden
KE-NRB-2016-01944,2016,44,35-44,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.9,low_burden
KE-NRB-2017-01945,2017,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.1,low_burden
KE-NRB-2016-01946,2016,71,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,7.9,low_burden
KE-NRB-2013-01947,2013,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,0.9,low_burden
KE-NRB-2013-01948,2013,68,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.9,low_burden
KE-NRB-2012-01949,2012,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.2,low_burden
KE-NRB-2017-01950,2017,27,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,47.0,low_burden
KE-NRB-2016-01951,2016,58,55-64,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,12.2,low_burden
KE-NRB-2015-01952,2015,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,46.2,low_burden
KE-NRB-2013-01953,2013,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,37.1,low_burden
KE-NRB-2012-01954,2012,26,25-34,Female,Breast,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,29.2,low_burden
KE-NRB-2014-01955,2014,67,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,8.1,low_burden
KE-NRB-2017-01956,2017,43,35-44,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.1,low_burden
KE-NRB-2016-01957,2016,60,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.6,low_burden
KE-NRB-2014-01958,2014,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,2.1,low_burden
KE-NRB-2014-01959,2014,51,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-01960,2017,23,15-24,Male,Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,51.0,low_burden
KE-NRB-2014-01961,2014,76,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,12.4,low_burden
KE-NRB-2011-01962,2011,67,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.4,low_burden
KE-NRB-2012-01963,2012,64,55-64,Male,Kaposi sarcoma,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,9.6,low_burden
KE-NRB-2012-01964,2012,70,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,low_burden
KE-NRB-2010-01965,2010,38,35-44,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-01966,2010,67,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.1,low_burden
KE-NRB-2018-01967,2018,41,35-44,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.5,low_burden
KE-NRB-2018-01968,2018,69,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-01969,2018,28,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.2,low_burden
KE-NRB-2010-01970,2010,47,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.3,low_burden
KE-NRB-2018-01971,2018,50,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,3.7,low_burden
KE-NRB-2013-01972,2013,67,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2015-01973,2015,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.4,low_burden
KE-NRB-2011-01974,2011,34,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.4,low_burden
KE-NRB-2015-01975,2015,47,45-54,Female,Other,Sarcoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,9.6,low_burden
KE-NRB-2017-01976,2017,73,65-74,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,13.5,low_burden
KE-NRB-2014-01977,2014,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-01978,2013,53,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,7.4,low_burden
KE-NRB-2014-01979,2014,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,7.0,low_burden
KE-NRB-2018-01980,2018,42,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,4.4,low_burden
KE-NRB-2018-01981,2018,69,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-01982,2018,53,45-54,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.5,low_burden
KE-NRB-2014-01983,2014,50,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-01984,2011,70,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,41.7,low_burden
KE-NRB-2009-01985,2009,58,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,20.6,low_burden
KE-NRB-2012-01986,2012,57,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,1.8,low_burden
KE-NRB-2013-01987,2013,30,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,12.3,low_burden
KE-NRB-2015-01988,2015,30,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,5.3,low_burden
KE-NRB-2018-01989,2018,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.3,low_burden
KE-NRB-2014-01990,2014,21,15-24,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,27.2,low_burden
KE-NRB-2013-01991,2013,69,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2010-01992,2010,67,65-74,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.1,low_burden
KE-NRB-2017-01993,2017,48,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,4.3,low_burden
KE-NRB-2016-01994,2016,84,75+,Male,Lung,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,13.8,low_burden
KE-NRB-2016-01995,2016,44,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Benign/uncertain,Urban,N/A,Dead,5.2,low_burden
KE-NRB-2013-01996,2013,65,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.5,low_burden
KE-NRB-2017-01997,2017,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,13.0,low_burden
KE-NRB-2011-01998,2011,63,55-64,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.1,low_burden
KE-NRB-2015-01999,2015,60,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,10.2,low_burden
KE-NRB-2010-02000,2010,56,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.5,low_burden
KE-NRB-2017-02001,2017,36,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,4.9,low_burden
KE-NRB-2011-02002,2011,58,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.3,low_burden
KE-NRB-2013-02003,2013,73,65-74,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.0,low_burden
KE-NRB-2013-02004,2013,52,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,33.6,low_burden
KE-NRB-2012-02005,2012,7,0-14,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,17.7,low_burden
KE-NRB-2011-02006,2011,39,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-02007,2015,51,45-54,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.9,low_burden
KE-NRB-2014-02008,2014,47,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02009,2016,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,8.1,low_burden
KE-NRB-2014-02010,2014,38,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,41.5,low_burden
KE-NRB-2012-02011,2012,35,35-44,Male,Bladder,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,5.0,low_burden
KE-NRB-2010-02012,2010,72,65-74,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,28.5,low_burden
KE-NRB-2015-02013,2015,64,55-64,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,35.3,low_burden
KE-NRB-2009-02014,2009,9,0-14,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-02015,2017,50,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.3,low_burden
KE-NRB-2012-02016,2012,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.0,low_burden
KE-NRB-2016-02017,2016,60,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,38.2,low_burden
KE-NRB-2018-02018,2018,32,25-34,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,18.8,low_burden
KE-NRB-2017-02019,2017,22,15-24,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.0,low_burden
KE-NRB-2018-02020,2018,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.2,low_burden
KE-NRB-2011-02021,2011,40,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,19.5,low_burden
KE-NRB-2016-02022,2016,65,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,26.4,low_burden
KE-NRB-2014-02023,2014,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02024,2016,75,75+,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,52.8,low_burden
KE-NRB-2018-02025,2018,43,35-44,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,55.2,low_burden
KE-NRB-2013-02026,2013,52,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.1,low_burden
KE-NRB-2011-02027,2011,39,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.0,low_burden
KE-NRB-2017-02028,2017,47,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,19.2,low_burden
KE-NRB-2013-02029,2013,56,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.1,low_burden
KE-NRB-2017-02030,2017,27,25-34,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,31.4,low_burden
KE-NRB-2015-02031,2015,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,36.6,low_burden
KE-NRB-2018-02032,2018,42,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-02033,2018,71,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-02034,2018,55,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.8,low_burden
KE-NRB-2017-02035,2017,61,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-02036,2011,34,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,7.7,low_burden
KE-NRB-2010-02037,2010,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.0,low_burden
KE-NRB-2012-02038,2012,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.1,low_burden
KE-NRB-2012-02039,2012,57,55-64,Female,Ovary,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,46.1,low_burden
KE-NRB-2018-02040,2018,77,75+,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-02041,2013,25,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,13.7,low_burden
KE-NRB-2017-02042,2017,41,35-44,Female,Other,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Alive,1.1,low_burden
KE-NRB-2014-02043,2014,55,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,9.5,low_burden
KE-NRB-2009-02044,2009,53,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,59.1,low_burden
KE-NRB-2018-02045,2018,56,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,18.4,low_burden
KE-NRB-2016-02046,2016,68,65-74,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,42.2,low_burden
KE-NRB-2017-02047,2017,33,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.5,low_burden
KE-NRB-2018-02048,2018,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2010-02049,2010,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,0.5,low_burden
KE-NRB-2010-02050,2010,26,25-34,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,2.1,low_burden
KE-NRB-2016-02051,2016,64,55-64,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-02052,2016,63,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,16.8,low_burden
KE-NRB-2018-02053,2018,67,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.7,low_burden
KE-NRB-2014-02054,2014,43,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.1,low_burden
KE-NRB-2017-02055,2017,26,25-34,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.2,low_burden
KE-NRB-2013-02056,2013,58,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-02057,2018,59,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,7.4,low_burden
KE-NRB-2011-02058,2011,78,75+,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.4,low_burden
KE-NRB-2009-02059,2009,69,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.6,low_burden
KE-NRB-2010-02060,2010,55,55-64,Female,Other,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.6,low_burden
KE-NRB-2018-02061,2018,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,4.2,low_burden
KE-NRB-2010-02062,2010,53,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,4.8,low_burden
KE-NRB-2009-02063,2009,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,9.2,low_burden
KE-NRB-2016-02064,2016,68,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.7,low_burden
KE-NRB-2016-02065,2016,32,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,12.2,low_burden
KE-NRB-2017-02066,2017,38,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,3.3,low_burden
KE-NRB-2014-02067,2014,60,55-64,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-02068,2011,64,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.5,low_burden
KE-NRB-2017-02069,2017,79,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2016-02070,2016,7,0-14,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-02071,2011,49,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.4,low_burden
KE-NRB-2015-02072,2015,63,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,29.2,low_burden
KE-NRB-2017-02073,2017,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,17.3,low_burden
KE-NRB-2017-02074,2017,28,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,4.4,low_burden
KE-NRB-2012-02075,2012,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,6.6,low_burden
KE-NRB-2018-02076,2018,39,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,16.3,low_burden
KE-NRB-2018-02077,2018,19,15-24,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,53.2,low_burden
KE-NRB-2009-02078,2009,38,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,31.1,low_burden
KE-NRB-2013-02079,2013,39,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.8,low_burden
KE-NRB-2014-02080,2014,65,65-74,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-02081,2017,93,75+,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.6,low_burden
KE-NRB-2018-02082,2018,55,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,32.6,low_burden
KE-NRB-2017-02083,2017,31,25-34,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.0,low_burden
KE-NRB-2010-02084,2010,74,65-74,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,39.1,low_burden
KE-NRB-2015-02085,2015,73,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,33.3,low_burden
KE-NRB-2017-02086,2017,60,55-64,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2016-02087,2016,58,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.1,low_burden
KE-NRB-2017-02088,2017,67,65-74,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-02089,2017,24,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-02090,2015,50,45-54,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02091,2015,71,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,37.4,low_burden
KE-NRB-2013-02092,2013,69,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-02093,2014,63,55-64,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,2.5,low_burden
KE-NRB-2015-02094,2015,66,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,11.8,low_burden
KE-NRB-2010-02095,2010,59,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,3.4,low_burden
KE-NRB-2016-02096,2016,36,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-02097,2017,48,45-54,Male,Pancreas,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,51.4,low_burden
KE-NRB-2018-02098,2018,54,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2014-02099,2014,74,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.1,low_burden
KE-NRB-2013-02100,2013,62,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.4,low_burden
KE-NRB-2018-02101,2018,65,65-74,Male,Oesophagus,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2014-02102,2014,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,51.1,low_burden
KE-NRB-2015-02103,2015,38,35-44,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.4,low_burden
KE-NRB-2018-02104,2018,35,35-44,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,22.8,low_burden
KE-NRB-2014-02105,2014,30,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,48.2,low_burden
KE-NRB-2013-02106,2013,50,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,low_burden
KE-NRB-2012-02107,2012,52,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,19.2,low_burden
KE-NRB-2012-02108,2012,25,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,3.1,low_burden
KE-NRB-2009-02109,2009,42,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,10.6,low_burden
KE-NRB-2013-02110,2013,39,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.6,low_burden
KE-NRB-2015-02111,2015,14,0-14,Male,Oesophagus,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,48.7,low_burden
KE-NRB-2017-02112,2017,6,0-14,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,23.4,low_burden
KE-NRB-2012-02113,2012,73,65-74,Male,Leukemia,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02114,2016,85,75+,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,4.9,low_burden
KE-NRB-2017-02115,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.9,low_burden
KE-NRB-2018-02116,2018,71,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.8,low_burden
KE-NRB-2017-02117,2017,64,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,33.3,low_burden
KE-NRB-2014-02118,2014,36,35-44,Female,Cervix uteri,Sarcoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2011-02119,2011,39,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,12.0,low_burden
KE-NRB-2015-02120,2015,55,55-64,Male,Stomach,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.0,low_burden
KE-NRB-2011-02121,2011,27,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,32.3,low_burden
KE-NRB-2014-02122,2014,47,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2017-02123,2017,62,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.8,low_burden
KE-NRB-2012-02124,2012,38,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.3,low_burden
KE-NRB-2012-02125,2012,49,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,22.5,low_burden
KE-NRB-2010-02126,2010,0,0-14,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,5.2,low_burden
KE-NRB-2010-02127,2010,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,12.1,low_burden
KE-NRB-2013-02128,2013,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,18.3,low_burden
KE-NRB-2011-02129,2011,25,25-34,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,7.3,low_burden
KE-NRB-2013-02130,2013,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.4,low_burden
KE-NRB-2016-02131,2016,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,11.5,low_burden
KE-NRB-2017-02132,2017,81,75+,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Dead,14.7,low_burden
KE-NRB-2017-02133,2017,73,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,35.4,low_burden
KE-NRB-2016-02134,2016,39,35-44,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,56.2,low_burden
KE-NRB-2009-02135,2009,80,75+,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2013-02136,2013,85,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,1.3,low_burden
KE-NRB-2013-02137,2013,93,75+,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-02138,2015,71,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.6,low_burden
KE-NRB-2016-02139,2016,92,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2018-02140,2018,37,35-44,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.7,low_burden
KE-NRB-2018-02141,2018,69,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.7,low_burden
KE-NRB-2014-02142,2014,74,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.4,low_burden
KE-NRB-2018-02143,2018,58,55-64,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.5,low_burden
KE-NRB-2013-02144,2013,52,45-54,Male,Skin (melanoma),Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.8,low_burden
KE-NRB-2012-02145,2012,48,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,37.8,low_burden
KE-NRB-2014-02146,2014,68,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.3,low_burden
KE-NRB-2012-02147,2012,42,35-44,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.3,low_burden
KE-NRB-2010-02148,2010,35,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,26.6,low_burden
KE-NRB-2016-02149,2016,45,45-54,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-02150,2011,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,51.7,low_burden
KE-NRB-2015-02151,2015,92,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.5,low_burden
KE-NRB-2018-02152,2018,43,35-44,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.8,low_burden
KE-NRB-2017-02153,2017,37,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,41.4,low_burden
KE-NRB-2018-02154,2018,90,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2010-02155,2010,63,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.8,low_burden
KE-NRB-2012-02156,2012,50,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,43.4,low_burden
KE-NRB-2017-02157,2017,76,75+,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,35.8,low_burden
KE-NRB-2018-02158,2018,36,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,14.3,low_burden
KE-NRB-2018-02159,2018,47,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.1,low_burden
KE-NRB-2012-02160,2012,56,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,9.7,low_burden
KE-NRB-2016-02161,2016,46,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.3,low_burden
KE-NRB-2018-02162,2018,32,25-34,Female,Corpus uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.0,low_burden
KE-NRB-2018-02163,2018,43,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,52.4,low_burden
KE-NRB-2014-02164,2014,47,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.6,low_burden
KE-NRB-2012-02165,2012,44,35-44,Female,Breast,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,4.7,low_burden
KE-NRB-2014-02166,2014,55,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.9,low_burden
KE-NRB-2012-02167,2012,38,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,19.3,low_burden
KE-NRB-2016-02168,2016,21,15-24,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2017-02169,2017,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.9,low_burden
KE-NRB-2012-02170,2012,79,75+,Male,Kidney,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.5,low_burden
KE-NRB-2014-02171,2014,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,4.0,low_burden
KE-NRB-2012-02172,2012,70,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,12.6,low_burden
KE-NRB-2016-02173,2016,58,55-64,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-02174,2017,91,75+,Male,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Rural,Radiotherapy only,Alive,16.8,low_burden
KE-NRB-2016-02175,2016,50,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,41.9,low_burden
KE-NRB-2016-02176,2016,30,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,56.2,low_burden
KE-NRB-2014-02177,2014,73,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-02178,2017,69,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.5,low_burden
KE-NRB-2009-02179,2009,71,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.6,low_burden
KE-NRB-2012-02180,2012,52,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,33.0,low_burden
KE-NRB-2016-02181,2016,42,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,20.7,low_burden
KE-NRB-2009-02182,2009,54,45-54,Male,Pancreas,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-02183,2017,60,55-64,Female,Other,Leukemia,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,18.4,low_burden
KE-NRB-2015-02184,2015,49,45-54,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.4,low_burden
KE-NRB-2013-02185,2013,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,41.9,low_burden
KE-NRB-2013-02186,2013,21,15-24,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,6.8,low_burden
KE-NRB-2017-02187,2017,49,45-54,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,36.2,low_burden
KE-NRB-2017-02188,2017,46,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,45.4,low_burden
KE-NRB-2016-02189,2016,88,75+,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.2,low_burden
KE-NRB-2017-02190,2017,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,34.1,low_burden
KE-NRB-2017-02191,2017,36,35-44,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,19.8,low_burden
KE-NRB-2011-02192,2011,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,5.0,low_burden
KE-NRB-2015-02193,2015,32,25-34,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery + Chemotherapy,Alive,57.9,low_burden
KE-NRB-2014-02194,2014,52,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-02195,2012,48,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,36.2,low_burden
KE-NRB-2009-02196,2009,63,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,40.4,low_burden
KE-NRB-2015-02197,2015,47,45-54,Male,Brain and CNS,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,60.0,low_burden
KE-NRB-2011-02198,2011,66,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.9,low_burden
KE-NRB-2014-02199,2014,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,46.3,low_burden
KE-NRB-2012-02200,2012,43,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,36.5,low_burden
KE-NRB-2014-02201,2014,60,55-64,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.8,low_burden
KE-NRB-2016-02202,2016,68,65-74,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,37.6,low_burden
KE-NRB-2013-02203,2013,38,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,16.1,low_burden
KE-NRB-2016-02204,2016,41,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.8,low_burden
KE-NRB-2013-02205,2013,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,44.3,low_burden
KE-NRB-2017-02206,2017,55,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-02207,2009,89,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.8,low_burden
KE-NRB-2018-02208,2018,44,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.3,low_burden
KE-NRB-2015-02209,2015,53,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,18.9,low_burden
KE-NRB-2018-02210,2018,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.9,low_burden
KE-NRB-2016-02211,2016,77,75+,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,15.4,low_burden
KE-NRB-2017-02212,2017,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,16.7,low_burden
KE-NRB-2010-02213,2010,47,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,54.9,low_burden
KE-NRB-2014-02214,2014,95,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,38.4,low_burden
KE-NRB-2018-02215,2018,38,35-44,Male,Non-Hodgkin lymphoma,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.5,low_burden
KE-NRB-2013-02216,2013,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,41.3,low_burden
KE-NRB-2013-02217,2013,39,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.9,low_burden
KE-NRB-2012-02218,2012,59,55-64,Male,Skin (melanoma),Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,24.0,low_burden
KE-NRB-2015-02219,2015,25,25-34,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.0,low_burden
KE-NRB-2016-02220,2016,46,45-54,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,1.6,low_burden
KE-NRB-2012-02221,2012,55,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.5,low_burden
KE-NRB-2016-02222,2016,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,30.1,low_burden
KE-NRB-2011-02223,2011,57,55-64,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,17.2,low_burden
KE-NRB-2009-02224,2009,94,75+,Male,Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,50.8,low_burden
KE-NRB-2010-02225,2010,42,35-44,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,14.7,low_burden
KE-NRB-2014-02226,2014,3,0-14,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.8,low_burden
KE-NRB-2012-02227,2012,55,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.1,low_burden
KE-NRB-2015-02228,2015,70,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,4.2,low_burden
KE-NRB-2018-02229,2018,42,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,21.5,low_burden
KE-NRB-2018-02230,2018,84,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.7,low_burden
KE-NRB-2009-02231,2009,35,35-44,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,23.2,low_burden
KE-NRB-2016-02232,2016,36,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.0,low_burden
KE-NRB-2013-02233,2013,42,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,18.2,low_burden
KE-NRB-2015-02234,2015,56,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-02235,2016,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-02236,2017,64,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-02237,2014,70,65-74,Male,Non-Hodgkin lymphoma,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2018-02238,2018,52,45-54,Male,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,15.7,low_burden
KE-NRB-2015-02239,2015,71,65-74,Male,Non-Hodgkin lymphoma,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,17.3,low_burden
KE-NRB-2017-02240,2017,24,15-24,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,17.8,low_burden
KE-NRB-2013-02241,2013,74,65-74,Male,Lung,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,24.4,low_burden
KE-NRB-2013-02242,2013,42,35-44,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.6,low_burden
KE-NRB-2018-02243,2018,74,65-74,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,7.9,low_burden
KE-NRB-2015-02244,2015,36,35-44,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-02245,2010,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,33.6,low_burden
KE-NRB-2012-02246,2012,72,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.5,low_burden
KE-NRB-2016-02247,2016,58,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,39.5,low_burden
KE-NRB-2013-02248,2013,85,75+,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.4,low_burden
KE-NRB-2015-02249,2015,64,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,56.6,low_burden
KE-NRB-2016-02250,2016,69,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.0,low_burden
KE-NRB-2010-02251,2010,66,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,7.4,low_burden
KE-NRB-2015-02252,2015,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,5.2,low_burden
KE-NRB-2011-02253,2011,62,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.4,low_burden
KE-NRB-2015-02254,2015,60,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-02255,2013,35,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.1,low_burden
KE-NRB-2013-02256,2013,69,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,low_burden
KE-NRB-2011-02257,2011,73,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.7,low_burden
KE-NRB-2018-02258,2018,48,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.1,low_burden
KE-NRB-2011-02259,2011,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.4,low_burden
KE-NRB-2011-02260,2011,79,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2016-02261,2016,51,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,35.5,low_burden
KE-NRB-2016-02262,2016,54,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Dead,16.7,low_burden
KE-NRB-2013-02263,2013,52,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,0.6,low_burden
KE-NRB-2016-02264,2016,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.9,low_burden
KE-NRB-2011-02265,2011,82,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,8.5,low_burden
KE-NRB-2012-02266,2012,66,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.2,low_burden
KE-NRB-2012-02267,2012,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-02268,2016,78,75+,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.1,low_burden
KE-NRB-2011-02269,2011,65,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.1,low_burden
KE-NRB-2014-02270,2014,50,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Alive,32.9,low_burden
KE-NRB-2010-02271,2010,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,44.4,low_burden
KE-NRB-2012-02272,2012,70,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,32.4,low_burden
KE-NRB-2015-02273,2015,74,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-02274,2009,68,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,38.0,low_burden
KE-NRB-2017-02275,2017,79,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-02276,2014,29,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.0,low_burden
KE-NRB-2017-02277,2017,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.2,low_burden
KE-NRB-2016-02278,2016,67,65-74,Male,Oesophagus,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Dead,0.8,low_burden
KE-NRB-2013-02279,2013,73,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,52.1,low_burden
KE-NRB-2013-02280,2013,74,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,32.3,low_burden
KE-NRB-2012-02281,2012,78,75+,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Rural,N/A,Dead,15.0,low_burden
KE-NRB-2010-02282,2010,58,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-02283,2011,88,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.5,low_burden
KE-NRB-2015-02284,2015,34,25-34,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-02285,2017,91,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2009-02286,2009,59,55-64,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,5.5,low_burden
KE-NRB-2013-02287,2013,60,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,18.2,low_burden
KE-NRB-2010-02288,2010,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-02289,2018,48,45-54,Female,Breast,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,21.2,low_burden
KE-NRB-2016-02290,2016,47,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.6,low_burden
KE-NRB-2014-02291,2014,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,21.6,low_burden
KE-NRB-2015-02292,2015,68,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,23.7,low_burden
KE-NRB-2012-02293,2012,53,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.3,low_burden
KE-NRB-2018-02294,2018,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,58.4,low_burden
KE-NRB-2012-02295,2012,48,45-54,Female,Breast,Sarcoma,Unknown,Other,Malignant,Urban,Surgery + Chemotherapy,Alive,35.7,low_burden
KE-NRB-2015-02296,2015,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,12.2,low_burden
KE-NRB-2015-02297,2015,62,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2014-02298,2014,47,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,8.9,low_burden
KE-NRB-2012-02299,2012,41,35-44,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-02300,2013,46,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,20.4,low_burden
KE-NRB-2018-02301,2018,67,65-74,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.2,low_burden
KE-NRB-2017-02302,2017,52,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.1,low_burden
KE-NRB-2017-02303,2017,57,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,49.8,low_burden
KE-NRB-2014-02304,2014,76,75+,Female,Other,Other specified,Moderately differentiated (Grade II),Other,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2010-02305,2010,40,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-02306,2011,27,25-34,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,50.9,low_burden
KE-NRB-2011-02307,2011,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,1.0,low_burden
KE-NRB-2014-02308,2014,66,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,30.5,low_burden
KE-NRB-2015-02309,2015,53,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-02310,2017,59,55-64,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.7,low_burden
KE-NRB-2017-02311,2017,31,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,35.0,low_burden
KE-NRB-2018-02312,2018,37,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,14.8,low_burden
KE-NRB-2014-02313,2014,38,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,10.9,low_burden
KE-NRB-2009-02314,2009,41,35-44,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-02315,2016,8,0-14,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,13.5,low_burden
KE-NRB-2016-02316,2016,52,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.0,low_burden
KE-NRB-2018-02317,2018,64,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.7,low_burden
KE-NRB-2016-02318,2016,37,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.0,low_burden
KE-NRB-2017-02319,2017,60,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.4,low_burden
KE-NRB-2017-02320,2017,37,35-44,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,40.9,low_burden
KE-NRB-2009-02321,2009,73,65-74,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,49.5,low_burden
KE-NRB-2010-02322,2010,20,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.0,low_burden
KE-NRB-2013-02323,2013,52,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,34.2,low_burden
KE-NRB-2017-02324,2017,30,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,14.4,low_burden
KE-NRB-2012-02325,2012,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.6,low_burden
KE-NRB-2013-02326,2013,65,65-74,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.2,low_burden
KE-NRB-2013-02327,2013,29,25-34,Male,Prostate,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,2.9,low_burden
KE-NRB-2011-02328,2011,63,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,No treatment,Dead,57.1,low_burden
KE-NRB-2015-02329,2015,69,65-74,Female,Breast,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,1.2,low_burden
KE-NRB-2011-02330,2011,85,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,18.0,low_burden
KE-NRB-2014-02331,2014,79,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-02332,2014,65,65-74,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,26.9,low_burden
KE-NRB-2009-02333,2009,57,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,4.0,low_burden
KE-NRB-2010-02334,2010,49,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,34.0,low_burden
KE-NRB-2016-02335,2016,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.8,low_burden
KE-NRB-2012-02336,2012,30,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,11.0,low_burden
KE-NRB-2013-02337,2013,49,45-54,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Alive,3.5,low_burden
KE-NRB-2016-02338,2016,61,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.3,low_burden
KE-NRB-2017-02339,2017,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,19.5,low_burden
KE-NRB-2016-02340,2016,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,5.7,low_burden
KE-NRB-2012-02341,2012,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-02342,2010,65,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.2,low_burden
KE-NRB-2017-02343,2017,65,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-02344,2010,68,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,25.3,low_burden
KE-NRB-2015-02345,2015,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,19.7,low_burden
KE-NRB-2018-02346,2018,33,25-34,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-02347,2017,37,35-44,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.6,low_burden
KE-NRB-2018-02348,2018,27,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,36.3,low_burden
KE-NRB-2018-02349,2018,70,65-74,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.8,low_burden
KE-NRB-2017-02350,2017,30,25-34,Female,Cervix uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,19.0,low_burden
KE-NRB-2013-02351,2013,39,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,24.3,low_burden
KE-NRB-2018-02352,2018,72,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2018-02353,2018,52,45-54,Male,Liver,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,55.1,low_burden
KE-NRB-2012-02354,2012,68,65-74,Male,Colorectum,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,13.9,low_burden
KE-NRB-2009-02355,2009,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,58.7,low_burden
KE-NRB-2014-02356,2014,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2010-02357,2010,34,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,3.0,low_burden
KE-NRB-2015-02358,2015,54,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,17.2,low_burden
KE-NRB-2014-02359,2014,55,55-64,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2016-02360,2016,62,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,15.0,low_burden
KE-NRB-2010-02361,2010,11,0-14,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.4,low_burden
KE-NRB-2009-02362,2009,43,35-44,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-02363,2011,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-02364,2018,32,25-34,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,10.6,low_burden
KE-NRB-2017-02365,2017,33,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.7,low_burden
KE-NRB-2016-02366,2016,64,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2009-02367,2009,41,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,0.6,low_burden
KE-NRB-2014-02368,2014,74,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Radiotherapy only,Dead,4.7,low_burden
KE-NRB-2017-02369,2017,37,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,20.9,low_burden
KE-NRB-2016-02370,2016,67,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,11.0,low_burden
KE-NRB-2016-02371,2016,39,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02372,2015,68,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-02373,2010,54,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,23.4,low_burden
KE-NRB-2016-02374,2016,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2018-02375,2018,84,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,43.7,low_burden
KE-NRB-2015-02376,2015,63,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.4,low_burden
KE-NRB-2017-02377,2017,50,45-54,Male,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,In situ,Rural,N/A,Alive,12.1,low_burden
KE-NRB-2014-02378,2014,39,35-44,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.3,low_burden
KE-NRB-2015-02379,2015,44,35-44,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,0.1,low_burden
KE-NRB-2014-02380,2014,57,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,16.4,low_burden
KE-NRB-2014-02381,2014,58,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.6,low_burden
KE-NRB-2011-02382,2011,43,35-44,Female,Other,Sarcoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Alive,4.2,low_burden
KE-NRB-2015-02383,2015,64,55-64,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,20.0,low_burden
KE-NRB-2014-02384,2014,64,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.0,low_burden
KE-NRB-2017-02385,2017,20,15-24,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.4,low_burden
KE-NRB-2018-02386,2018,66,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,22.1,low_burden
KE-NRB-2017-02387,2017,74,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.3,low_burden
KE-NRB-2015-02388,2015,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,20.5,low_burden
KE-NRB-2018-02389,2018,95,75+,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2009-02390,2009,43,35-44,Female,Corpus uteri,Other specified,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Dead,47.5,low_burden
KE-NRB-2017-02391,2017,64,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,5.8,low_burden
KE-NRB-2015-02392,2015,63,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.3,low_burden
KE-NRB-2016-02393,2016,36,35-44,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.5,low_burden
KE-NRB-2014-02394,2014,43,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.6,low_burden
KE-NRB-2013-02395,2013,47,45-54,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,42.8,low_burden
KE-NRB-2012-02396,2012,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,43.6,low_burden
KE-NRB-2017-02397,2017,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02398,2016,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-02399,2009,1,0-14,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,23.5,low_burden
KE-NRB-2015-02400,2015,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,41.9,low_burden
KE-NRB-2014-02401,2014,45,45-54,Male,Bladder,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,low_burden
KE-NRB-2016-02402,2016,57,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,42.5,low_burden
KE-NRB-2016-02403,2016,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Lost to follow-up,7.4,low_burden
KE-NRB-2015-02404,2015,44,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-02405,2010,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,44.0,low_burden
KE-NRB-2017-02406,2017,49,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,24.5,low_burden
KE-NRB-2012-02407,2012,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,25.5,low_burden
KE-NRB-2012-02408,2012,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,53.4,low_burden
KE-NRB-2011-02409,2011,62,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,30.9,low_burden
KE-NRB-2017-02410,2017,70,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2011-02411,2011,62,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.9,low_burden
KE-NRB-2012-02412,2012,43,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,35.4,low_burden
KE-NRB-2018-02413,2018,46,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,38.7,low_burden
KE-NRB-2016-02414,2016,25,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-02415,2017,89,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,53.9,low_burden
KE-NRB-2011-02416,2011,61,55-64,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.0,low_burden
KE-NRB-2016-02417,2016,59,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,0.6,low_burden
KE-NRB-2017-02418,2017,67,65-74,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,36.1,low_burden
KE-NRB-2012-02419,2012,35,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,9.6,low_burden
KE-NRB-2009-02420,2009,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,39.8,low_burden
KE-NRB-2010-02421,2010,58,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.8,low_burden
KE-NRB-2012-02422,2012,29,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.3,low_burden
KE-NRB-2018-02423,2018,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Alive,27.0,low_burden
KE-NRB-2014-02424,2014,34,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-02425,2010,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,38.5,low_burden
KE-NRB-2013-02426,2013,67,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.8,low_burden
KE-NRB-2017-02427,2017,58,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.5,low_burden
KE-NRB-2017-02428,2017,65,65-74,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,low_burden
KE-NRB-2013-02429,2013,4,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-02430,2010,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-02431,2010,55,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,23.4,low_burden
KE-NRB-2016-02432,2016,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,14.9,low_burden
KE-NRB-2015-02433,2015,14,0-14,Female,Breast,Adenocarcinoma,Unknown,Death certificate only,In situ,Rural,N/A,Dead,20.3,low_burden
KE-NRB-2011-02434,2011,66,65-74,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-02435,2014,56,55-64,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,In situ,Peri-urban,N/A,Dead,27.3,low_burden
KE-NRB-2015-02436,2015,39,35-44,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.5,low_burden
KE-NRB-2018-02437,2018,51,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,46.6,low_burden
KE-NRB-2014-02438,2014,66,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.7,low_burden
KE-NRB-2009-02439,2009,58,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,10.4,low_burden
KE-NRB-2011-02440,2011,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,31.7,low_burden
KE-NRB-2013-02441,2013,51,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,12.8,low_burden
KE-NRB-2016-02442,2016,52,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,12.8,low_burden
KE-NRB-2018-02443,2018,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-02444,2013,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,17.3,low_burden
KE-NRB-2017-02445,2017,51,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.4,low_burden
KE-NRB-2017-02446,2017,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.5,low_burden
KE-NRB-2009-02447,2009,41,35-44,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,24.9,low_burden
KE-NRB-2015-02448,2015,66,65-74,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.2,low_burden
KE-NRB-2011-02449,2011,53,45-54,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Dead,29.4,low_burden
KE-NRB-2017-02450,2017,32,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,12.5,low_burden
KE-NRB-2017-02451,2017,77,75+,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,9.0,low_burden
KE-NRB-2017-02452,2017,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.7,low_burden
KE-NRB-2012-02453,2012,35,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,18.4,low_burden
KE-NRB-2010-02454,2010,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,16.2,low_burden
KE-NRB-2017-02455,2017,75,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.3,low_burden
KE-NRB-2009-02456,2009,64,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,41.9,low_burden
KE-NRB-2011-02457,2011,54,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.5,low_burden
KE-NRB-2017-02458,2017,25,25-34,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,27.0,low_burden
KE-NRB-2012-02459,2012,84,75+,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,3.3,low_burden
KE-NRB-2018-02460,2018,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,19.3,low_burden
KE-NRB-2011-02461,2011,72,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-02462,2018,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,50.5,low_burden
KE-NRB-2016-02463,2016,53,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,43.7,low_burden
KE-NRB-2013-02464,2013,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.9,low_burden
KE-NRB-2016-02465,2016,49,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.0,low_burden
KE-NRB-2017-02466,2017,83,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2018-02467,2018,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,23.1,low_burden
KE-NRB-2016-02468,2016,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,21.5,low_burden
KE-NRB-2009-02469,2009,44,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,60.0,low_burden
KE-NRB-2012-02470,2012,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-02471,2014,57,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2010-02472,2010,24,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-02473,2016,57,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,8.7,low_burden
KE-NRB-2018-02474,2018,4,0-14,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-02475,2017,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,60.0,low_burden
KE-NRB-2017-02476,2017,68,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.3,low_burden
KE-NRB-2017-02477,2017,30,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,5.1,low_burden
KE-NRB-2010-02478,2010,69,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,7.0,low_burden
KE-NRB-2010-02479,2010,85,75+,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,10.0,low_burden
KE-NRB-2011-02480,2011,40,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.5,low_burden
KE-NRB-2018-02481,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,42.3,low_burden
KE-NRB-2010-02482,2010,54,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,32.2,low_burden
KE-NRB-2014-02483,2014,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-02484,2011,47,45-54,Male,Colorectum,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.6,low_burden
KE-NRB-2010-02485,2010,53,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.2,low_burden
KE-NRB-2010-02486,2010,40,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.2,low_burden
KE-NRB-2012-02487,2012,45,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Lost to follow-up,36.8,low_burden
KE-NRB-2016-02488,2016,43,35-44,Male,Leukemia,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,2.2,low_burden
KE-NRB-2014-02489,2014,71,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Lost to follow-up,47.8,low_burden
KE-NRB-2017-02490,2017,50,45-54,Male,Other,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-02491,2009,52,45-54,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,27.4,low_burden
KE-NRB-2009-02492,2009,36,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.5,low_burden
KE-NRB-2014-02493,2014,66,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.0,low_burden
KE-NRB-2013-02494,2013,40,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.1,low_burden
KE-NRB-2013-02495,2013,49,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,35.4,low_burden
KE-NRB-2017-02496,2017,43,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-02497,2018,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.4,low_burden
KE-NRB-2013-02498,2013,75,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.4,low_burden
KE-NRB-2017-02499,2017,50,45-54,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,41.3,low_burden
KE-NRB-2013-02500,2013,51,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,57.2,low_burden
KE-NRB-2012-02501,2012,64,55-64,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.6,low_burden
KE-NRB-2010-02502,2010,50,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.0,low_burden
KE-NRB-2014-02503,2014,64,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,5.3,low_burden
KE-NRB-2014-02504,2014,41,35-44,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,8.0,low_burden
KE-NRB-2016-02505,2016,74,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.5,low_burden
KE-NRB-2013-02506,2013,42,35-44,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,1.8,low_burden
KE-NRB-2015-02507,2015,71,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.4,low_burden
KE-NRB-2009-02508,2009,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,4.2,low_burden
KE-NRB-2016-02509,2016,38,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-02510,2018,54,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.2,low_burden
KE-NRB-2013-02511,2013,52,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.6,low_burden
KE-NRB-2016-02512,2016,72,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,8.7,low_burden
KE-NRB-2018-02513,2018,70,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.6,low_burden
KE-NRB-2015-02514,2015,45,45-54,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-02515,2011,28,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.3,low_burden
KE-NRB-2010-02516,2010,25,25-34,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.5,low_burden
KE-NRB-2009-02517,2009,28,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,35.9,low_burden
KE-NRB-2012-02518,2012,68,65-74,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,9.6,low_burden
KE-NRB-2018-02519,2018,63,55-64,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.8,low_burden
KE-NRB-2014-02520,2014,89,75+,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-02521,2017,13,0-14,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,42.6,low_burden
KE-NRB-2012-02522,2012,66,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.8,low_burden
KE-NRB-2010-02523,2010,68,65-74,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.6,low_burden
KE-NRB-2011-02524,2011,53,45-54,Male,Oesophagus,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.4,low_burden
KE-NRB-2016-02525,2016,36,35-44,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2013-02526,2013,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,31.3,low_burden
KE-NRB-2017-02527,2017,66,65-74,Male,Lung,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,16.8,low_burden
KE-NRB-2018-02528,2018,52,45-54,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,26.0,low_burden
KE-NRB-2013-02529,2013,60,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.2,low_burden
KE-NRB-2017-02530,2017,51,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,32.5,low_burden
KE-NRB-2018-02531,2018,52,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,11.2,low_burden
KE-NRB-2016-02532,2016,49,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,47.4,low_burden
KE-NRB-2013-02533,2013,79,75+,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.6,low_burden
KE-NRB-2017-02534,2017,28,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.8,low_burden
KE-NRB-2016-02535,2016,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,28.3,low_burden
KE-NRB-2015-02536,2015,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.1,low_burden
KE-NRB-2014-02537,2014,67,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2009-02538,2009,46,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,39.2,low_burden
KE-NRB-2014-02539,2014,59,55-64,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.5,low_burden
KE-NRB-2015-02540,2015,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.5,low_burden
KE-NRB-2015-02541,2015,58,55-64,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,33.1,low_burden
KE-NRB-2017-02542,2017,94,75+,Female,Other,Sarcoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,47.9,low_burden
KE-NRB-2016-02543,2016,62,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,42.4,low_burden
KE-NRB-2016-02544,2016,90,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-02545,2015,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.6,low_burden
KE-NRB-2012-02546,2012,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.8,low_burden
KE-NRB-2013-02547,2013,40,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,13.1,low_burden
KE-NRB-2010-02548,2010,64,55-64,Female,Corpus uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-02549,2011,71,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,27.3,low_burden
KE-NRB-2016-02550,2016,30,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02551,2016,89,75+,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,34.3,low_burden
KE-NRB-2012-02552,2012,36,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Lost to follow-up,39.3,low_burden
KE-NRB-2009-02553,2009,37,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,1.2,low_burden
KE-NRB-2013-02554,2013,58,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.2,low_burden
KE-NRB-2013-02555,2013,68,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2010-02556,2010,72,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-02557,2015,67,65-74,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.4,low_burden
KE-NRB-2013-02558,2013,65,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.7,low_burden
KE-NRB-2016-02559,2016,49,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,25.1,low_burden
KE-NRB-2012-02560,2012,54,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-02561,2012,53,45-54,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.2,low_burden
KE-NRB-2009-02562,2009,47,45-54,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-02563,2012,13,0-14,Female,Ovary,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,44.6,low_burden
KE-NRB-2016-02564,2016,79,75+,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-02565,2012,64,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.7,low_burden
KE-NRB-2017-02566,2017,56,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.6,low_burden
KE-NRB-2018-02567,2018,55,55-64,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,18.6,low_burden
KE-NRB-2015-02568,2015,62,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,33.6,low_burden
KE-NRB-2015-02569,2015,55,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-02570,2017,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-02571,2015,27,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,26.7,low_burden
KE-NRB-2018-02572,2018,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,60.0,low_burden
KE-NRB-2017-02573,2017,37,35-44,Male,Kidney,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,15.0,low_burden
KE-NRB-2013-02574,2013,31,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.2,low_burden
KE-NRB-2011-02575,2011,83,75+,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.6,low_burden
KE-NRB-2015-02576,2015,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,8.0,low_burden
KE-NRB-2015-02577,2015,54,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,9.3,low_burden
KE-NRB-2015-02578,2015,62,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,41.7,low_burden
KE-NRB-2013-02579,2013,37,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.1,low_burden
KE-NRB-2016-02580,2016,87,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.2,low_burden
KE-NRB-2016-02581,2016,36,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.7,low_burden
KE-NRB-2014-02582,2014,68,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.8,low_burden
KE-NRB-2011-02583,2011,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,11.9,low_burden
KE-NRB-2012-02584,2012,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.9,low_burden
KE-NRB-2015-02585,2015,50,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,6.2,low_burden
KE-NRB-2011-02586,2011,38,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Peri-urban,N/A,Dead,36.2,low_burden
KE-NRB-2017-02587,2017,34,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.8,low_burden
KE-NRB-2014-02588,2014,57,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,1.0,low_burden
KE-NRB-2010-02589,2010,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.1,low_burden
KE-NRB-2015-02590,2015,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-02591,2018,45,45-54,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,33.4,low_burden
KE-NRB-2013-02592,2013,57,55-64,Male,Pancreas,Adenocarcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,23.8,low_burden
KE-NRB-2012-02593,2012,27,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,22.4,low_burden
KE-NRB-2012-02594,2012,89,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Dead,12.0,low_burden
KE-NRB-2013-02595,2013,78,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.0,low_burden
KE-NRB-2013-02596,2013,63,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.7,low_burden
KE-NRB-2017-02597,2017,57,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-02598,2011,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-02599,2013,54,45-54,Male,Multiple myeloma,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-02600,2013,67,65-74,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,2.1,low_burden
KE-NRB-2017-02601,2017,60,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,5.9,low_burden
KE-NRB-2011-02602,2011,51,45-54,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-02603,2011,73,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,35.9,low_burden
KE-NRB-2014-02604,2014,58,55-64,Male,Lung,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.4,low_burden
KE-NRB-2016-02605,2016,42,35-44,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.0,low_burden
KE-NRB-2015-02606,2015,65,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.6,low_burden
KE-NRB-2009-02607,2009,56,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,46.5,low_burden
KE-NRB-2014-02608,2014,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-02609,2012,28,25-34,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,28.8,low_burden
KE-NRB-2018-02610,2018,70,65-74,Male,Skin (melanoma),Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.3,low_burden
KE-NRB-2018-02611,2018,35,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,15.7,low_burden
KE-NRB-2015-02612,2015,46,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.8,low_burden
KE-NRB-2018-02613,2018,49,45-54,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,48.1,low_burden
KE-NRB-2011-02614,2011,36,35-44,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2009-02615,2009,24,15-24,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,3.9,low_burden
KE-NRB-2012-02616,2012,47,45-54,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,46.0,low_burden
KE-NRB-2017-02617,2017,70,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,16.6,low_burden
KE-NRB-2018-02618,2018,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.9,low_burden
KE-NRB-2017-02619,2017,65,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02620,2016,57,55-64,Male,Stomach,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,18.9,low_burden
KE-NRB-2017-02621,2017,36,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,52.8,low_burden
KE-NRB-2017-02622,2017,45,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,17.9,low_burden
KE-NRB-2016-02623,2016,32,25-34,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,2.5,low_burden
KE-NRB-2013-02624,2013,70,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-02625,2010,28,25-34,Female,Ovary,Sarcoma,Well differentiated (Grade I),Imaging + clinical,In situ,Peri-urban,N/A,Dead,4.0,low_burden
KE-NRB-2017-02626,2017,69,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,14.4,low_burden
KE-NRB-2014-02627,2014,75,75+,Female,Other,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,8.3,low_burden
KE-NRB-2009-02628,2009,60,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,39.6,low_burden
KE-NRB-2016-02629,2016,35,35-44,Male,Kaposi sarcoma,Lymphoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,45.3,low_burden
KE-NRB-2012-02630,2012,71,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.4,low_burden
KE-NRB-2016-02631,2016,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,4.5,low_burden
KE-NRB-2016-02632,2016,51,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-02633,2015,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,34.1,low_burden
KE-NRB-2014-02634,2014,34,25-34,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.7,low_burden
KE-NRB-2012-02635,2012,45,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,5.4,low_burden
KE-NRB-2017-02636,2017,72,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2009-02637,2009,72,65-74,Female,Breast,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,53.8,low_burden
KE-NRB-2016-02638,2016,16,15-24,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2014-02639,2014,50,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.8,low_burden
KE-NRB-2015-02640,2015,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-02641,2011,73,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.7,low_burden
KE-NRB-2016-02642,2016,51,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,45.3,low_burden
KE-NRB-2018-02643,2018,89,75+,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.5,low_burden
KE-NRB-2017-02644,2017,47,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-02645,2012,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,10.1,low_burden
KE-NRB-2017-02646,2017,49,45-54,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.8,low_burden
KE-NRB-2017-02647,2017,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,23.8,low_burden
KE-NRB-2016-02648,2016,69,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,2.9,low_burden
KE-NRB-2013-02649,2013,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.2,low_burden
KE-NRB-2013-02650,2013,55,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,19.2,low_burden
KE-NRB-2010-02651,2010,37,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.6,low_burden
KE-NRB-2015-02652,2015,50,45-54,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,14.9,low_burden
KE-NRB-2016-02653,2016,39,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.6,low_burden
KE-NRB-2018-02654,2018,73,65-74,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.0,low_burden
KE-NRB-2009-02655,2009,56,55-64,Female,Cervix uteri,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,19.8,low_burden
KE-NRB-2014-02656,2014,62,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2010-02657,2010,58,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.6,low_burden
KE-NRB-2015-02658,2015,56,55-64,Male,Colorectum,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,4.2,low_burden
KE-NRB-2011-02659,2011,58,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,44.2,low_burden
KE-NRB-2016-02660,2016,40,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.9,low_burden
KE-NRB-2012-02661,2012,56,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2010-02662,2010,36,35-44,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02663,2016,66,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.7,low_burden
KE-NRB-2009-02664,2009,53,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,5.4,low_burden
KE-NRB-2017-02665,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,56.4,low_burden
KE-NRB-2009-02666,2009,29,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.0,low_burden
KE-NRB-2016-02667,2016,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,19.4,low_burden
KE-NRB-2009-02668,2009,70,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,38.3,low_burden
KE-NRB-2010-02669,2010,28,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,42.0,low_burden
KE-NRB-2011-02670,2011,53,45-54,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2011-02671,2011,43,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,23.9,low_burden
KE-NRB-2016-02672,2016,65,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,7.9,low_burden
KE-NRB-2009-02673,2009,69,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,42.7,low_burden
KE-NRB-2011-02674,2011,15,15-24,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,25.0,low_burden
KE-NRB-2015-02675,2015,55,55-64,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,29.2,low_burden
KE-NRB-2010-02676,2010,36,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.3,low_burden
KE-NRB-2015-02677,2015,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.7,low_burden
KE-NRB-2016-02678,2016,41,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,18.6,low_burden
KE-NRB-2011-02679,2011,58,55-64,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02680,2015,40,35-44,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,17.8,low_burden
KE-NRB-2012-02681,2012,40,35-44,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-02682,2014,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,29.3,low_burden
KE-NRB-2017-02683,2017,50,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Rural,N/A,Alive,21.1,low_burden
KE-NRB-2018-02684,2018,72,65-74,Female,Breast,Adenocarcinoma,Unknown,Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-02685,2018,69,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Lost to follow-up,23.1,low_burden
KE-NRB-2013-02686,2013,50,45-54,Male,Stomach,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.1,low_burden
KE-NRB-2009-02687,2009,60,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,35.1,low_burden
KE-NRB-2014-02688,2014,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-02689,2015,56,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.2,low_burden
KE-NRB-2017-02690,2017,51,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Other,Benign/uncertain,Urban,N/A,Dead,38.2,low_burden
KE-NRB-2013-02691,2013,42,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,1.1,low_burden
KE-NRB-2012-02692,2012,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,33.1,low_burden
KE-NRB-2014-02693,2014,65,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,7.5,low_burden
KE-NRB-2017-02694,2017,55,55-64,Male,Kaposi sarcoma,Other specified,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Alive,4.2,low_burden
KE-NRB-2009-02695,2009,49,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,18.6,low_burden
KE-NRB-2014-02696,2014,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02697,2016,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,0.9,low_burden
KE-NRB-2010-02698,2010,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Palliative care only,Alive,10.0,low_burden
KE-NRB-2015-02699,2015,78,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-02700,2013,40,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,47.7,low_burden
KE-NRB-2018-02701,2018,56,55-64,Male,Leukemia,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.1,low_burden
KE-NRB-2014-02702,2014,34,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.8,low_burden
KE-NRB-2012-02703,2012,41,35-44,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,14.5,low_burden
KE-NRB-2011-02704,2011,35,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,10.0,low_burden
KE-NRB-2013-02705,2013,42,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.4,low_burden
KE-NRB-2016-02706,2016,46,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,11.3,low_burden
KE-NRB-2017-02707,2017,54,45-54,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.8,low_burden
KE-NRB-2017-02708,2017,47,45-54,Male,Colorectum,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,3.2,low_burden
KE-NRB-2012-02709,2012,49,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-02710,2011,64,55-64,Female,Ovary,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,17.4,low_burden
KE-NRB-2016-02711,2016,64,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.6,low_burden
KE-NRB-2015-02712,2015,85,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,40.1,low_burden
KE-NRB-2011-02713,2011,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.8,low_burden
KE-NRB-2016-02714,2016,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.7,low_burden
KE-NRB-2016-02715,2016,64,55-64,Male,Pancreas,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.2,low_burden
KE-NRB-2010-02716,2010,54,45-54,Male,Kaposi sarcoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-02717,2016,49,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-02718,2017,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.0,low_burden
KE-NRB-2017-02719,2017,58,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.5,low_burden
KE-NRB-2018-02720,2018,47,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.8,low_burden
KE-NRB-2009-02721,2009,57,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.1,low_burden
KE-NRB-2017-02722,2017,62,55-64,Male,Hodgkin lymphoma,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,14.1,low_burden
KE-NRB-2014-02723,2014,73,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,In situ,Peri-urban,N/A,Alive,39.3,low_burden
KE-NRB-2013-02724,2013,28,25-34,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,12.9,low_burden
KE-NRB-2013-02725,2013,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,47.4,low_burden
KE-NRB-2017-02726,2017,51,45-54,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,41.1,low_burden
KE-NRB-2015-02727,2015,65,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,17.2,low_burden
KE-NRB-2015-02728,2015,77,75+,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,51.3,low_burden
KE-NRB-2009-02729,2009,37,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,5.2,low_burden
KE-NRB-2016-02730,2016,84,75+,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.3,low_burden
KE-NRB-2015-02731,2015,28,25-34,Male,Kidney,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,14.0,low_burden
KE-NRB-2015-02732,2015,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,5.2,low_burden
KE-NRB-2012-02733,2012,31,25-34,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,38.4,low_burden
KE-NRB-2015-02734,2015,49,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,3.4,low_burden
KE-NRB-2013-02735,2013,38,35-44,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,19.1,low_burden
KE-NRB-2013-02736,2013,59,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,27.0,low_burden
KE-NRB-2016-02737,2016,52,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,46.7,low_burden
KE-NRB-2016-02738,2016,19,15-24,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02739,2016,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,25.9,low_burden
KE-NRB-2015-02740,2015,70,65-74,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.6,low_burden
KE-NRB-2014-02741,2014,25,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02742,2015,85,75+,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,5.2,low_burden
KE-NRB-2017-02743,2017,66,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.5,low_burden
KE-NRB-2015-02744,2015,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.5,low_burden
KE-NRB-2009-02745,2009,69,65-74,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,45.9,low_burden
KE-NRB-2016-02746,2016,53,45-54,Male,Kidney,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.8,low_burden
KE-NRB-2016-02747,2016,45,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,2.6,low_burden
KE-NRB-2016-02748,2016,38,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,19.5,low_burden
KE-NRB-2013-02749,2013,51,45-54,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,35.2,low_burden
KE-NRB-2014-02750,2014,35,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,10.9,low_burden
KE-NRB-2010-02751,2010,48,45-54,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.9,low_burden
KE-NRB-2013-02752,2013,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,29.0,low_burden
KE-NRB-2012-02753,2012,32,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,40.2,low_burden
KE-NRB-2016-02754,2016,53,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-02755,2010,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.4,low_burden
KE-NRB-2012-02756,2012,0,0-14,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,52.7,low_burden
KE-NRB-2013-02757,2013,0,0-14,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,38.8,low_burden
KE-NRB-2011-02758,2011,61,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,59.9,low_burden
KE-NRB-2011-02759,2011,70,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.4,low_burden
KE-NRB-2012-02760,2012,63,55-64,Male,Stomach,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.6,low_burden
KE-NRB-2018-02761,2018,53,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.6,low_burden
KE-NRB-2017-02762,2017,67,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.1,low_burden
KE-NRB-2017-02763,2017,46,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,13.9,low_burden
KE-NRB-2018-02764,2018,83,75+,Male,Oesophagus,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,0.7,low_burden
KE-NRB-2015-02765,2015,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,35.2,low_burden
KE-NRB-2015-02766,2015,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.9,low_burden
KE-NRB-2012-02767,2012,64,55-64,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,5.5,low_burden
KE-NRB-2016-02768,2016,56,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,51.5,low_burden
KE-NRB-2016-02769,2016,51,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,27.6,low_burden
KE-NRB-2017-02770,2017,9,0-14,Male,Kaposi sarcoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,3.3,low_burden
KE-NRB-2018-02771,2018,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,7.1,low_burden
KE-NRB-2012-02772,2012,90,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-02773,2017,68,65-74,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,27.5,low_burden
KE-NRB-2010-02774,2010,52,45-54,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02775,2016,52,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,13.9,low_burden
KE-NRB-2014-02776,2014,74,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2015-02777,2015,33,25-34,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.8,low_burden
KE-NRB-2015-02778,2015,16,15-24,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,3.2,low_burden
KE-NRB-2012-02779,2012,83,75+,Male,Kidney,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,18.8,low_burden
KE-NRB-2018-02780,2018,42,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,36.8,low_burden
KE-NRB-2012-02781,2012,57,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,13.7,low_burden
KE-NRB-2012-02782,2012,67,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,low_burden
KE-NRB-2015-02783,2015,38,35-44,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,37.1,low_burden
KE-NRB-2016-02784,2016,36,35-44,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,52.6,low_burden
KE-NRB-2017-02785,2017,66,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,10.6,low_burden
KE-NRB-2013-02786,2013,47,45-54,Male,Bladder,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-02787,2018,53,45-54,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2013-02788,2013,93,75+,Male,Pancreas,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.2,low_burden
KE-NRB-2013-02789,2013,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,35.9,low_burden
KE-NRB-2018-02790,2018,33,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,23.6,low_burden
KE-NRB-2015-02791,2015,55,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Dead,40.2,low_burden
KE-NRB-2016-02792,2016,51,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,23.5,low_burden
KE-NRB-2015-02793,2015,47,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,27.4,low_burden
KE-NRB-2011-02794,2011,28,25-34,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,13.9,low_burden
KE-NRB-2012-02795,2012,95,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.1,low_burden
KE-NRB-2017-02796,2017,46,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.1,low_burden
KE-NRB-2013-02797,2013,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,47.3,low_burden
KE-NRB-2011-02798,2011,89,75+,Male,Multiple myeloma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,7.6,low_burden
KE-NRB-2018-02799,2018,77,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.9,low_burden
KE-NRB-2016-02800,2016,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.3,low_burden
KE-NRB-2016-02801,2016,59,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,6.3,low_burden
KE-NRB-2014-02802,2014,44,35-44,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.5,low_burden
KE-NRB-2017-02803,2017,77,75+,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.8,low_burden
KE-NRB-2018-02804,2018,74,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.5,low_burden
KE-NRB-2013-02805,2013,21,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,38.0,low_burden
KE-NRB-2016-02806,2016,48,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,23.3,low_burden
KE-NRB-2017-02807,2017,83,75+,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02808,2016,63,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,32.1,low_burden
KE-NRB-2017-02809,2017,88,75+,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Peri-urban,N/A,Dead,3.0,low_burden
KE-NRB-2016-02810,2016,50,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02811,2015,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,38.2,low_burden
KE-NRB-2009-02812,2009,60,55-64,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.0,low_burden
KE-NRB-2017-02813,2017,57,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.7,low_burden
KE-NRB-2018-02814,2018,57,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.1,low_burden
KE-NRB-2018-02815,2018,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,8.9,low_burden
KE-NRB-2014-02816,2014,30,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,21.4,low_burden
KE-NRB-2018-02817,2018,48,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.4,low_burden
KE-NRB-2011-02818,2011,68,65-74,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.4,low_burden
KE-NRB-2016-02819,2016,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,48.0,low_burden
KE-NRB-2014-02820,2014,48,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.5,low_burden
KE-NRB-2010-02821,2010,50,45-54,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,1.1,low_burden
KE-NRB-2016-02822,2016,68,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.4,low_burden
KE-NRB-2016-02823,2016,38,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,6.1,low_burden
KE-NRB-2010-02824,2010,45,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,14.3,low_burden
KE-NRB-2018-02825,2018,48,45-54,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,27.4,low_burden
KE-NRB-2012-02826,2012,60,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-02827,2016,54,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.2,low_burden
KE-NRB-2016-02828,2016,27,25-34,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2016-02829,2016,59,55-64,Male,Prostate,Sarcoma,Unknown,Other,Malignant,Urban,Surgery only,Dead,20.3,low_burden
KE-NRB-2017-02830,2017,39,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,40.9,low_burden
KE-NRB-2018-02831,2018,69,65-74,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.9,low_burden
KE-NRB-2014-02832,2014,64,55-64,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,11.6,low_burden
KE-NRB-2017-02833,2017,57,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.9,low_burden
KE-NRB-2013-02834,2013,68,65-74,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,2.8,low_burden
KE-NRB-2009-02835,2009,55,55-64,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,18.2,low_burden
KE-NRB-2015-02836,2015,57,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,51.1,low_burden
KE-NRB-2010-02837,2010,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,31.5,low_burden
KE-NRB-2011-02838,2011,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,5.7,low_burden
KE-NRB-2013-02839,2013,13,0-14,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,56.4,low_burden
KE-NRB-2014-02840,2014,61,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,20.6,low_burden
KE-NRB-2009-02841,2009,47,45-54,Male,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.5,low_burden
KE-NRB-2018-02842,2018,29,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.6,low_burden
KE-NRB-2013-02843,2013,67,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,21.2,low_burden
KE-NRB-2010-02844,2010,56,55-64,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.4,low_burden
KE-NRB-2010-02845,2010,55,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,2.3,low_burden
KE-NRB-2018-02846,2018,21,15-24,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,10.7,low_burden
KE-NRB-2013-02847,2013,64,55-64,Male,Prostate,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,8.8,low_burden
KE-NRB-2015-02848,2015,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,8.6,low_burden
KE-NRB-2015-02849,2015,43,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-02850,2014,55,55-64,Male,Brain and CNS,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,35.9,low_burden
KE-NRB-2017-02851,2017,45,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,3.2,low_burden
KE-NRB-2014-02852,2014,64,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,37.5,low_burden
KE-NRB-2011-02853,2011,51,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Radiotherapy only,Dead,9.2,low_burden
KE-NRB-2011-02854,2011,44,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,8.0,low_burden
KE-NRB-2010-02855,2010,43,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,9.9,low_burden
KE-NRB-2014-02856,2014,52,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,56.2,low_burden
KE-NRB-2015-02857,2015,52,45-54,Male,Non-Hodgkin lymphoma,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-02858,2014,22,15-24,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-02859,2010,40,35-44,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-02860,2015,65,65-74,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,9.1,low_burden
KE-NRB-2009-02861,2009,60,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,In situ,Urban,N/A,Alive,20.5,low_burden
KE-NRB-2009-02862,2009,65,65-74,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,44.9,low_burden
KE-NRB-2016-02863,2016,28,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,59.5,low_burden
KE-NRB-2013-02864,2013,64,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-02865,2015,25,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.0,low_burden
KE-NRB-2014-02866,2014,51,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2016-02867,2016,50,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.4,low_burden
KE-NRB-2017-02868,2017,54,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-02869,2014,20,15-24,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-02870,2018,65,65-74,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Dead,12.1,low_burden
KE-NRB-2015-02871,2015,71,65-74,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-02872,2017,39,35-44,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,30.1,low_burden
KE-NRB-2014-02873,2014,63,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2016-02874,2016,38,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,27.1,low_burden
KE-NRB-2016-02875,2016,79,75+,Male,Kidney,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.6,low_burden
KE-NRB-2017-02876,2017,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,43.5,low_burden
KE-NRB-2009-02877,2009,43,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.2,low_burden
KE-NRB-2018-02878,2018,71,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,3.1,low_burden
KE-NRB-2018-02879,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-02880,2014,46,45-54,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.1,low_burden
KE-NRB-2010-02881,2010,46,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.8,low_burden
KE-NRB-2013-02882,2013,50,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.2,low_burden
KE-NRB-2011-02883,2011,59,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,16.1,low_burden
KE-NRB-2018-02884,2018,50,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-02885,2011,53,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,28.7,low_burden
KE-NRB-2009-02886,2009,53,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-02887,2013,55,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,low_burden
KE-NRB-2013-02888,2013,62,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,5.3,low_burden
KE-NRB-2011-02889,2011,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-02890,2015,29,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,59.6,low_burden
KE-NRB-2015-02891,2015,48,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.3,low_burden
KE-NRB-2016-02892,2016,74,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,33.2,low_burden
KE-NRB-2011-02893,2011,49,45-54,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,low_burden
KE-NRB-2015-02894,2015,65,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,12.9,low_burden
KE-NRB-2018-02895,2018,62,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.2,low_burden
KE-NRB-2018-02896,2018,33,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.0,low_burden
KE-NRB-2017-02897,2017,40,35-44,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2014-02898,2014,51,45-54,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,7.0,low_burden
KE-NRB-2018-02899,2018,56,55-64,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2016-02900,2016,46,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-02901,2011,62,55-64,Female,Cervix uteri,Sarcoma,Unknown,Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,11.2,low_burden
KE-NRB-2013-02902,2013,71,65-74,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,15.7,low_burden
KE-NRB-2016-02903,2016,95,75+,Female,Ovary,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,9.1,low_burden
KE-NRB-2016-02904,2016,71,65-74,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.8,low_burden
KE-NRB-2018-02905,2018,53,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.2,low_burden
KE-NRB-2014-02906,2014,44,35-44,Female,Cervix uteri,Lymphoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-02907,2012,70,65-74,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,34.7,low_burden
KE-NRB-2009-02908,2009,50,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,18.1,low_burden
KE-NRB-2014-02909,2014,48,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2015-02910,2015,63,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.1,low_burden
KE-NRB-2015-02911,2015,53,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,12.2,low_burden
KE-NRB-2016-02912,2016,80,75+,Male,Oesophagus,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,39.4,low_burden
KE-NRB-2013-02913,2013,57,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,20.4,low_burden
KE-NRB-2012-02914,2012,51,45-54,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-02915,2018,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.8,low_burden
KE-NRB-2013-02916,2013,8,0-14,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.4,low_burden
KE-NRB-2013-02917,2013,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-02918,2015,57,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,31.0,low_burden
KE-NRB-2009-02919,2009,73,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.1,low_burden
KE-NRB-2010-02920,2010,69,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,29.5,low_burden
KE-NRB-2017-02921,2017,35,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,59.3,low_burden
KE-NRB-2018-02922,2018,69,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,22.9,low_burden
KE-NRB-2009-02923,2009,23,15-24,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.6,low_burden
KE-NRB-2015-02924,2015,57,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,44.4,low_burden
KE-NRB-2018-02925,2018,60,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.5,low_burden
KE-NRB-2014-02926,2014,27,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.5,low_burden
KE-NRB-2012-02927,2012,74,65-74,Male,Oesophagus,Lymphoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,55.2,low_burden
KE-NRB-2012-02928,2012,60,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,43.4,low_burden
KE-NRB-2018-02929,2018,25,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,25.8,low_burden
KE-NRB-2011-02930,2011,25,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2018-02931,2018,35,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2015-02932,2015,33,25-34,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.9,low_burden
KE-NRB-2016-02933,2016,63,55-64,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,52.0,low_burden
KE-NRB-2017-02934,2017,62,55-64,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.1,low_burden
KE-NRB-2010-02935,2010,63,55-64,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,11.6,low_burden
KE-NRB-2018-02936,2018,55,55-64,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,39.5,low_burden
KE-NRB-2017-02937,2017,48,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2018-02938,2018,70,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,3.6,low_burden
KE-NRB-2015-02939,2015,57,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.1,low_burden
KE-NRB-2014-02940,2014,34,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.9,low_burden
KE-NRB-2011-02941,2011,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-02942,2014,45,45-54,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,0.3,low_burden
KE-NRB-2018-02943,2018,40,35-44,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,44.5,low_burden
KE-NRB-2013-02944,2013,39,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,40.1,low_burden
KE-NRB-2014-02945,2014,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,58.8,low_burden
KE-NRB-2012-02946,2012,61,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,17.4,low_burden
KE-NRB-2018-02947,2018,24,15-24,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,25.5,low_burden
KE-NRB-2012-02948,2012,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2014-02949,2014,50,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,11.1,low_burden
KE-NRB-2012-02950,2012,40,35-44,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2015-02951,2015,39,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,low_burden
KE-NRB-2017-02952,2017,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Dead,10.8,low_burden
KE-NRB-2017-02953,2017,50,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.1,low_burden
KE-NRB-2013-02954,2013,44,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-02955,2010,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.5,low_burden
KE-NRB-2010-02956,2010,59,55-64,Male,Lung,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-02957,2013,37,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,28.1,low_burden
KE-NRB-2015-02958,2015,49,45-54,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,5.1,low_burden
KE-NRB-2018-02959,2018,20,15-24,Female,Ovary,Lymphoma,Unknown,Death certificate only,Malignant,Rural,Surgery only,Alive,6.3,low_burden
KE-NRB-2017-02960,2017,65,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,28.8,low_burden
KE-NRB-2018-02961,2018,48,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.1,low_burden
KE-NRB-2017-02962,2017,74,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.2,low_burden
KE-NRB-2018-02963,2018,63,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,59.4,low_burden
KE-NRB-2012-02964,2012,67,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,5.9,low_burden
KE-NRB-2014-02965,2014,59,55-64,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.9,low_burden
KE-NRB-2009-02966,2009,44,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2018-02967,2018,73,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-02968,2016,33,25-34,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,51.8,low_burden
KE-NRB-2011-02969,2011,57,55-64,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.0,low_burden
KE-NRB-2014-02970,2014,28,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,7.9,low_burden
KE-NRB-2014-02971,2014,25,25-34,Female,Breast,Unspecified,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,34.1,low_burden
KE-NRB-2017-02972,2017,65,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,48.4,low_burden
KE-NRB-2016-02973,2016,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.4,low_burden
KE-NRB-2018-02974,2018,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,1.5,low_burden
KE-NRB-2014-02975,2014,46,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.8,low_burden
KE-NRB-2018-02976,2018,80,75+,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,49.2,low_burden
KE-NRB-2015-02977,2015,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.5,low_burden
KE-NRB-2017-02978,2017,65,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.9,low_burden
KE-NRB-2017-02979,2017,31,25-34,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.4,low_burden
KE-NRB-2018-02980,2018,17,15-24,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.1,low_burden
KE-NRB-2012-02981,2012,51,45-54,Female,Corpus uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,32.5,low_burden
KE-NRB-2016-02982,2016,50,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,5.3,low_burden
KE-NRB-2016-02983,2016,25,25-34,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.4,low_burden
KE-NRB-2017-02984,2017,53,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.4,low_burden
KE-NRB-2015-02985,2015,33,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-02986,2011,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.5,low_burden
KE-NRB-2014-02987,2014,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.4,low_burden
KE-NRB-2009-02988,2009,73,65-74,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,1.0,low_burden
KE-NRB-2011-02989,2011,59,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,11.6,low_burden
KE-NRB-2016-02990,2016,25,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.1,low_burden
KE-NRB-2013-02991,2013,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,40.5,low_burden
KE-NRB-2014-02992,2014,2,0-14,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,0.9,low_burden
KE-NRB-2016-02993,2016,29,25-34,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,50.9,low_burden
KE-NRB-2017-02994,2017,75,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Palliative care only,Dead,25.4,low_burden
KE-NRB-2015-02995,2015,36,35-44,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,39.1,low_burden
KE-NRB-2016-02996,2016,61,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.5,low_burden
KE-NRB-2012-02997,2012,57,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2014-02998,2014,19,15-24,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,35.2,low_burden
KE-NRB-2015-02999,2015,62,55-64,Male,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Alive,32.9,low_burden
KE-NRB-2009-03000,2009,62,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,25.4,low_burden
KE-NRB-2018-03001,2018,87,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.2,low_burden
KE-NRB-2018-03002,2018,41,35-44,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03003,2012,74,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,17.1,low_burden
KE-NRB-2012-03004,2012,43,35-44,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-03005,2017,87,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.8,low_burden
KE-NRB-2015-03006,2015,92,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,9.5,low_burden
KE-NRB-2013-03007,2013,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,29.3,low_burden
KE-NRB-2016-03008,2016,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03009,2015,7,0-14,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.2,low_burden
KE-NRB-2018-03010,2018,27,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.8,low_burden
KE-NRB-2011-03011,2011,24,15-24,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,4.4,low_burden
KE-NRB-2018-03012,2018,73,65-74,Female,Breast,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,In situ,Peri-urban,N/A,Dead,11.2,low_burden
KE-NRB-2017-03013,2017,57,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-03014,2017,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-03015,2018,25,25-34,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.3,low_burden
KE-NRB-2009-03016,2009,40,35-44,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,6.5,low_burden
KE-NRB-2013-03017,2013,54,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,11.0,low_burden
KE-NRB-2015-03018,2015,62,55-64,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,44.2,low_burden
KE-NRB-2015-03019,2015,62,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2013-03020,2013,47,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03021,2012,39,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,4.0,low_burden
KE-NRB-2017-03022,2017,71,65-74,Male,Multiple myeloma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-03023,2016,51,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-03024,2012,33,25-34,Male,Stomach,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,low_burden
KE-NRB-2009-03025,2009,65,65-74,Female,Ovary,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03026,2014,39,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,43.0,low_burden
KE-NRB-2014-03027,2014,52,45-54,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-03028,2013,47,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,34.6,low_burden
KE-NRB-2015-03029,2015,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-03030,2015,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,52.3,low_burden
KE-NRB-2018-03031,2018,55,55-64,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03032,2018,35,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,58.4,low_burden
KE-NRB-2018-03033,2018,66,65-74,Male,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2015-03034,2015,39,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.2,low_burden
KE-NRB-2016-03035,2016,70,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,21.5,low_burden
KE-NRB-2016-03036,2016,26,25-34,Male,Stomach,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,low_burden
KE-NRB-2015-03037,2015,54,45-54,Male,Prostate,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.5,low_burden
KE-NRB-2010-03038,2010,23,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-03039,2010,60,55-64,Male,Non-Hodgkin lymphoma,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-03040,2018,88,75+,Male,Skin (melanoma),Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,11.2,low_burden
KE-NRB-2018-03041,2018,63,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,33.9,low_burden
KE-NRB-2017-03042,2017,45,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.3,low_burden
KE-NRB-2009-03043,2009,48,45-54,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,7.3,low_burden
KE-NRB-2014-03044,2014,42,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-03045,2010,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,26.6,low_burden
KE-NRB-2017-03046,2017,33,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Alive,24.6,low_burden
KE-NRB-2011-03047,2011,39,35-44,Male,Pancreas,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,4.9,low_burden
KE-NRB-2017-03048,2017,62,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,60.0,low_burden
KE-NRB-2016-03049,2016,38,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Peri-urban,N/A,Dead,31.1,low_burden
KE-NRB-2016-03050,2016,69,65-74,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.7,low_burden
KE-NRB-2018-03051,2018,62,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,11.2,low_burden
KE-NRB-2013-03052,2013,92,75+,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,28.9,low_burden
KE-NRB-2017-03053,2017,51,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,3.9,low_burden
KE-NRB-2018-03054,2018,55,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,12.3,low_burden
KE-NRB-2016-03055,2016,89,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-03056,2017,49,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,2.4,low_burden
KE-NRB-2017-03057,2017,62,55-64,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.1,low_burden
KE-NRB-2017-03058,2017,72,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-03059,2011,70,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,47.3,low_burden
KE-NRB-2016-03060,2016,80,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.5,low_burden
KE-NRB-2016-03061,2016,53,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,18.1,low_burden
KE-NRB-2010-03062,2010,65,65-74,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.2,low_burden
KE-NRB-2017-03063,2017,66,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,46.1,low_burden
KE-NRB-2013-03064,2013,44,35-44,Male,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.9,low_burden
KE-NRB-2017-03065,2017,54,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.5,low_burden
KE-NRB-2015-03066,2015,50,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,20.3,low_burden
KE-NRB-2013-03067,2013,28,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Alive,21.4,low_burden
KE-NRB-2013-03068,2013,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-03069,2017,48,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,low_burden
KE-NRB-2011-03070,2011,64,55-64,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.7,low_burden
KE-NRB-2017-03071,2017,40,35-44,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,34.7,low_burden
KE-NRB-2017-03072,2017,71,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.9,low_burden
KE-NRB-2017-03073,2017,18,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.9,low_burden
KE-NRB-2017-03074,2017,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,25.6,low_burden
KE-NRB-2016-03075,2016,48,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Alive,41.5,low_burden
KE-NRB-2012-03076,2012,71,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2016-03077,2016,52,45-54,Male,Oesophagus,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.5,low_burden
KE-NRB-2014-03078,2014,83,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-03079,2011,73,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,40.2,low_burden
KE-NRB-2014-03080,2014,73,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,32.7,low_burden
KE-NRB-2011-03081,2011,55,55-64,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,43.1,low_burden
KE-NRB-2016-03082,2016,68,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,29.2,low_burden
KE-NRB-2017-03083,2017,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,51.3,low_burden
KE-NRB-2012-03084,2012,28,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.2,low_burden
KE-NRB-2017-03085,2017,28,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,60.0,low_burden
KE-NRB-2009-03086,2009,55,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03087,2012,50,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,24.0,low_burden
KE-NRB-2014-03088,2014,47,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2013-03089,2013,53,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.1,low_burden
KE-NRB-2015-03090,2015,72,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,low_burden
KE-NRB-2017-03091,2017,59,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Lost to follow-up,18.5,low_burden
KE-NRB-2009-03092,2009,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.1,low_burden
KE-NRB-2014-03093,2014,50,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.2,low_burden
KE-NRB-2012-03094,2012,8,0-14,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,27.2,low_burden
KE-NRB-2011-03095,2011,63,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,40.9,low_burden
KE-NRB-2015-03096,2015,1,0-14,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,16.8,low_burden
KE-NRB-2017-03097,2017,49,45-54,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.0,low_burden
KE-NRB-2009-03098,2009,68,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,32.5,low_burden
KE-NRB-2016-03099,2016,63,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-03100,2017,33,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,46.1,low_burden
KE-NRB-2015-03101,2015,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.1,low_burden
KE-NRB-2011-03102,2011,48,45-54,Male,Kidney,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,22.4,low_burden
KE-NRB-2013-03103,2013,28,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.8,low_burden
KE-NRB-2009-03104,2009,70,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,1.5,low_burden
KE-NRB-2018-03105,2018,39,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,50.3,low_burden
KE-NRB-2013-03106,2013,35,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-03107,2018,45,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.2,low_burden
KE-NRB-2012-03108,2012,36,35-44,Male,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-03109,2009,60,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-03110,2012,26,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2013-03111,2013,49,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03112,2018,52,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,7.9,low_burden
KE-NRB-2017-03113,2017,63,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,5.3,low_burden
KE-NRB-2014-03114,2014,53,45-54,Female,Ovary,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,7.2,low_burden
KE-NRB-2011-03115,2011,36,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,18.0,low_burden
KE-NRB-2017-03116,2017,31,25-34,Male,Pancreas,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,16.0,low_burden
KE-NRB-2017-03117,2017,71,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03118,2012,44,35-44,Male,Liver,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,34.1,low_burden
KE-NRB-2017-03119,2017,87,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,18.6,low_burden
KE-NRB-2015-03120,2015,73,65-74,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.2,low_burden
KE-NRB-2017-03121,2017,32,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,23.8,low_burden
KE-NRB-2011-03122,2011,39,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,9.3,low_burden
KE-NRB-2009-03123,2009,56,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,13.3,low_burden
KE-NRB-2013-03124,2013,59,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,14.7,low_burden
KE-NRB-2014-03125,2014,50,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,4.7,low_burden
KE-NRB-2014-03126,2014,67,65-74,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,52.8,low_burden
KE-NRB-2014-03127,2014,82,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-03128,2015,49,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-03129,2010,40,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-03130,2018,73,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-03131,2012,44,35-44,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Alive,25.3,low_burden
KE-NRB-2012-03132,2012,46,45-54,Female,Other,Other specified,Unknown,Imaging + clinical,Malignant,Rural,Surgery only,Dead,2.9,low_burden
KE-NRB-2013-03133,2013,75,75+,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,40.7,low_burden
KE-NRB-2012-03134,2012,48,45-54,Female,Other,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Radiotherapy only,Dead,12.3,low_burden
KE-NRB-2015-03135,2015,58,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Dead,15.4,low_burden
KE-NRB-2013-03136,2013,64,55-64,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,3.0,low_burden
KE-NRB-2013-03137,2013,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Lost to follow-up,25.3,low_burden
KE-NRB-2017-03138,2017,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.4,low_burden
KE-NRB-2018-03139,2018,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2015-03140,2015,26,25-34,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,47.0,low_burden
KE-NRB-2017-03141,2017,2,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,18.3,low_burden
KE-NRB-2010-03142,2010,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.1,low_burden
KE-NRB-2012-03143,2012,70,65-74,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.2,low_burden
KE-NRB-2015-03144,2015,63,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.9,low_burden
KE-NRB-2018-03145,2018,50,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,40.9,low_burden
KE-NRB-2015-03146,2015,55,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.4,low_burden
KE-NRB-2010-03147,2010,72,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2013-03148,2013,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,4.2,low_burden
KE-NRB-2015-03149,2015,82,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.1,low_burden
KE-NRB-2015-03150,2015,68,65-74,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.0,low_burden
KE-NRB-2014-03151,2014,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-03152,2018,55,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-03153,2009,65,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,25.1,low_burden
KE-NRB-2018-03154,2018,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,1.7,low_burden
KE-NRB-2017-03155,2017,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2012-03156,2012,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.3,low_burden
KE-NRB-2017-03157,2017,57,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.8,low_burden
KE-NRB-2012-03158,2012,58,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,34.7,low_burden
KE-NRB-2016-03159,2016,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,9.4,low_burden
KE-NRB-2017-03160,2017,43,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,9.1,low_burden
KE-NRB-2017-03161,2017,60,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,8.4,low_burden
KE-NRB-2009-03162,2009,37,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,29.7,low_burden
KE-NRB-2015-03163,2015,55,55-64,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03164,2018,22,15-24,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,55.4,low_burden
KE-NRB-2017-03165,2017,40,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,58.5,low_burden
KE-NRB-2011-03166,2011,61,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.4,low_burden
KE-NRB-2014-03167,2014,71,65-74,Female,Cervix uteri,Lymphoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,13.3,low_burden
KE-NRB-2018-03168,2018,47,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,low_burden
KE-NRB-2011-03169,2011,48,45-54,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,51.9,low_burden
KE-NRB-2014-03170,2014,45,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-03171,2018,77,75+,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.5,low_burden
KE-NRB-2016-03172,2016,31,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.0,low_burden
KE-NRB-2009-03173,2009,53,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Clinical only,In situ,Urban,N/A,Alive,11.4,low_burden
KE-NRB-2015-03174,2015,62,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,33.4,low_burden
KE-NRB-2014-03175,2014,47,45-54,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,9.5,low_burden
KE-NRB-2016-03176,2016,35,35-44,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,54.5,low_burden
KE-NRB-2014-03177,2014,70,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,21.9,low_burden
KE-NRB-2011-03178,2011,24,15-24,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03179,2017,91,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,20.4,low_burden
KE-NRB-2014-03180,2014,46,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.9,low_burden
KE-NRB-2017-03181,2017,50,45-54,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.0,low_burden
KE-NRB-2014-03182,2014,67,65-74,Female,Thyroid,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,low_burden
KE-NRB-2013-03183,2013,36,35-44,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,39.6,low_burden
KE-NRB-2017-03184,2017,65,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,30.2,low_burden
KE-NRB-2010-03185,2010,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.8,low_burden
KE-NRB-2015-03186,2015,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,23.3,low_burden
KE-NRB-2015-03187,2015,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,34.7,low_burden
KE-NRB-2011-03188,2011,35,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,11.6,low_burden
KE-NRB-2013-03189,2013,85,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,26.0,low_burden
KE-NRB-2011-03190,2011,72,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.0,low_burden
KE-NRB-2017-03191,2017,61,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.1,low_burden
KE-NRB-2011-03192,2011,46,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,34.8,low_burden
KE-NRB-2013-03193,2013,58,55-64,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,49.1,low_burden
KE-NRB-2009-03194,2009,70,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,10.5,low_burden
KE-NRB-2017-03195,2017,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.5,low_burden
KE-NRB-2017-03196,2017,56,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,31.2,low_burden
KE-NRB-2014-03197,2014,52,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,11.9,low_burden
KE-NRB-2011-03198,2011,74,65-74,Female,Ovary,Adenocarcinoma,Unknown,Other,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03199,2012,70,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,14.1,low_burden
KE-NRB-2017-03200,2017,28,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,9.6,low_burden
KE-NRB-2015-03201,2015,57,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03202,2017,47,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2012-03203,2012,42,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,10.0,low_burden
KE-NRB-2013-03204,2013,60,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-03205,2013,90,75+,Female,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,6.2,low_burden
KE-NRB-2015-03206,2015,85,75+,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,60.0,low_burden
KE-NRB-2017-03207,2017,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,2.1,low_burden
KE-NRB-2017-03208,2017,90,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,17.3,low_burden
KE-NRB-2014-03209,2014,62,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-03210,2013,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.4,low_burden
KE-NRB-2018-03211,2018,25,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.6,low_burden
KE-NRB-2014-03212,2014,38,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.7,low_burden
KE-NRB-2018-03213,2018,67,65-74,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.4,low_burden
KE-NRB-2013-03214,2013,54,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,2.2,low_burden
KE-NRB-2018-03215,2018,52,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,2.7,low_burden
KE-NRB-2016-03216,2016,44,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.2,low_burden
KE-NRB-2011-03217,2011,47,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.8,low_burden
KE-NRB-2011-03218,2011,62,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2011-03219,2011,42,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,43.3,low_burden
KE-NRB-2013-03220,2013,58,55-64,Male,Oesophagus,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,14.5,low_burden
KE-NRB-2015-03221,2015,42,35-44,Male,Leukemia,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,17.5,low_burden
KE-NRB-2016-03222,2016,51,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Palliative care only,Dead,58.2,low_burden
KE-NRB-2017-03223,2017,62,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-03224,2011,48,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,11.9,low_burden
KE-NRB-2018-03225,2018,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.8,low_burden
KE-NRB-2012-03226,2012,91,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03227,2016,47,45-54,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,16.6,low_burden
KE-NRB-2016-03228,2016,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,5.6,low_burden
KE-NRB-2018-03229,2018,52,45-54,Male,Skin (melanoma),Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.8,low_burden
KE-NRB-2011-03230,2011,57,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,No treatment,Dead,15.1,low_burden
KE-NRB-2016-03231,2016,26,25-34,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,58.4,low_burden
KE-NRB-2017-03232,2017,66,65-74,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.6,low_burden
KE-NRB-2013-03233,2013,80,75+,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,2.9,low_burden
KE-NRB-2013-03234,2013,80,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03235,2015,51,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-03236,2015,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.4,low_burden
KE-NRB-2012-03237,2012,28,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2016-03238,2016,50,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,16.0,low_burden
KE-NRB-2012-03239,2012,65,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2016-03240,2016,70,65-74,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,35.8,low_burden
KE-NRB-2013-03241,2013,68,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,22.4,low_burden
KE-NRB-2012-03242,2012,60,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.4,low_burden
KE-NRB-2016-03243,2016,38,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.6,low_burden
KE-NRB-2018-03244,2018,45,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,2.6,low_burden
KE-NRB-2014-03245,2014,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,8.2,low_burden
KE-NRB-2011-03246,2011,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.7,low_burden
KE-NRB-2014-03247,2014,62,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2013-03248,2013,36,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Chemotherapy only,Alive,1.1,low_burden
KE-NRB-2017-03249,2017,57,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,46.9,low_burden
KE-NRB-2018-03250,2018,94,75+,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.7,low_burden
KE-NRB-2017-03251,2017,29,25-34,Male,Bladder,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,52.2,low_burden
KE-NRB-2017-03252,2017,67,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,20.0,low_burden
KE-NRB-2016-03253,2016,28,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,23.4,low_burden
KE-NRB-2016-03254,2016,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.5,low_burden
KE-NRB-2010-03255,2010,41,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Alive,44.3,low_burden
KE-NRB-2012-03256,2012,67,65-74,Male,Bladder,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03257,2017,56,55-64,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,5.1,low_burden
KE-NRB-2017-03258,2017,56,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-03259,2010,75,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,17.8,low_burden
KE-NRB-2014-03260,2014,62,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.7,low_burden
KE-NRB-2018-03261,2018,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.4,low_burden
KE-NRB-2012-03262,2012,58,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,53.0,low_burden
KE-NRB-2014-03263,2014,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.2,low_burden
KE-NRB-2013-03264,2013,35,35-44,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.7,low_burden
KE-NRB-2016-03265,2016,26,25-34,Male,Bladder,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.6,low_burden
KE-NRB-2014-03266,2014,58,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,0.0,low_burden
KE-NRB-2018-03267,2018,39,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-03268,2017,63,55-64,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,29.9,low_burden
KE-NRB-2015-03269,2015,18,15-24,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-03270,2014,55,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.6,low_burden
KE-NRB-2016-03271,2016,68,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,15.5,low_burden
KE-NRB-2017-03272,2017,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2014-03273,2014,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,56.8,low_burden
KE-NRB-2016-03274,2016,64,55-64,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.3,low_burden
KE-NRB-2016-03275,2016,55,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,20.7,low_burden
KE-NRB-2017-03276,2017,52,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-03277,2018,76,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,14.6,low_burden
KE-NRB-2012-03278,2012,49,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03279,2015,17,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.2,low_burden
KE-NRB-2013-03280,2013,74,65-74,Female,Corpus uteri,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,11.6,low_burden
KE-NRB-2014-03281,2014,45,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,38.1,low_burden
KE-NRB-2018-03282,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-03283,2017,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03284,2018,32,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.9,low_burden
KE-NRB-2013-03285,2013,53,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemotherapy only,Alive,20.9,low_burden
KE-NRB-2014-03286,2014,41,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,7.0,low_burden
KE-NRB-2017-03287,2017,57,55-64,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,31.5,low_burden
KE-NRB-2010-03288,2010,68,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2011-03289,2011,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,16.4,low_burden
KE-NRB-2012-03290,2012,70,65-74,Male,Kaposi sarcoma,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,17.0,low_burden
KE-NRB-2012-03291,2012,52,45-54,Male,Lung,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-03292,2010,35,35-44,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.8,low_burden
KE-NRB-2018-03293,2018,39,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,36.8,low_burden
KE-NRB-2016-03294,2016,75,75+,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,41.6,low_burden
KE-NRB-2018-03295,2018,44,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.0,low_burden
KE-NRB-2014-03296,2014,73,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.9,low_burden
KE-NRB-2015-03297,2015,57,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2012-03298,2012,50,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.7,low_burden
KE-NRB-2016-03299,2016,22,15-24,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,27.5,low_burden
KE-NRB-2017-03300,2017,38,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.9,low_burden
KE-NRB-2014-03301,2014,53,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,5.7,low_burden
KE-NRB-2010-03302,2010,52,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,42.3,low_burden
KE-NRB-2013-03303,2013,44,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,31.1,low_burden
KE-NRB-2014-03304,2014,74,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,45.4,low_burden
KE-NRB-2011-03305,2011,84,75+,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,49.6,low_burden
KE-NRB-2018-03306,2018,26,25-34,Female,Other,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,31.5,low_burden
KE-NRB-2015-03307,2015,52,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,9.2,low_burden
KE-NRB-2018-03308,2018,67,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,30.6,low_burden
KE-NRB-2016-03309,2016,54,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.7,low_burden
KE-NRB-2010-03310,2010,83,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2014-03311,2014,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,11.1,low_burden
KE-NRB-2013-03312,2013,5,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,9.2,low_burden
KE-NRB-2015-03313,2015,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.8,low_burden
KE-NRB-2017-03314,2017,62,55-64,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,22.7,low_burden
KE-NRB-2009-03315,2009,32,25-34,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-03316,2016,58,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.7,low_burden
KE-NRB-2010-03317,2010,72,65-74,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.0,low_burden
KE-NRB-2012-03318,2012,45,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2016-03319,2016,71,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.1,low_burden
KE-NRB-2017-03320,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.7,low_burden
KE-NRB-2014-03321,2014,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,4.7,low_burden
KE-NRB-2011-03322,2011,49,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Palliative care only,Alive,60.0,low_burden
KE-NRB-2016-03323,2016,59,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,35.8,low_burden
KE-NRB-2017-03324,2017,51,45-54,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.8,low_burden
KE-NRB-2018-03325,2018,60,55-64,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,5.5,low_burden
KE-NRB-2013-03326,2013,32,25-34,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,26.3,low_burden
KE-NRB-2017-03327,2017,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.7,low_burden
KE-NRB-2017-03328,2017,45,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,34.1,low_burden
KE-NRB-2013-03329,2013,25,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.7,low_burden
KE-NRB-2009-03330,2009,31,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,26.5,low_burden
KE-NRB-2009-03331,2009,42,35-44,Male,Prostate,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,33.7,low_burden
KE-NRB-2015-03332,2015,68,65-74,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Palliative care only,Alive,3.4,low_burden
KE-NRB-2014-03333,2014,18,15-24,Male,Brain and CNS,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.4,low_burden
KE-NRB-2013-03334,2013,95,75+,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-03335,2011,15,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,6.9,low_burden
KE-NRB-2009-03336,2009,71,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,43.8,low_burden
KE-NRB-2016-03337,2016,48,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.4,low_burden
KE-NRB-2012-03338,2012,44,35-44,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03339,2012,80,75+,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.3,low_burden
KE-NRB-2013-03340,2013,65,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,19.0,low_burden
KE-NRB-2016-03341,2016,47,45-54,Male,Hodgkin lymphoma,Adenocarcinoma,Unknown,Imaging + clinical,In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03342,2014,18,15-24,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,54.7,low_burden
KE-NRB-2018-03343,2018,49,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery only,Dead,11.0,low_burden
KE-NRB-2018-03344,2018,28,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.7,low_burden
KE-NRB-2010-03345,2010,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,15.2,low_burden
KE-NRB-2015-03346,2015,48,45-54,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.1,low_burden
KE-NRB-2017-03347,2017,28,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,39.8,low_burden
KE-NRB-2016-03348,2016,43,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,21.8,low_burden
KE-NRB-2018-03349,2018,47,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,25.2,low_burden
KE-NRB-2017-03350,2017,53,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.5,low_burden
KE-NRB-2016-03351,2016,41,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,2.2,low_burden
KE-NRB-2016-03352,2016,48,45-54,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.0,low_burden
KE-NRB-2016-03353,2016,67,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,12.0,low_burden
KE-NRB-2010-03354,2010,22,15-24,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2009-03355,2009,57,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,58.3,low_burden
KE-NRB-2015-03356,2015,44,35-44,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Palliative care only,Alive,6.1,low_burden
KE-NRB-2017-03357,2017,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,26.2,low_burden
KE-NRB-2014-03358,2014,62,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,51.5,low_burden
KE-NRB-2015-03359,2015,72,65-74,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.2,low_burden
KE-NRB-2012-03360,2012,4,0-14,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,17.8,low_burden
KE-NRB-2009-03361,2009,54,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.4,low_burden
KE-NRB-2014-03362,2014,55,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,34.8,low_burden
KE-NRB-2015-03363,2015,34,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2017-03364,2017,51,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,3.9,low_burden
KE-NRB-2010-03365,2010,34,25-34,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03366,2014,49,45-54,Female,Thyroid,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.6,low_burden
KE-NRB-2015-03367,2015,64,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.6,low_burden
KE-NRB-2015-03368,2015,77,75+,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,22.1,low_burden
KE-NRB-2015-03369,2015,93,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,21.0,low_burden
KE-NRB-2011-03370,2011,46,45-54,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2011-03371,2011,49,45-54,Female,Breast,Adenocarcinoma,Unknown,Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-03372,2010,61,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,12.6,low_burden
KE-NRB-2016-03373,2016,83,75+,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.8,low_burden
KE-NRB-2016-03374,2016,51,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,51.3,low_burden
KE-NRB-2016-03375,2016,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,8.2,low_burden
KE-NRB-2017-03376,2017,55,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.2,low_burden
KE-NRB-2009-03377,2009,46,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,8.8,low_burden
KE-NRB-2014-03378,2014,41,35-44,Male,Skin (melanoma),Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,5.8,low_burden
KE-NRB-2014-03379,2014,90,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.4,low_burden
KE-NRB-2018-03380,2018,46,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.7,low_burden
KE-NRB-2011-03381,2011,69,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.2,low_burden
KE-NRB-2011-03382,2011,71,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,0.8,low_burden
KE-NRB-2013-03383,2013,32,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,1.1,low_burden
KE-NRB-2016-03384,2016,33,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,56.8,low_burden
KE-NRB-2014-03385,2014,64,55-64,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03386,2017,40,35-44,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,3.0,low_burden
KE-NRB-2017-03387,2017,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,33.1,low_burden
KE-NRB-2018-03388,2018,67,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.1,low_burden
KE-NRB-2016-03389,2016,71,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,51.7,low_burden
KE-NRB-2015-03390,2015,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,40.0,low_burden
KE-NRB-2018-03391,2018,45,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.4,low_burden
KE-NRB-2009-03392,2009,58,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,31.4,low_burden
KE-NRB-2012-03393,2012,60,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,10.7,low_burden
KE-NRB-2016-03394,2016,35,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.7,low_burden
KE-NRB-2009-03395,2009,70,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03396,2015,45,45-54,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.6,low_burden
KE-NRB-2015-03397,2015,77,75+,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.5,low_burden
KE-NRB-2011-03398,2011,59,55-64,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.5,low_burden
KE-NRB-2017-03399,2017,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,8.5,low_burden
KE-NRB-2009-03400,2009,73,65-74,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.3,low_burden
KE-NRB-2010-03401,2010,46,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.5,low_burden
KE-NRB-2016-03402,2016,13,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,31.3,low_burden
KE-NRB-2017-03403,2017,52,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.3,low_burden
KE-NRB-2015-03404,2015,16,15-24,Female,Ovary,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,16.3,low_burden
KE-NRB-2017-03405,2017,49,45-54,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,51.3,low_burden
KE-NRB-2016-03406,2016,42,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,19.3,low_burden
KE-NRB-2012-03407,2012,62,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.8,low_burden
KE-NRB-2013-03408,2013,65,65-74,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.2,low_burden
KE-NRB-2012-03409,2012,67,65-74,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,27.5,low_burden
KE-NRB-2012-03410,2012,91,75+,Male,Leukemia,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2013-03411,2013,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.3,low_burden
KE-NRB-2017-03412,2017,56,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,23.0,low_burden
KE-NRB-2018-03413,2018,13,0-14,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,3.1,low_burden
KE-NRB-2016-03414,2016,73,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-03415,2011,26,25-34,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.0,low_burden
KE-NRB-2018-03416,2018,71,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,5.4,low_burden
KE-NRB-2018-03417,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.3,low_burden
KE-NRB-2018-03418,2018,18,15-24,Male,Non-Hodgkin lymphoma,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,6.4,low_burden
KE-NRB-2010-03419,2010,60,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,2.6,low_burden
KE-NRB-2017-03420,2017,42,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.1,low_burden
KE-NRB-2010-03421,2010,57,55-64,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,22.3,low_burden
KE-NRB-2014-03422,2014,66,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,28.1,low_burden
KE-NRB-2015-03423,2015,26,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,17.4,low_burden
KE-NRB-2017-03424,2017,39,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.9,low_burden
KE-NRB-2018-03425,2018,50,45-54,Male,Other,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,39.1,low_burden
KE-NRB-2017-03426,2017,92,75+,Female,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,11.3,low_burden
KE-NRB-2011-03427,2011,54,45-54,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,17.5,low_burden
KE-NRB-2018-03428,2018,40,35-44,Female,Thyroid,Other specified,Unknown,Other,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-03429,2010,5,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2018-03430,2018,45,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.7,low_burden
KE-NRB-2011-03431,2011,92,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,39.1,low_burden
KE-NRB-2012-03432,2012,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.2,low_burden
KE-NRB-2009-03433,2009,32,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.8,low_burden
KE-NRB-2018-03434,2018,39,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2012-03435,2012,57,55-64,Female,Corpus uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,34.6,low_burden
KE-NRB-2013-03436,2013,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,15.0,low_burden
KE-NRB-2016-03437,2016,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-03438,2016,64,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,56.4,low_burden
KE-NRB-2016-03439,2016,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2014-03440,2014,20,15-24,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.2,low_burden
KE-NRB-2015-03441,2015,41,35-44,Female,Ovary,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,1.5,low_burden
KE-NRB-2011-03442,2011,66,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,14.5,low_burden
KE-NRB-2014-03443,2014,27,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2017-03444,2017,71,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,38.7,low_burden
KE-NRB-2016-03445,2016,31,25-34,Male,Stomach,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.5,low_burden
KE-NRB-2014-03446,2014,74,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,19.1,low_burden
KE-NRB-2018-03447,2018,28,25-34,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,9.6,low_burden
KE-NRB-2009-03448,2009,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,52.8,low_burden
KE-NRB-2017-03449,2017,66,65-74,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,7.8,low_burden
KE-NRB-2014-03450,2014,49,45-54,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.4,low_burden
KE-NRB-2013-03451,2013,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.4,low_burden
KE-NRB-2017-03452,2017,49,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,0.1,low_burden
KE-NRB-2018-03453,2018,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,27.4,low_burden
KE-NRB-2018-03454,2018,43,35-44,Male,Brain and CNS,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,0.9,low_burden
KE-NRB-2011-03455,2011,92,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,30.4,low_burden
KE-NRB-2018-03456,2018,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03457,2012,56,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.4,low_burden
KE-NRB-2018-03458,2018,49,45-54,Male,Pancreas,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.4,low_burden
KE-NRB-2012-03459,2012,28,25-34,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.3,low_burden
KE-NRB-2015-03460,2015,27,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,46.5,low_burden
KE-NRB-2017-03461,2017,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.5,low_burden
KE-NRB-2013-03462,2013,15,15-24,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,19.1,low_burden
KE-NRB-2011-03463,2011,70,65-74,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,48.9,low_burden
KE-NRB-2016-03464,2016,71,65-74,Female,Breast,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2014-03465,2014,55,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03466,2018,46,45-54,Male,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,28.5,low_burden
KE-NRB-2011-03467,2011,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,26.5,low_burden
KE-NRB-2013-03468,2013,44,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-03469,2010,51,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.3,low_burden
KE-NRB-2012-03470,2012,66,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.6,low_burden
KE-NRB-2009-03471,2009,68,65-74,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.6,low_burden
KE-NRB-2012-03472,2012,47,45-54,Female,Thyroid,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.7,low_burden
KE-NRB-2018-03473,2018,67,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-03474,2014,42,35-44,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,22.7,low_burden
KE-NRB-2011-03475,2011,58,55-64,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03476,2016,62,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,7.6,low_burden
KE-NRB-2010-03477,2010,72,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,48.7,low_burden
KE-NRB-2016-03478,2016,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2017-03479,2017,42,35-44,Male,Colorectum,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.9,low_burden
KE-NRB-2018-03480,2018,26,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-03481,2010,54,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,10.3,low_burden
KE-NRB-2015-03482,2015,44,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,3.5,low_burden
KE-NRB-2015-03483,2015,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,42.6,low_burden
KE-NRB-2013-03484,2013,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,28.4,low_burden
KE-NRB-2017-03485,2017,62,55-64,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.3,low_burden
KE-NRB-2013-03486,2013,71,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2014-03487,2014,48,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.2,low_burden
KE-NRB-2013-03488,2013,25,25-34,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.2,low_burden
KE-NRB-2016-03489,2016,61,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,27.8,low_burden
KE-NRB-2011-03490,2011,61,55-64,Male,Liver,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,9.3,low_burden
KE-NRB-2017-03491,2017,73,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.1,low_burden
KE-NRB-2015-03492,2015,86,75+,Female,Cervix uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,36.7,low_burden
KE-NRB-2012-03493,2012,73,65-74,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2014-03494,2014,35,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,36.2,low_burden
KE-NRB-2010-03495,2010,36,35-44,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,53.0,low_burden
KE-NRB-2015-03496,2015,86,75+,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2013-03497,2013,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,25.3,low_burden
KE-NRB-2014-03498,2014,25,25-34,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,15.8,low_burden
KE-NRB-2010-03499,2010,25,25-34,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,21.0,low_burden
KE-NRB-2018-03500,2018,72,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.6,low_burden
KE-NRB-2018-03501,2018,84,75+,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,9.5,low_burden
KE-NRB-2013-03502,2013,61,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2009-03503,2009,74,65-74,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.0,low_burden
KE-NRB-2010-03504,2010,82,75+,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.8,low_burden
KE-NRB-2015-03505,2015,0,0-14,Female,Other,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,36.5,low_burden
KE-NRB-2012-03506,2012,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,1.7,low_burden
KE-NRB-2014-03507,2014,33,25-34,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,19.5,low_burden
KE-NRB-2011-03508,2011,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2016-03509,2016,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Dead,4.5,low_burden
KE-NRB-2017-03510,2017,51,45-54,Male,Skin (melanoma),Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,25.1,low_burden
KE-NRB-2015-03511,2015,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.9,low_burden
KE-NRB-2014-03512,2014,48,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.0,low_burden
KE-NRB-2017-03513,2017,45,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,33.6,low_burden
KE-NRB-2017-03514,2017,78,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.9,low_burden
KE-NRB-2010-03515,2010,32,25-34,Male,Oesophagus,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,55.2,low_burden
KE-NRB-2015-03516,2015,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,45.2,low_burden
KE-NRB-2018-03517,2018,63,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.9,low_burden
KE-NRB-2015-03518,2015,71,65-74,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,6.4,low_burden
KE-NRB-2014-03519,2014,44,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.2,low_burden
KE-NRB-2012-03520,2012,45,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.0,low_burden
KE-NRB-2017-03521,2017,58,55-64,Male,Brain and CNS,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-03522,2013,68,65-74,Male,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Dead,6.5,low_burden
KE-NRB-2011-03523,2011,41,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,17.4,low_burden
KE-NRB-2012-03524,2012,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.5,low_burden
KE-NRB-2009-03525,2009,67,65-74,Male,Stomach,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,31.9,low_burden
KE-NRB-2016-03526,2016,20,15-24,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-03527,2015,33,25-34,Male,Brain and CNS,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.4,low_burden
KE-NRB-2014-03528,2014,52,45-54,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,5.4,low_burden
KE-NRB-2018-03529,2018,34,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03530,2017,48,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,17.7,low_burden
KE-NRB-2017-03531,2017,61,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,31.7,low_burden
KE-NRB-2015-03532,2015,30,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,25.4,low_burden
KE-NRB-2009-03533,2009,46,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,45.1,low_burden
KE-NRB-2012-03534,2012,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03535,2017,63,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,6.6,low_burden
KE-NRB-2010-03536,2010,64,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.6,low_burden
KE-NRB-2010-03537,2010,28,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2011-03538,2011,46,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.4,low_burden
KE-NRB-2015-03539,2015,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,52.4,low_burden
KE-NRB-2011-03540,2011,56,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2011-03541,2011,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,10.6,low_burden
KE-NRB-2014-03542,2014,2,0-14,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,7.9,low_burden
KE-NRB-2010-03543,2010,62,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,26.3,low_burden
KE-NRB-2012-03544,2012,47,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.1,low_burden
KE-NRB-2015-03545,2015,40,35-44,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,12.0,low_burden
KE-NRB-2016-03546,2016,36,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,10.7,low_burden
KE-NRB-2014-03547,2014,48,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,54.5,low_burden
KE-NRB-2014-03548,2014,5,0-14,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,15.3,low_burden
KE-NRB-2009-03549,2009,46,45-54,Male,Pancreas,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,52.3,low_burden
KE-NRB-2015-03550,2015,60,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.4,low_burden
KE-NRB-2016-03551,2016,46,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,13.5,low_burden
KE-NRB-2016-03552,2016,20,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2016-03553,2016,42,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,6.5,low_burden
KE-NRB-2015-03554,2015,16,15-24,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-03555,2016,48,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,34.0,low_burden
KE-NRB-2010-03556,2010,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,50.0,low_burden
KE-NRB-2011-03557,2011,76,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,58.0,low_burden
KE-NRB-2012-03558,2012,59,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,32.0,low_burden
KE-NRB-2018-03559,2018,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.1,low_burden
KE-NRB-2018-03560,2018,70,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,33.3,low_burden
KE-NRB-2011-03561,2011,54,45-54,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,44.3,low_burden
KE-NRB-2012-03562,2012,44,35-44,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.0,low_burden
KE-NRB-2017-03563,2017,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.6,low_burden
KE-NRB-2017-03564,2017,56,55-64,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,31.6,low_burden
KE-NRB-2009-03565,2009,52,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2010-03566,2010,62,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,0.7,low_burden
KE-NRB-2018-03567,2018,81,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.8,low_burden
KE-NRB-2013-03568,2013,34,25-34,Female,Thyroid,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.1,low_burden
KE-NRB-2016-03569,2016,17,15-24,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,46.9,low_burden
KE-NRB-2010-03570,2010,70,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,7.9,low_burden
KE-NRB-2011-03571,2011,37,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.0,low_burden
KE-NRB-2018-03572,2018,56,55-64,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.6,low_burden
KE-NRB-2015-03573,2015,60,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.5,low_burden
KE-NRB-2018-03574,2018,39,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.5,low_burden
KE-NRB-2014-03575,2014,72,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.4,low_burden
KE-NRB-2016-03576,2016,55,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2015-03577,2015,56,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,5.4,low_burden
KE-NRB-2014-03578,2014,33,25-34,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.6,low_burden
KE-NRB-2018-03579,2018,34,25-34,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,21.0,low_burden
KE-NRB-2016-03580,2016,69,65-74,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,4.8,low_burden
KE-NRB-2018-03581,2018,28,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,32.8,low_burden
KE-NRB-2010-03582,2010,73,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,23.7,low_burden
KE-NRB-2015-03583,2015,54,45-54,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,19.0,low_burden
KE-NRB-2010-03584,2010,40,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,27.0,low_burden
KE-NRB-2010-03585,2010,47,45-54,Male,Liver,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,11.9,low_burden
KE-NRB-2012-03586,2012,40,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03587,2016,48,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,24.0,low_burden
KE-NRB-2014-03588,2014,49,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.5,low_burden
KE-NRB-2016-03589,2016,26,25-34,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.9,low_burden
KE-NRB-2018-03590,2018,14,0-14,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,21.1,low_burden
KE-NRB-2016-03591,2016,54,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,39.3,low_burden
KE-NRB-2011-03592,2011,60,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,28.1,low_burden
KE-NRB-2009-03593,2009,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,17.2,low_burden
KE-NRB-2013-03594,2013,90,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.1,low_burden
KE-NRB-2012-03595,2012,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-03596,2018,67,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,1.3,low_burden
KE-NRB-2017-03597,2017,86,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,16.4,low_burden
KE-NRB-2013-03598,2013,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,48.5,low_burden
KE-NRB-2011-03599,2011,65,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,16.6,low_burden
KE-NRB-2018-03600,2018,55,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.6,low_burden
KE-NRB-2016-03601,2016,47,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,9.2,low_burden
KE-NRB-2014-03602,2014,67,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.3,low_burden
KE-NRB-2015-03603,2015,3,0-14,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2013-03604,2013,39,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,29.3,low_burden
KE-NRB-2018-03605,2018,57,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,10.4,low_burden
KE-NRB-2016-03606,2016,51,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.5,low_burden
KE-NRB-2014-03607,2014,77,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.0,low_burden
KE-NRB-2018-03608,2018,67,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,4.5,low_burden
KE-NRB-2016-03609,2016,32,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,low_burden
KE-NRB-2014-03610,2014,46,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.6,low_burden
KE-NRB-2018-03611,2018,95,75+,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,18.7,low_burden
KE-NRB-2018-03612,2018,42,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,22.5,low_burden
KE-NRB-2014-03613,2014,38,35-44,Female,Ovary,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2015-03614,2015,44,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,low_burden
KE-NRB-2010-03615,2010,80,75+,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03616,2012,40,35-44,Male,Kidney,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,7.0,low_burden
KE-NRB-2014-03617,2014,71,65-74,Female,Breast,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,7.4,low_burden
KE-NRB-2017-03618,2017,36,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.2,low_burden
KE-NRB-2018-03619,2018,41,35-44,Female,Thyroid,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,30.0,low_burden
KE-NRB-2017-03620,2017,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.0,low_burden
KE-NRB-2014-03621,2014,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,53.1,low_burden
KE-NRB-2016-03622,2016,61,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,No treatment,Dead,17.2,low_burden
KE-NRB-2015-03623,2015,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,29.9,low_burden
KE-NRB-2011-03624,2011,47,45-54,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.9,low_burden
KE-NRB-2018-03625,2018,56,55-64,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.1,low_burden
KE-NRB-2017-03626,2017,43,35-44,Male,Other,Leukemia,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,33.3,low_burden
KE-NRB-2017-03627,2017,85,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.8,low_burden
KE-NRB-2017-03628,2017,43,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,21.7,low_burden
KE-NRB-2014-03629,2014,35,35-44,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,26.2,low_burden
KE-NRB-2013-03630,2013,29,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-03631,2013,29,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,49.6,low_burden
KE-NRB-2013-03632,2013,18,15-24,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.8,low_burden
KE-NRB-2017-03633,2017,53,45-54,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,12.3,low_burden
KE-NRB-2015-03634,2015,43,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,11.2,low_burden
KE-NRB-2013-03635,2013,35,35-44,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.6,low_burden
KE-NRB-2017-03636,2017,42,35-44,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,10.0,low_burden
KE-NRB-2014-03637,2014,55,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,46.7,low_burden
KE-NRB-2010-03638,2010,69,65-74,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,31.9,low_burden
KE-NRB-2017-03639,2017,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-03640,2009,31,25-34,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,8.7,low_burden
KE-NRB-2011-03641,2011,37,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,34.9,low_burden
KE-NRB-2009-03642,2009,70,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,50.4,low_burden
KE-NRB-2013-03643,2013,39,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2012-03644,2012,66,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,51.6,low_burden
KE-NRB-2014-03645,2014,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.8,low_burden
KE-NRB-2016-03646,2016,48,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.7,low_burden
KE-NRB-2014-03647,2014,26,25-34,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,10.8,low_burden
KE-NRB-2017-03648,2017,51,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,8.7,low_burden
KE-NRB-2015-03649,2015,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,39.2,low_burden
KE-NRB-2014-03650,2014,67,65-74,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.4,low_burden
KE-NRB-2016-03651,2016,73,65-74,Male,Lung,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.2,low_burden
KE-NRB-2014-03652,2014,27,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,low_burden
KE-NRB-2018-03653,2018,65,65-74,Male,Oesophagus,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,24.7,low_burden
KE-NRB-2013-03654,2013,56,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,11.3,low_burden
KE-NRB-2010-03655,2010,52,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,33.6,low_burden
KE-NRB-2010-03656,2010,69,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,No treatment,Alive,3.5,low_burden
KE-NRB-2013-03657,2013,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,1.5,low_burden
KE-NRB-2016-03658,2016,51,45-54,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-03659,2013,39,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,7.6,low_burden
KE-NRB-2015-03660,2015,70,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.8,low_burden
KE-NRB-2016-03661,2016,63,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.5,low_burden
KE-NRB-2013-03662,2013,72,65-74,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.5,low_burden
KE-NRB-2017-03663,2017,30,25-34,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.6,low_burden
KE-NRB-2018-03664,2018,19,15-24,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.7,low_burden
KE-NRB-2013-03665,2013,31,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,low_burden
KE-NRB-2014-03666,2014,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.3,low_burden
KE-NRB-2015-03667,2015,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.2,low_burden
KE-NRB-2016-03668,2016,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,low_burden
KE-NRB-2009-03669,2009,43,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,20.6,low_burden
KE-NRB-2009-03670,2009,27,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,0.4,low_burden
KE-NRB-2018-03671,2018,28,25-34,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,43.1,low_burden
KE-NRB-2013-03672,2013,30,25-34,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.9,low_burden
KE-NRB-2014-03673,2014,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.1,low_burden
KE-NRB-2016-03674,2016,64,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2016-03675,2016,35,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,31.6,low_burden
KE-NRB-2012-03676,2012,60,55-64,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2010-03677,2010,18,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2017-03678,2017,25,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,2.1,low_burden
KE-NRB-2018-03679,2018,55,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.7,low_burden
KE-NRB-2017-03680,2017,42,35-44,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.3,low_burden
KE-NRB-2010-03681,2010,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.5,low_burden
KE-NRB-2011-03682,2011,17,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,51.0,low_burden
KE-NRB-2009-03683,2009,65,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.5,low_burden
KE-NRB-2015-03684,2015,54,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,16.5,low_burden
KE-NRB-2016-03685,2016,67,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,28.0,low_burden
KE-NRB-2011-03686,2011,78,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-03687,2013,56,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.5,low_burden
KE-NRB-2011-03688,2011,54,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,18.0,low_burden
KE-NRB-2014-03689,2014,57,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,6.4,low_burden
KE-NRB-2015-03690,2015,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2013-03691,2013,53,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,37.0,low_burden
KE-NRB-2017-03692,2017,65,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.6,low_burden
KE-NRB-2012-03693,2012,60,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,51.8,low_burden
KE-NRB-2011-03694,2011,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,17.3,low_burden
KE-NRB-2015-03695,2015,72,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2014-03696,2014,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,32.1,low_burden
KE-NRB-2013-03697,2013,16,15-24,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,23.2,low_burden
KE-NRB-2010-03698,2010,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,23.8,low_burden
KE-NRB-2010-03699,2010,61,55-64,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.2,low_burden
KE-NRB-2012-03700,2012,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,5.2,low_burden
KE-NRB-2018-03701,2018,95,75+,Female,Cervix uteri,Unspecified,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,35.6,low_burden
KE-NRB-2010-03702,2010,50,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,18.5,low_burden
KE-NRB-2014-03703,2014,67,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.1,low_burden
KE-NRB-2018-03704,2018,57,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03705,2016,47,45-54,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.4,low_burden
KE-NRB-2011-03706,2011,69,65-74,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.6,low_burden
KE-NRB-2015-03707,2015,91,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,4.6,low_burden
KE-NRB-2014-03708,2014,87,75+,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Peri-urban,N/A,Alive,19.4,low_burden
KE-NRB-2015-03709,2015,40,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.2,low_burden
KE-NRB-2015-03710,2015,63,55-64,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2017-03711,2017,68,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.2,low_burden
KE-NRB-2013-03712,2013,35,35-44,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,37.9,low_burden
KE-NRB-2012-03713,2012,54,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.0,low_burden
KE-NRB-2018-03714,2018,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,12.5,low_burden
KE-NRB-2016-03715,2016,51,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,9.3,low_burden
KE-NRB-2015-03716,2015,33,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2012-03717,2012,10,0-14,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-03718,2011,57,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,33.5,low_burden
KE-NRB-2012-03719,2012,61,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.9,low_burden
KE-NRB-2012-03720,2012,66,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,1.6,low_burden
KE-NRB-2014-03721,2014,57,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,1.8,low_burden
KE-NRB-2013-03722,2013,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2009-03723,2009,68,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2011-03724,2011,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.9,low_burden
KE-NRB-2017-03725,2017,74,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,13.2,low_burden
KE-NRB-2018-03726,2018,57,55-64,Male,Colorectum,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.0,low_burden
KE-NRB-2011-03727,2011,39,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Dead,0.1,low_burden
KE-NRB-2012-03728,2012,95,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,60.0,low_burden
KE-NRB-2017-03729,2017,37,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,28.0,low_burden
KE-NRB-2012-03730,2012,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.1,low_burden
KE-NRB-2010-03731,2010,57,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,58.3,low_burden
KE-NRB-2014-03732,2014,73,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.5,low_burden
KE-NRB-2010-03733,2010,34,25-34,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,22.9,low_burden
KE-NRB-2011-03734,2011,68,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,23.1,low_burden
KE-NRB-2017-03735,2017,57,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,32.0,low_burden
KE-NRB-2018-03736,2018,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.4,low_burden
KE-NRB-2010-03737,2010,8,0-14,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Radiotherapy only,Dead,0.4,low_burden
KE-NRB-2014-03738,2014,74,65-74,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,16.2,low_burden
KE-NRB-2016-03739,2016,60,55-64,Male,Brain and CNS,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.1,low_burden
KE-NRB-2015-03740,2015,86,75+,Male,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,16.8,low_burden
KE-NRB-2016-03741,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.5,low_burden
KE-NRB-2013-03742,2013,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03743,2012,68,65-74,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,57.4,low_burden
KE-NRB-2009-03744,2009,38,35-44,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2011-03745,2011,48,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.1,low_burden
KE-NRB-2018-03746,2018,30,25-34,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,35.0,low_burden
KE-NRB-2017-03747,2017,54,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.9,low_burden
KE-NRB-2013-03748,2013,42,35-44,Male,Lung,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,19.1,low_burden
KE-NRB-2012-03749,2012,94,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2012-03750,2012,58,55-64,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.3,low_burden
KE-NRB-2014-03751,2014,45,45-54,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,33.1,low_burden
KE-NRB-2014-03752,2014,58,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2014-03753,2014,66,65-74,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.3,low_burden
KE-NRB-2016-03754,2016,42,35-44,Female,Other,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,50.3,low_burden
KE-NRB-2010-03755,2010,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03756,2014,22,15-24,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.0,low_burden
KE-NRB-2012-03757,2012,35,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,19.8,low_burden
KE-NRB-2012-03758,2012,35,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,41.2,low_burden
KE-NRB-2013-03759,2013,34,25-34,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Dead,54.9,low_burden
KE-NRB-2013-03760,2013,60,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.0,low_burden
KE-NRB-2016-03761,2016,53,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,11.9,low_burden
KE-NRB-2011-03762,2011,69,65-74,Male,Oesophagus,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Alive,14.5,low_burden
KE-NRB-2012-03763,2012,46,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2017-03764,2017,55,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,low_burden
KE-NRB-2017-03765,2017,62,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.8,low_burden
KE-NRB-2017-03766,2017,58,55-64,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,33.0,low_burden
KE-NRB-2009-03767,2009,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,27.8,low_burden
KE-NRB-2015-03768,2015,40,35-44,Male,Brain and CNS,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,10.4,low_burden
KE-NRB-2010-03769,2010,59,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.6,low_burden
KE-NRB-2014-03770,2014,55,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,27.8,low_burden
KE-NRB-2016-03771,2016,57,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,25.0,low_burden
KE-NRB-2014-03772,2014,69,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,9.4,low_burden
KE-NRB-2011-03773,2011,71,65-74,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.2,low_burden
KE-NRB-2009-03774,2009,41,35-44,Male,Stomach,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,7.8,low_burden
KE-NRB-2016-03775,2016,20,15-24,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.5,low_burden
KE-NRB-2009-03776,2009,31,25-34,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.6,low_burden
KE-NRB-2012-03777,2012,46,45-54,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,30.9,low_burden
KE-NRB-2014-03778,2014,72,65-74,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,15.1,low_burden
KE-NRB-2013-03779,2013,59,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.6,low_burden
KE-NRB-2017-03780,2017,59,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Death certificate only,In situ,Urban,N/A,Dead,4.9,low_burden
KE-NRB-2013-03781,2013,43,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.0,low_burden
KE-NRB-2016-03782,2016,59,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Palliative care only,Alive,58.0,low_burden
KE-NRB-2009-03783,2009,59,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.9,low_burden
KE-NRB-2009-03784,2009,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2013-03785,2013,72,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,5.5,low_burden
KE-NRB-2018-03786,2018,63,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.0,low_burden
KE-NRB-2013-03787,2013,40,35-44,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,9.0,low_burden
KE-NRB-2018-03788,2018,50,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,22.7,low_burden
KE-NRB-2013-03789,2013,36,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.2,low_burden
KE-NRB-2014-03790,2014,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,42.0,low_burden
KE-NRB-2013-03791,2013,68,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.7,low_burden
KE-NRB-2013-03792,2013,65,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,3.1,low_burden
KE-NRB-2017-03793,2017,63,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Rural,No treatment,Alive,17.9,low_burden
KE-NRB-2012-03794,2012,63,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,42.0,low_burden
KE-NRB-2011-03795,2011,39,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-03796,2015,71,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03797,2014,56,55-64,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,2.4,low_burden
KE-NRB-2017-03798,2017,36,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.4,low_burden
KE-NRB-2016-03799,2016,60,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,15.8,low_burden
KE-NRB-2015-03800,2015,24,15-24,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,57.0,low_burden
KE-NRB-2018-03801,2018,59,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03802,2016,34,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,24.8,low_burden
KE-NRB-2017-03803,2017,73,65-74,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,23.6,low_burden
KE-NRB-2016-03804,2016,59,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.9,low_burden
KE-NRB-2018-03805,2018,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.2,low_burden
KE-NRB-2018-03806,2018,58,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,23.6,low_burden
KE-NRB-2014-03807,2014,73,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,59.0,low_burden
KE-NRB-2011-03808,2011,55,55-64,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,21.0,low_burden
KE-NRB-2011-03809,2011,62,55-64,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.8,low_burden
KE-NRB-2014-03810,2014,56,55-64,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.1,low_burden
KE-NRB-2018-03811,2018,64,55-64,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03812,2012,53,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,42.2,low_burden
KE-NRB-2012-03813,2012,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2018-03814,2018,38,35-44,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.1,low_burden
KE-NRB-2016-03815,2016,32,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.4,low_burden
KE-NRB-2016-03816,2016,67,65-74,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Dead,5.4,low_burden
KE-NRB-2018-03817,2018,48,45-54,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,51.6,low_burden
KE-NRB-2009-03818,2009,55,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.1,low_burden
KE-NRB-2017-03819,2017,49,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,35.2,low_burden
KE-NRB-2014-03820,2014,61,55-64,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.3,low_burden
KE-NRB-2015-03821,2015,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,32.7,low_burden
KE-NRB-2017-03822,2017,42,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2017-03823,2017,74,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.7,low_burden
KE-NRB-2017-03824,2017,56,55-64,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2010-03825,2010,55,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.7,low_burden
KE-NRB-2017-03826,2017,74,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.9,low_burden
KE-NRB-2014-03827,2014,48,45-54,Female,Breast,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2017-03828,2017,65,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.0,low_burden
KE-NRB-2011-03829,2011,34,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03830,2015,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,5.5,low_burden
KE-NRB-2016-03831,2016,45,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,50.1,low_burden
KE-NRB-2012-03832,2012,44,35-44,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2009-03833,2009,37,35-44,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,28.9,low_burden
KE-NRB-2011-03834,2011,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.2,low_burden
KE-NRB-2017-03835,2017,82,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.4,low_burden
KE-NRB-2017-03836,2017,36,35-44,Male,Stomach,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,25.3,low_burden
KE-NRB-2014-03837,2014,59,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.5,low_burden
KE-NRB-2018-03838,2018,27,25-34,Female,Thyroid,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2018-03839,2018,35,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.5,low_burden
KE-NRB-2016-03840,2016,60,55-64,Male,Prostate,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,17.2,low_burden
KE-NRB-2009-03841,2009,32,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Benign/uncertain,Urban,N/A,Dead,7.8,low_burden
KE-NRB-2015-03842,2015,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,low_burden
KE-NRB-2009-03843,2009,67,65-74,Male,Leukemia,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,56.9,low_burden
KE-NRB-2018-03844,2018,73,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,23.6,low_burden
KE-NRB-2013-03845,2013,49,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,4.2,low_burden
KE-NRB-2015-03846,2015,56,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,13.8,low_burden
KE-NRB-2015-03847,2015,82,75+,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.1,low_burden
KE-NRB-2018-03848,2018,27,25-34,Male,Kaposi sarcoma,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,21.9,low_burden
KE-NRB-2011-03849,2011,29,25-34,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,26.8,low_burden
KE-NRB-2015-03850,2015,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2013-03851,2013,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2016-03852,2016,74,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,42.2,low_burden
KE-NRB-2016-03853,2016,56,55-64,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,8.6,low_burden
KE-NRB-2017-03854,2017,58,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2015-03855,2015,63,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,18.8,low_burden
KE-NRB-2014-03856,2014,45,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.6,low_burden
KE-NRB-2009-03857,2009,69,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,5.0,low_burden
KE-NRB-2011-03858,2011,95,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,9.1,low_burden
KE-NRB-2015-03859,2015,52,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.2,low_burden
KE-NRB-2016-03860,2016,33,25-34,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,low_burden
KE-NRB-2016-03861,2016,37,35-44,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,5.5,low_burden
KE-NRB-2009-03862,2009,33,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Rural,Surgery only,Alive,15.2,low_burden
KE-NRB-2018-03863,2018,65,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,33.7,low_burden
KE-NRB-2011-03864,2011,25,25-34,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.7,low_burden
KE-NRB-2015-03865,2015,62,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-03866,2015,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2009-03867,2009,61,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2013-03868,2013,43,35-44,Female,Ovary,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2015-03869,2015,34,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.0,low_burden
KE-NRB-2017-03870,2017,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,40.6,low_burden
KE-NRB-2013-03871,2013,58,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.3,low_burden
KE-NRB-2011-03872,2011,68,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,26.8,low_burden
KE-NRB-2013-03873,2013,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,low_burden
KE-NRB-2014-03874,2014,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2012-03875,2012,55,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,60.0,low_burden
KE-NRB-2013-03876,2013,73,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,20.8,low_burden
KE-NRB-2016-03877,2016,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,10.5,low_burden
KE-NRB-2014-03878,2014,65,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.4,low_burden
KE-NRB-2015-03879,2015,35,35-44,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,39.2,low_burden
KE-NRB-2012-03880,2012,48,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,50.2,low_burden
KE-NRB-2016-03881,2016,63,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,13.1,low_burden
KE-NRB-2013-03882,2013,28,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.2,low_burden
KE-NRB-2017-03883,2017,62,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2015-03884,2015,51,45-54,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2014-03885,2014,47,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.9,low_burden
KE-NRB-2010-03886,2010,48,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Alive,7.2,low_burden
KE-NRB-2018-03887,2018,70,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,21.8,low_burden
KE-NRB-2016-03888,2016,63,55-64,Male,Pancreas,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,25.5,low_burden
KE-NRB-2011-03889,2011,93,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2010-03890,2010,26,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.4,low_burden
KE-NRB-2010-03891,2010,22,15-24,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Dead,31.0,low_burden
KE-NRB-2011-03892,2011,74,65-74,Male,Bladder,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.6,low_burden
KE-NRB-2016-03893,2016,90,75+,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.3,low_burden
KE-NRB-2011-03894,2011,35,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,low_burden
KE-NRB-2016-03895,2016,52,45-54,Female,Ovary,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.1,low_burden
KE-NRB-2015-03896,2015,31,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,43.2,low_burden
KE-NRB-2010-03897,2010,48,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,19.0,low_burden
KE-NRB-2012-03898,2012,16,15-24,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,22.5,low_burden
KE-NRB-2017-03899,2017,48,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,8.5,low_burden
KE-NRB-2016-03900,2016,49,45-54,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2017-03901,2017,95,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.8,low_burden
KE-NRB-2018-03902,2018,74,65-74,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,low_burden
KE-NRB-2018-03903,2018,59,55-64,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,36.7,low_burden
KE-NRB-2016-03904,2016,56,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,16.5,low_burden
KE-NRB-2011-03905,2011,33,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,40.1,low_burden
KE-NRB-2017-03906,2017,49,45-54,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,34.3,low_burden
KE-NRB-2010-03907,2010,3,0-14,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,37.6,low_burden
KE-NRB-2014-03908,2014,89,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,20.5,low_burden
KE-NRB-2018-03909,2018,46,45-54,Male,Non-Hodgkin lymphoma,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.2,low_burden
KE-NRB-2017-03910,2017,79,75+,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,3.4,low_burden
KE-NRB-2013-03911,2013,50,45-54,Male,Liver,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.5,low_burden
KE-NRB-2013-03912,2013,46,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,29.0,low_burden
KE-NRB-2017-03913,2017,85,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.0,low_burden
KE-NRB-2016-03914,2016,81,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,21.3,low_burden
KE-NRB-2011-03915,2011,38,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,41.0,low_burden
KE-NRB-2013-03916,2013,27,25-34,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.5,low_burden
KE-NRB-2015-03917,2015,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,20.1,low_burden
KE-NRB-2017-03918,2017,67,65-74,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,29.6,low_burden
KE-NRB-2016-03919,2016,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.0,low_burden
KE-NRB-2010-03920,2010,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.5,low_burden
KE-NRB-2013-03921,2013,59,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.8,low_burden
KE-NRB-2014-03922,2014,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,26.7,low_burden
KE-NRB-2014-03923,2014,14,0-14,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,9.4,low_burden
KE-NRB-2018-03924,2018,52,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,7.5,low_burden
KE-NRB-2010-03925,2010,55,55-64,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,29.0,low_burden
KE-NRB-2016-03926,2016,55,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,30.5,low_burden
KE-NRB-2013-03927,2013,58,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,37.0,low_burden
KE-NRB-2014-03928,2014,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.5,low_burden
KE-NRB-2016-03929,2016,54,45-54,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,low_burden
KE-NRB-2015-03930,2015,73,65-74,Male,Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Alive,10.2,low_burden
KE-NRB-2018-03931,2018,35,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,26.5,low_burden
KE-NRB-2013-03932,2013,43,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2010-03933,2010,46,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,46.7,low_burden
KE-NRB-2015-03934,2015,66,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,25.2,low_burden
KE-NRB-2016-03935,2016,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.3,low_burden
KE-NRB-2012-03936,2012,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,27.1,low_burden
KE-NRB-2011-03937,2011,41,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,9.0,low_burden
KE-NRB-2015-03938,2015,45,45-54,Male,Leukemia,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,13.8,low_burden
KE-NRB-2017-03939,2017,60,55-64,Male,Kidney,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.8,low_burden
KE-NRB-2013-03940,2013,48,45-54,Male,Pancreas,Other specified,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2018-03941,2018,64,55-64,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.8,low_burden
KE-NRB-2015-03942,2015,62,55-64,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Palliative care only,Dead,10.1,low_burden
KE-NRB-2018-03943,2018,33,25-34,Male,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2012-03944,2012,58,55-64,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,20.3,low_burden
KE-NRB-2015-03945,2015,36,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,16.8,low_burden
KE-NRB-2017-03946,2017,54,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2016-03947,2016,34,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,low_burden
KE-NRB-2015-03948,2015,51,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.4,low_burden
KE-NRB-2018-03949,2018,35,35-44,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2014-03950,2014,55,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,low_burden
KE-NRB-2018-03951,2018,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Alive,48.2,low_burden
KE-NRB-2018-03952,2018,29,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.8,low_burden
KE-NRB-2013-03953,2013,35,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.6,low_burden
KE-NRB-2016-03954,2016,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,39.4,low_burden
KE-NRB-2017-03955,2017,24,15-24,Male,Stomach,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,19.7,low_burden
KE-NRB-2015-03956,2015,82,75+,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.5,low_burden
KE-NRB-2009-03957,2009,41,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,1.4,low_burden
KE-NRB-2012-03958,2012,74,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.3,low_burden
KE-NRB-2009-03959,2009,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,18.0,low_burden
KE-NRB-2014-03960,2014,23,15-24,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.1,low_burden
KE-NRB-2011-03961,2011,34,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.1,low_burden
KE-NRB-2015-03962,2015,92,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2009-03963,2009,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.3,low_burden
KE-NRB-2015-03964,2015,26,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,29.6,low_burden
KE-NRB-2010-03965,2010,20,15-24,Male,Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.7,low_burden
KE-NRB-2013-03966,2013,59,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,4.9,low_burden
KE-NRB-2016-03967,2016,31,25-34,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,52.4,low_burden
KE-NRB-2013-03968,2013,57,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,30.5,low_burden
KE-NRB-2018-03969,2018,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,low_burden
KE-NRB-2011-03970,2011,70,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Dead,9.1,low_burden
KE-NRB-2017-03971,2017,58,55-64,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Dead,4.4,low_burden
KE-NRB-2018-03972,2018,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,26.7,low_burden
KE-NRB-2017-03973,2017,52,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-03974,2013,27,25-34,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,34.7,low_burden
KE-NRB-2013-03975,2013,94,75+,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,31.7,low_burden
KE-NRB-2013-03976,2013,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.3,low_burden
KE-NRB-2016-03977,2016,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,60.0,low_burden
KE-NRB-2010-03978,2010,40,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,low_burden
KE-NRB-2013-03979,2013,37,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.0,low_burden
KE-NRB-2018-03980,2018,50,45-54,Male,Colorectum,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,low_burden
KE-NRB-2015-03981,2015,74,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,34.6,low_burden
KE-NRB-2011-03982,2011,35,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,3.5,low_burden
KE-NRB-2014-03983,2014,58,55-64,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.4,low_burden
KE-NRB-2014-03984,2014,22,15-24,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,56.5,low_burden
KE-NRB-2018-03985,2018,67,65-74,Male,Liver,Other specified,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,22.9,low_burden
KE-NRB-2012-03986,2012,52,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.0,low_burden
KE-NRB-2016-03987,2016,51,45-54,Male,Bladder,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,9.9,low_burden
KE-NRB-2018-03988,2018,49,45-54,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,23.0,low_burden
KE-NRB-2014-03989,2014,41,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Palliative care only,Lost to follow-up,60.0,low_burden
KE-NRB-2016-03990,2016,59,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,low_burden
KE-NRB-2014-03991,2014,41,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Dead,16.8,low_burden
KE-NRB-2015-03992,2015,30,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.1,low_burden
KE-NRB-2018-03993,2018,48,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,low_burden
KE-NRB-2013-03994,2013,94,75+,Female,Corpus uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,30.5,low_burden
KE-NRB-2011-03995,2011,80,75+,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Dead,23.0,low_burden
KE-NRB-2013-03996,2013,34,25-34,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.5,low_burden
KE-NRB-2012-03997,2012,58,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,22.3,low_burden
KE-NRB-2009-03998,2009,42,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.7,low_burden
KE-NRB-2014-03999,2014,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,20.3,low_burden
KE-NRB-2014-04000,2014,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,low_burden